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Scope of the work  
	  
The scope of my PhD thesis was to develop novel biomimetic nanomaterials with potential of use in 
innovative smart and personalized applications in medicine, with particular respect to bone tissue 
engineering. The relevance of this activity is in the need of bioactive, bioresorbable and smart nanomaterials, 
able to substantially activate, promote and sustain biologic processes yielding tissue regeneration. Nowadays 
this need is made extremely crucial by the steady ageing of the population and increase in the occurrence of 
bone diseases generating high disability and remarkable healthcare costs. Particularly, smart, stimuli-
responsive biocompatible materials are highly desired, as they can enable more effective and personalized 
therapies in nanomedicine. In this respect, the development of magnetically active materials is today raising 
substantial interest among scientists, as magnetic signalling is considered as minimally invasive mechanism 
for biomaterial activation that can open to a plethora of new applications in nanomedicine. 
Current limitations in this respect are in the achievement of biocompatible materials with factual cell-
instructive ability and magnetic properties for which the development of materials exhibiting high 
physicochemical and ultrastructural mimesis with natural tissues (i.e. biomimetic) are considered as an 
elective approach.  
In this respect the main concept at the basis of my research work was to apply a bio-inspired synthesis 
process (i.e. biomineralisation) to a recombinant collagen type I-like macromolecule, with the purpose to 
develop hybrid mineralised composites mimicking natural bone tissue. In particular, I directed the 
biomineralisation process to obtain the assembling of the organic macromolecule and simultaneous 
mineralization with nanocrystalline, iron-substituted hydroxyapatite where the precise positioning of iron 
ions conferred superparamagnetic properties to the final hybrid materials. Then, I settled an emulsification 
process to engineer the obtained materials into hybrid magnetic microspheres, which were extensively tested 
by means of their physicochemical, morphological, magnetic and biological properties.  
In particular, my thesis describes, after an introductory section illustrating the biomimetic approach to 
materials development, specific activities dedicated to material synthesis and testing, particularly to assess 
how physicochemical properties of the new microspheres affected the fate of specific cell lines relevant for 
bone regeneration such as pre-osteoblasts and human mesenchymal stem cells. Besides, the ability of the 
new devices to incorporate and release relevant growth factors by mediation of applied magnetic fields was 
investigated. 
As a general conclusion, the unique features exhibited by the new hybrid magnetic microspheres are 
interesting and promising for application as new smart biomaterials with ability of remote magnetic 
activation and control, which might be addressed to smart and personalized applications in medicine, 
particularly in bone tissue regeneration or smart drug delivery systems.  
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Chapter 1: Introduction 
1.1 Overview: Bone defects and current treatments  
Bone defects are among the main causes of reduced life quality due to trauma, diseases (e.g. cancer, 
osteoporosis-related fractures, congenital bone malformations), aging process, intense sport activity, obesity, 
or ions deficiency (e.g. leads to dysfunction and diseases in bone tissue, such as osteoporosis and 
osteomalacia). The natural process of bone repair is enough to regenerate in most of the bone fractures, 
although bone tissue can not handle with large size “critical” lesion (Boskey 2007; Ferreira et al. 2012; Perez 
et al. 2015; Wang et al. 2014; Fernandez-Yague et al. 2015). Every year in United States, about $2.5 billion 
of dollars in replacements of bone defects was expended, while with increasing of life expectance, until 
2020, an increase of costs in bone replacements was predicted (Amini et al. 2012).  
Autografts, allografts and xenografts were the first used therapeutic approaches in bone tissue replacement 
and still a major choice for surgeons. Prior to select the ideal graft, i.e. autografts (i.e. bone transplantation 
from one part to another part of the same body), allografts (i.e. bone transplantation from donor of the same 
species) and xenografts (i.e. from other species), bone disabilities, bone defect sizes, tissue viability, 
biomechanical properties, graft handling and costs are studied (Harvey et al. 2010; Oryan et al. 2014; 
Poinern et al. 2013; Shibuya & Jupiter 2015). Osteoinductivity and osteoconductivity are the main 
characteristics of allografts and xenografts, while autografts are defined as “gold standard” due to their 
osteoinductivity, osteoconductivity and osteogenic properties, relevant on bone healing, modelling and 
remodelling (Oryan et al. 2014). Moreover, various drawbacks, such as risk of rejection, infection, diseases 
transmission, pain, bone graft loss/resorption, lack of vascularisation, reduced availability and high cost were 
identified (Harvey et al. 2010; Oryan et al. 2014; Tang et al. 2016); thus new strategies have been designed 
and investigated. Bone substitutes based on calcium phosphate, bioactive glasses, polymers and composites 
were approved by Food and Drug Administration (FDA). The problems with bone grafts availability and 
donor site morbidity were supported, but still new achievements must be implemented, mainly on synthetic 
materials that closely mimic the structure and function of bone tissue and the production of scaffolds with 
suitable mechanical properties for regeneration of critical sized bone defects (Di Silvio 2007; Oryan et al. 
2014).  
Intensive efforts on development of smart materials were performed, with the perspective to present 
customised and efficient solutions for the recovery of tissue functionality. In respect to bone tissue 
regeneration, the challenge is to achieve effective therapies that helps on completely function recovery from 
diseased tissues without second surgery intervention (Tampieri et al. 2012). On the other hand, smart 
biomaterials can be engineered as systems for delivery of therapeutic substances directly on the target site, 
thus avoiding systemic administration. Progress in this respect can guarantee standardized performances (e.g. 
contrary to autologous or heterologous bone), as well as reduced adverse effects and improvement on 
osteoconductivity, osteoinductivity and osseointegration (Oryan et al. 2014; Tang et al. 2016).  
Tissue Engineering (TE) has been investigated as an innovative approach to develop biomimetic templates 
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for regeneration of bone tissue defects (Di Silvio 2007). In mid-1980s, Langer and Vacanti defined TE as 
“an emerging and multidisciplinary scientific area that applies principles of engineering and life sciences 
towards the development of biological substitutes that repair, restore or enhance tissue and organs 
functions”, by combining cells, biomaterials and biomolecular signals (e.g. growth factors or bone 
morphogenic proteins) (Minuth et al. 2006; Bártolo et al. 2011) and osteogenicity, osteoconductivity and 
osteoinductivity properties of biomaterials are improved (Oryan et al. 2014). On the other hand, suitable 
mechanical properties and appropriated degradation rate have been achieved on bone scaffold design, as well 
as easy-to-use in clinical practise (Di Silvio 2007; Panseri et al. 2013; Stevens 2008).  
Therefore, new strategy in tissue engineering is the use of magnetic nanoparticles, in particular 
superparamagnetic iron oxides (SPIONs), where their functionality is controlled by means of external 
magnetic fields. The introduction of superparamagnetic features in biomaterials is gaining high importance 
due to the possibility of stimulating cell activity, or to induce hyperthermia effects by applying magnetic 
field or simply by releasing relevant ions for osteoblasts proliferation and osteogenic activity. This approach 
can represent a new tool for boosting metabolic activity towards bone regeneration (Gil & Mano 2014; 
Tampieri et al. 2014; Meng et al. 2010).  
 
1.2 Bone tissue  
Bone is a dynamic tissue in constant remodelling to maintain the structural integrity of the skeleton and 
allowing the maintenance of bone volume, by cascade of phenomena including homeostasis of calcium and 
phosphorus metabolism, essential to the life (Engel et al. 2009). Therefore, bone is a porous tissue with 
complex hierarchical structure, from nanoscale to macroscale, mainly composed of calcium phosphate 
(Ca10(PO4)6(OH)2; 69-80wt.%), type I collagen (17-20wt.%), non-collagenous proteins (e.g. sialoprotein, 
osteonectin, osteopontin), growth factors, water and cells (Boskey 2007; Ferreira et al. 2012; Dorozhkin 
2011).  
Bone is organised in compact (pore size: 1-100 µm and porosity: 5-10 wt%) and spongy bone (pore size: 
200-400 µm and porosity: 75-95 wt%) and at the nanoscale level, non-stoichiometric carbonate 
hydroxyapatite nanocrystals (plate-shaped, 100-50 nm × 25 nm in size, 1.5–4 nm thick) are heterogeneously 
nucleated onto non-mineralised organic macromolecules (i.e. type I collagen, ~300 nm long, ~1.5 nm in 
diameter) with preferential orientation along the c axis and parallel to collagen fibrils and organised in a 
periodic, staggered array along the fibrils (Wang et al. 2014; Wegst et al. 2014; Saiz et al. 2013; Dorozhkin 
2011; Florencio-Silva et al. 2015). The self-assembly of the collagen fibrils and the formation of crystals of 
the mineral phase are phenomena governed by various control mechanisms activated by the same structure of 
the protein macromolecule thanks to specific conditions of pH and ion concentrations (Tampieri et al. 2011; 
Sprio et al. 2012; Perez et al. 2014) (Figure 1A).  
The mature skeleton of humans is supported through the equilibrated activity of the bone-forming osteoblasts 
and the bone-resorbing osteoclasts (Long 2011; Ferreira et al. 2012). In bone tissue various types of cells are 
presented, i.e. osteoblasts, bone lining cells, osteoclasts and osteocytes, as well as extracellular matrix 
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(ECM) (Engel et al. 2009). Osteoblasts result from mesenchymal progenitor (MPs) via preosteoblasts and 
control the mineralisation of extracellular collagen protein matrix. The subset of osteoblasts become 
osteocytes, mature bone cells embedded into the bone matrix, which are thought to control and direct the 
physiological bone turnover based on continuous formation and resorption of bone tissue, in response to 
damaging or to mechanical stimuli (bone remodelling). In the early stage of new bone formation, osteoblasts 
attachment, proliferation and differentiation are key phenomena for bone formation, by the production of 
matrix proteins, such as collagen type I, osteopontin, bone sialoprotein, osteonectin, osteocalcin, fibronectin 
and bone morphogenetic proteins (BMPs) prior to mineral deposition (Roveri & Iafisco 2010). Osteoclasts 
are multinucleated resorptive cells derived from bone marrow-derived macrophages, which are in turn 
progenies of haematopoietic stem cells (HSCs). Osteoclasts remove bone mineral and bone matrix in a 
process named as bone resorption, therefore bone-lining cells prevents osteoclasts interaction with bone 
matrix in dysfunctional situation, as well as it seems to be relevant in coupling bone resorption to bone 
formation (Figure 1B) (Florencio-Silva et al. 2015; Miller et al. 1989; Perez et al. 2015; Long 2011). 
 
 
Figure 1. A) Hierarchical structure of bone tissue and B) cells activity in bone tissue (Wegst et al. 2014; 
Long 2011).  
	  
Bone fracture healing occurs via direct intramembranous bone formation, if fractures are well stabilised (e.g. 
flat bones) or via endochondral bone formation, in the case of large defects, (e.g. long bones) and several 
molecular regulators are involved in both processes (e.g. indian hedgehog (Ihh), parathyroid hormone related 
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peptide (PTHrP), bone morphogenetic proteins (BMPs), vascular endothelial growth factor (VEGF) and 
fibroblastic growth factors (FGFs)) (Amini et al. 2012; Lienemann et al. 2012) (Figure 2). In endochondral 
bone formation, different stages (i.e. inflammation, soft callus formation, hard callus formation and 
remodelling) are involved and at the stabilisation of the fracture site mesenchymal progenitor cells 
differentiated into chondrocytes, to form cartilaginous template that is mineralized and replaced by bone 
tissue. Therefore, in intramembranous bone formation the differentiation of mesenchymal progenitor cells 
into osteoblasts and mineralized matrix without chondrogenic differentiation was formed. The as-produced 
de novo bone is remodelled into cortical or trabecular bone at later stages. (Amini et al. 2012; Lienemann et 
al. 2012; Poinern et al. 2013). 
 
 
Figure 2. Steps of bone fracture healing (Lienemann et al. 2012). 
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Bone hydroxyapatite is a non-stoichiometric phase presenting calcium and hydroxyl deficiency with various 
ion substitutions and vacancies, thus resulting in Ca/P molar ratios different from the stoichiometric 
hydroxyapatite (1.67) (Boskey 2007; Gomez-Morales et al. 2013). Various ions are presented in 
physiological environment and the low crystallinity is affected by the presence of those ions into 
hydroxyapatite lattice (e.g. CO32-, Na+, Mg2+, SiO44- and HPO42-) and the typical ion substitutions are: F- to 
Cl- or OH- position; carbonate for phosphate or OH- position, while Sr2+, Mg2+ and Na+ for Ca2+ position 
(Yang et al. 2008; Wang & Nancollas 2009; Fernandez-Yague et al. 2015; Tampieri et al. 2011). CO32- ions 
mainly substitute phosphate (B type position) and, in a lesser extent, OH- ions (A type position). Particularly, 
B-type substitution is typical of young and immature bone; indeed B-carbonation enhances structural 
disorder in the mineral phase lattice and consequently increases its chemical reactivity and ability to be 
remodelled. In young bone, high amount of CO32- ions in non-apatitic phase, more disordered domains is also 
presented, thus representing a reservoir of ions, which enhance the exchange with the extracellular matrix 
(Sprio et al. 2012; Tampieri et al. 2016). Nevertheless, the presence of ions in physiological conditions 
represented high importance on cells function, as well as, on bone healing and regeneration (Tampieri et al. 
2011; Perez et al. 2015). 
 
1.3 Biomimetic strategies applied on bone tissue engineering  
Various devices have been investigated to help in the regeneration of bone tissue, such as scaffolds, 
microspheres and nanoparticles (Bao et al. 2013). Bone scaffolds are proposed 3D templates to repair critical 
size bone defects, whereas microspheres and nanoparticles have been applied as drug delivery systems, bone 
cements, bone fillers, among others (Wang et al. 2011; Wu et al. 2011; Lee & Yun 2014). Nevertheless, 
biomimetic concept uses bottom-up methodologies to fabricate scaffolds with compositions and pore 
network similar to the native tissues, by creating a suitable and efficient template able to mimic the 
characteristics of natural extracellular matrix, including biodegradability and mechanical properties, as well 
as to provide an appropriate design able to instruct cells to adhere, proliferate, differentiate and neo tissue 
genesis (Ma 2008; Perez et al. 2015; Pérez et al. 2013). 
 
1.3.1 Scaffolds 
In bone tissue engineering, biological, physical and chemical mechanisms of bone tissue were investigated in 
order to improve the healing or regeneration mechanism (Wu et al. 2014; Cui et al. 2007). The main 
challenge is to produce a functional scaffold (e.g. by combining biomaterials with cells, growth factors, 
drugs) able to regulate the healing process and to provide biomechanical support, during the new tissue 
formation (Fernandez-Yague et al. 2015). Bone scaffolds should exhibit: (i) biocompatibility (i.e. non-
toxic); (ii) biodegradability (i.e. appropriated degradation rate with new tissue formation); (iii) wide open 
and interconnected porosity (with pore size ≥50µm) (i.e. suitable for high surface-to-volume ratio for cells 
interactions) but maintaining (iv) adequate mechanical properties; (v) osteoconductivity (i.e. induction of 
osteoblasts cells, to adhesion, growth and differentiation); (vi) osteoinductivity, as well as (vii) easy to 
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produce, sterilize and handle (Engel et al. 2009). Scaffolds porosity favors the tissue ingrowth by guiding 
cells to proliferate and differentiate, transport nutrients and integrate with the host bone, as well as controlled 
degradation rate with osteogenic activity (Ma 2008; Amini et al. 2012; Wu et al. 2014). Equilibrium on 
physiological, chemical and mechanical properties are key aspects for cell behaviour, thus providing an 
appropriate framework for bone tissue regeneration (Saiz et al. 2013; Wu et al. 2014; Gil & Mano 2014). 
Conventional and additive bio-manufacturing technologies were investigated to produce scaffolds with 
biocompatible biomaterials (e.g. polymers, ceramics, composites), with suitable porosity, pore 
interconnectivity and biomechanical properties (Bártolo et al. 2011; Amini et al. 2012). In conventional 
techniques (e.g. gas foaming, phase separation, freeze-drying) an improvement on scaffold porosity, 
heterogeneous pore shape and distribution were obtained by the use of porogens (Amini et al. 2012). 
Additionally, additive bio-fabrication was investigated to guarantee accurate, reproducible and customised 
scaffolds fabrication. Customised structures with defined size and porosity are created by computer-assisted 
design (CAD) software or acquired by DICOM data (e.g. from X-ray computed tomography) and printed by 
computer-assisted manufacturing (CAM). Tailored structures are 3D printed in a wide range of natural or 
synthetic biomaterials, while another interesting characteristic is to fabricate scaffold assembled with cells 
and signalling factors, thus creating more efficient scaffold, ready to be implanted (Bártolo et al. 2011). 
Poly lactic acid (PLA), poly glycolic acid (PGA), ε-polycaprolactone (PCL) are examples of synthetic 
biopolymers approved by FDA and used by a wide range of technology and proposed in bone tissue 
engineering (Stevens 2008; Woodruff et al. 2012; Patrício et al. 2014; Engel et al. 2009). Several 
investigations were carried out on development of biomimetic scaffolds with appropriate properties to 
enhance cell adhesion, growth, migration and differentiation. For example, PLA was chemically modified 
with RGD motif (i.e. arginine-glycine-aspartic acid) and cell interaction with biomaterial was improved (Ma 
2008). An alternative, is the use of natural derived polymers, such as collagen, glycosaminoglycans (GAGs), 
gelatin, as well as the use of drugs or growth factors, which enhances the cells activity.  
Biomimetic scaffolds based on calcium phosphates were investigated to regenerate bone tissue due to 
similarity with bone composition and by adding foreign ions into calcium phosphate; degradation rate was 
controlled; mechanical strength and biological response were enhanced, thus osteogenesis and 
neovascularization were improved and might be used in bone tissue applications (Wang et al. 2016; Bose & 
Tarafder 2012; Perez et al. 2015). 
Nevertheless, an improvement on physicochemical and biological properties of the scaffolds, in terms of 
porosity, mechanical properties, biodegradation and bioactivity was achieved by assembling microspheres or 
nanoparticles into the scaffold (Lee & Yun 2014).   
 
1.3.2 Nanoparticles /Microbeads 
Nano and microbeads were investigated as carriers of growth factors, drugs, biomolecules, among others 
(Solorio et al. 2013; Gu et al. 2013). The small size of nanoparticles yielding to specific biological entity or 
markers to be coupled at cellular (10 to 100µm), subcellular (20 to 250nm), protein (3 to 50 nm) or genetic 
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(10 to 100nm) scale (Wimpenny et al. 2012). On the other hand, nanoparticles offer the possibility to protect 
and carry the drug to a specific target. Poly-L-lysine, poly(d,l-lactide-co-glycolide) (PLGA), silica-based 
mesoporous, calcium phosphates are examples of materials used in nanoparticles production and proposed to 
be applied in various biomedical fields (Gu et al. 2013; Di Mauro et al. 2016). 
Microspheres are defined as particles with spherical shape with diameter from 1-1000 µm and are mainly 
produced by emulsification process (i.e. single or double), polymerization, photopolymerization, phase 
separation/coacervation, spray drying and solvent extraction (Oliveira & Mano 2011; Solorio et al. 2013). 
During the production of microspheres, pore interconnectivity, surface topography, surface chemistry or 
particle size can be tailored to improve the microspheres functionality (Oliveira & Mano 2011; Solorio et al. 
2013). Polymeric based microspheres are the most commonly used material as delivery of several growth 
factors, drugs and others (Oliveira & Mano 2011). Moreover, hybrid microspheres composed by 
collagen/hydroxyapatite, gelatin/hydroxyapatite, chitosan/hydroxyapatite, PLGA/hydroxyapatite have 
greatly showed their potential as growth factor encapsulation of basic fibroblast growth factor (bFGF) and 
bone morphogenic proteins. Gelatin/chitosan/hydroxyapatite microspheres presented high absorption and 
controled delivery of lysozyme and gelatin/hydroxyapatite microspheres was showed as a suitable carrier of 
human osteoblast-like Saos-2 cells (Lee & Yun 2014).  
 
1.3.3 Powerful properties of calcium phosphate and ions substitution  
To mimic bone tissue architecture, composition and to activate the bone regenerative cascade are the main 
challenges in bone tissue engineering. Hydroxyapatite (HAp) was investigated as a promising biomaterial to 
substitute damaged bone tissue, due to high biocompatibility, bioactivity, non-toxicity and osteoinductive 
properties with lack of any immune responses (Boanini et al. 2010; Sprio et al. 2012), as provided by its high 
similarity with the inorganic part of bone tissue. Wet chemical precipitation, sol-gel synthesis, co-
precipitation, hydrothermal synthesis, rapid or continuous precipitation from solution, thermal-decomplexing 
batch method, are some of the methodologies that have been successfully investigated for the production of 
synthetic hydroxyapatite (Vallet-Regi & Gonzalez-Calbet 2004; Dorozhkin 2009; Gomez-Morales et al. 
2013; Delgado-López et al. 2012). On the other hand, ion substitutions in anionic or cationic positions in the 
hydroxyapatite lattice strongly improve biomimetic, biological and mechanical properties (Boanini et al. 
2010; Sprio et al. 2012). Silicon (Si), strontium (Sr), magnesium (Mg), zinc (Zn) and iron (Fe) are relevant 
examples (Pon-On et al. 2013; Denry & Kuhn 2016). The use of magnesium doped apatite materials induces 
osteoblasts and osteoclasts activity, as well as enhanced bone metabolism. Biagini and co-workers showed 
that substituted HAp with magnesium enhances the solubility of the material at physiological pH, as well as 
improve adhesion, proliferation and metabolic activation of osteoblasts (Landi et al. 2006). The presence of 
silicon in calcium phosphates improves cartilage growth, osteoblasts cell activity, thus enhancing bone tissue 
remodelling and repair (Hing et al. 2006; Tampieri et al. 2012; Tampieri et al. 2016), while the presence of 
carbonate and strontium improves dissolution behaviour thus facilitating the implant resorption (Boer A., 
Urk H., Bouwstra J. 2012). Besides, mechanical performance was enhanced by the use of silicates (Vallet-
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Regi & Gonzalez-Calbet 2004). Silver and gallium were instead investigated as antibacterial regulator and in 
the treatment of bone cancer, respectively (Perez et al. 2015). 
 
1.3.4 Nature-inspired approaches  
Taking inspiration from nature or by using nature sources are an emerging approach to develop new 
innovative biomaterials (Stevens 2008; Wegst et al. 2014). Alginate and chitin are two examples of materials 
that are extracted from nature sources, algae and crustaceans exoskeletons, respectively. Marine coral from 
porites species (Polo-Corrales et al. 2014; Nandi et al. 2015) sea urchins or wood (e.g. rattan, bamboo, palm) 
are natural sources with interesting properties, e.g. pore size, interconnected pores and high mechanical 
performance (Wegst et al. 2014). Moreover, by using chemical and physical processes, marine coral and 
wood can be transformed into suitable bone-like materials. For example, rattan wood showed promising 
properties to be transformed into biomimetic scaffold for load-bearing bones, due to their similarity with 
bone morphology (e.g. system of channel-like pores interconnected with smaller channels), presenting 85% 
of porosity and porous diameter around 240 µm. In vitro and in vivo tests showed MG63 osteoblasts-like 
cells viability with bone formation into scaffold channels and no inflammatory response after implantation 
into adult New Zealand White disease-free rabbits was observed (Sprio et al. 2010; Sprio et al. 2012). 
 
1.3.4.1 Biomineralisation Process  
The development of innovative and biomimetic biomaterials has been steadily increased. Particular focus is 
addressed to biomineralisation process, that is defined as a complex cascade of phenomena used by natural 
organisms to develop hybrid nano-structured materials, that works as endoskeleton (in mammals), 
exoskeleton (in insects and crustaceans), protective shell (in molluscs), and masticatory systems (i.e., the 
teeth in vertebrates) (B.- Sprio; et al. 2016; Skinner & Ehrlich 2014) 
The formation of bone tissue is an example of biomineralisation process in humans; its translation to 
laboratory was pursued to develop innovative biomaterials with tailored chemical composition, 
nano/microstructure and architecture, in order to provide key signalling to cells for activation of the 
regenerative cascade (Wegst et al. 2014). Various investigations on in vitro mineralisation were carried out 
with non-collagenous proteins and collagen. For example, hydroxyapatite nucleation on polypeptides was 
improved by hydrophobic alkyl tails covalently bonded to thick hydrophilic peptide head groups with 
phosphorylated serine, while bone cells adhesion and chemotactic response was improved by adding RGD 
motifs to the biomaterials (Hartgerink et al. 2001; Stevens & George 2005; Tan et al. 2009). On the other 
hand, an innovative in lab synthesis was optimised to develop bone-like materials made of collagen type I 
mineralized with hydroxyapatite nanocrystals and was denominated as Biomineralisation process. Acidic 
natural type I collagen in form of nanofibrils was mineralised with hydroxyapatite nanocrystals by mediation 
of neutralisation process, while the content of additional ions (e.g. Mg2+, Sr2+) can be tailored. Therefore, the 
crystallization degree of hydroxyapatite nanocrystals can be controlled by the presence of foreign ions into 
HAp lattice (e.g. Mg2+) (Ramírez-Rodríguez et al. 2016; Tampieri et al. 2016). During the biomineralisation 
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process, carbonate ions might occupy the phosphate site of hydroxyapatite lattice (B type position) and can 
be beneficial for cell adhesion and development of new bone tissue (Kon, Delcogliano, et al. 2010; Tampieri 
et al. 2011; Sprio et al. 2012). The presence of specific functional groups on collagen surface induces the 
crystal size and the specific orientation of apatite nuclei in respect to the collagen fibrils, thus bone-like 
properties in HAp/collagen hybrid composites were obtained. Scaffold composed of HAp/collagen 
composites with good interconnected porosity and adequate pore size was achieved by tailoring the freeze-
drying process and biomechanical properties were stabilised by crosslinking methods (B.- Sprio; et al. 2016).  
Biomineralisation process can be considered as a new approach for the development of biomimetic 
biomaterials with outstanding properties; in particular, by varying the mineralisation extent, graded scaffolds 
for osteochondral applications or periodontal regions can be developed. By applying the as-mentioned 
methodology, a new bio-device with biomimetic properties was developed and investigated for 
osteochondral regeneration, named as MaioRegen (Finceramica, Italy). MaioRegen is a scaffold composed 
of 3 different layers and mimics the different zones of osteochondral region (i.e. cartilaginous tissue, tide-
mark and subchondral bone structure). The potentiality of MaioRegen was proved by clinical studies, with 
progressive regeneration of osteo-cartilagineous defects (Finceramica, Italy) (A.- Sprio; et al. 2016).  
An innovative biomaterial without animal sources and composed by recombinant peptide based on human 
collagen type I (RCP) and enriched with RGD motif is commercially available as Cellnest® (Fujifilm 
Manufacturing Europe B.V. (The Netherlands)). Herein, the biomineralisation process was applied to 
produce RCP mineralized with iron doped hydroxyapatite (Fe-HA) and new devices with potentiality and 
outstanding properties for bone tissue applications were developed.  
 
1.4 Smart strategies for advanced bone regenerative therapies  
Smart biomaterials were designed to be sensitive and to deliver drugs in spatial, temporal and in dosage-
controlled fashions. Drug release devices can be controlled by temperature, magnetic field, ultrasound 
intensity, light, electric pulses or by pH changing, enzyme concentration and / or redox gradients (Mura et al. 
2013). The most common stimuli systems in on demand drug delivery are pH and temperature, (e.g. drug is 
released by stimulus from surrounding implantation environment) (Costa 2015).  
For example, micro and nanoparticles can be labelled with drugs and introduced in a thermosensitive 
hydrogel composed of chitosan and β-glycerophosphate (Pérez et al. 2013; Zhu et al. 2015; Anil et al. 2015), 
while chemically modified gelatin microparticles were used as a pH-sensitive device (Pérez et al. 2013). On 
the other hand, nanoparticles are well known as a suitable tool in this field, due to their small size, large 
specific surface area, high drug loading efficiency and faster response to the surrounding environment 
(Walmsley et al. 2015).  
Regards to the lacunae’s on reconstruction of critical sized bone defects; the use of biomaterials combined 
with relevant growth factors can be a promising tool to induce bone healing. Human bone morphogenetic 
proteins (BMP-2) was approved by FDA and is one of the most studied growth factors in bone tissue 
engineering, due to its effect in bone healing, by induction of osteogenic differentiation of stem cells, thus 
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new bone tissue formation. The available BMP-2 carriers use supra-therapeutic doses and non-controlled 
release over the time often results in severe side effects (Davis et al. 2011; Kim et al. 2016). The scientific 
interest is therefore focused to innovative systems able to bind, deliver and to guarantee a controlled release 
of anabolic factors (Davis et al. 2011; Quinlan et al. 2015; Qiao et al. 2015). In particular it was found that 
mineralised biomaterials allow enhanced BMP-2 adsorption and also exhibit more hydrophilic surface 
compared with non-mineralised substrate, as well as enhancement of osteogenic response of human 
mesenchymal stem cells (Davis et al. 2011). A huge variety of biomaterials have been investigated as a 
suitable device for controlled BMP-2 deliver, although hydroxyapatite is one of the most investigated 
biomaterials to be applied on bone tissue regeneration, due to chemical bone-like composition, as well as 
high affinity to growth factors were described (Zhang et al. 2003; Huang et al. 2016; Iafisco et al. 2014; 
Sprio et al. 2012; Landi et al. 2006).  
Nevertheless, new strategies on bone tissue engineering were purposed, as the application of magnetic 
assisted tissue engineering (Mag-TE) (e.g. cell labelling with magnetic particles) and magnetic biomaterials 
(Wimpenny et al. 2012; Santos et al. 2015). 
 
1.5 Biocompatible magnetic materials: new approaches for bone tissue regeneration 
Several devices are currently available on the market for bone tissue regeneration, but still there is some 
limitations, with particular respect to induction of cell differentiation and angiogenesis process. Therefore, a 
new focus in tissue engineering has been highlighted by the use of magnetic particles combined with 
magnetic fields that might be applied as a carrier of drugs, on cancer therapies and / or stimulation of bone 
tissue regeneration. Smart magnetic materials were also proposed, as an additional angiogenesis control in 
vivo. The highest advantage of this new concept is to control their activity by mean of an external magnetic 
field (EMF), and the bone regeneration process can be governed by switching the magnetization input 
provided by superparamagnetic features of biomaterials, thus boosting tissue regeneration on demand, which 
can be considered a revolutionary approach in medicine (Tampieri et al. 2011; Gil & Mano 2014; Sprio et al. 
2012). Iron oxides are an example of those materials, while new bone-like biomaterials with 
superparamagnetic properties have been developed. Some authors have been investigated scaffolds 
functionalized with magnetic nanoparticles that increases scaffold stiffness and influence on cell adhesion 
(Tampieri et al. 2014; Gil & Mano 2014). Cells response to an external magnetic field depends on material 
surface, as well as a cross-talk between integrin-mediated signals from cells and soluble factors, thus 
promoting bone tissue regeneration (Xu et al. 2014). In figure 3, various examples of magnetic stimulation 
on cells behaviour were presented. By applying an external magnetic field the cell membrane is deformed 
and Rac and CDC42 was activated, as well as the signalling cascade events by p38/MAPK pathway, 
promoting actin cytoskeleton reorganisation, apoptosis, cytokine production and transcriptional regulation 
(Figure 3A). On the other hand, magnetic cells (i.e. cells labelled with magnetic nanoparticles (MNPs)) can 
be moved to a specific target by using external magnetic fields (Figure 3B). By combining external magnetic 
field with magnetic microspheres various cellular events can be activated, such as migration, survival, cell–
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cell interaction and angiogenesis (Figure 3C) (Santos et al. 2015). Moreover, on demand release of drugs or 
growth factors from magnetic carriers can be tailored by applying external magnetic fields (Figure 3D, D1), 
as well as cells behaviour can be achieved by the exposition of singular magnetic nanoparticle and 
micromotions at the interface between cells and the scaffold might affect the ion channels in the cell 
membrane and trigger the mechanotransduction pathway (Figure 3D, D2) (Gil & Mano 2014). 
 
 
 
Figure 3. The use of magnetic nanoparticles in bone tissue regeneration. A) Effect of external magnetic 
field on cells surface; B) Magnetic cells; C) Interaction of magnetic beads with cells; D, D1) Effect of 
EMF and magnetic scaffold in tissue regeneration and magnetic stimulation on cell behaviour (D2) 
(Santos et al. 2015; Gil & Mano 2014).  
 
The interest of superparamagnetic materials in medical application was increased and investigated as drug or 
cell targeting, magnetic resonance imaging (MRI), in the treatment of tumour, by conjugation with 
antibodies (e.g. tumour growth inhibition), hyperthermia and target therapy (Pankhurst; et al. 2003; Kumar & 
Mohammad 2011). Research work on magnetic nanoparticles (MNPs), MNPs labelled to cells, MNPs 
incorporated into the scaffolds, as well as some examples of use MNPs in drug delivery systems, cancer 
therapy (e.g. hyperthermia) and diagnostic and prognosis by magnetic resonance imaging, as well as the 
development of innovative magnetic materials (i.e. iron doped hydroxyapatite (Fe-HA)) are followed 
described (Mura et al. 2013; Singh et al. 2014). 
 
1.5.1 Magnetic nanoparticles  
The most common magnetic materials that have been assembled to the cells or to 3D templates are 
superparamagnetic iron oxide nanoparticles (SPIONS) (size range from 10 nm to 3.5 µm), regards to the 
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unique magnetic features (Wimpenny et al. 2012). Magnetite and maghemite are the most common SPIONS 
used in medical applications (Gil & Mano 2014). Excellent magnetic properties, good biocompatibility and 
low toxicity response, in presence of the cells prompt their use in tissue engineering (Wimpenny et al. 2012; 
Gil & Mano 2014). Magnetic properties are induced by external magnetic fields, while by removing the 
magnetic field the crystal-containing regions with disordered unpaired spins and non-magnetic materials are 
obtained, thus prevents particles aggregation (Gil & Mano 2014; LaConte et al. 2005).  
Magnetic nanoparticles loaded with drugs or growth factors are guided to a specific target and dose release is 
controlled by external magnetic fields, thus improving the therapy efficacy (Chomoucka et al. 2010; Mura et 
al. 2013; Pankhurst; et al. 2003; Perez et al. 2015). Zhou and co-authors showed magnetic calcium phosphate 
nanoparticles with suitable properties for cancer therapy. Briefly, nanoparticles through biomineralisation of 
calcium phosphate on the surface of superparamagnetic iron oxide nanoparticles was synthesised and two 
types of particles were obtained. Doxorubicin (DOX.HCl) was loaded to the nanoparticles, and by using an 
external magnetic field an inhibition of tumour growth was observed. On the other hand, DNA was 
electrostatically compressed to the nanoparticles and by applying external magnetic field high transfection 
efficiency in A549 (adenocarcinomic human alveolar basal epithelial cells) and HepG2 (human liver 
carcinoma cell line) cells, was showed (Tang et al. 2014). 
In cancer treatment, the potential of hyperthermia on “killing” cancer cells by increasing the temperature, 
without negative effect on the surrounding healthy cells was successfully investigated (Pankhurst; et al. 
2003; Perez et al. 2015). The heating mechanism in superparamagnetic particles is explained by Brown 
relaxation (i.e. heat effect stimulated by friction arising from total particle oscillations) and Neél relaxation 
(i.e. heat is mediated by the rotation of the magnetic moment with each field oscillation) (Kumar & 
Mohammad 2011). An increase of temperature (40 ºC – 46 ºC) changes the physiology of malignant cells 
leading to apoptosis, whereas temperatures higher than 46 ºC promote necrosis (Silva et al. 2012). This 
heating phenomenon is improved by the use of an alternating external magnetic field, due to the high 
Brownian and Neel fluctuation (Singh et al. 2014). Moreover, the use of lower temperature (T<41ºC) was 
investigated in the treatment of rheumatic diseases (Silva et al. 2012). SPIONs coated with growth factors, 
drugs, RGD peptides, can be a promising tool on bone tissue engineering, but still further investigations must 
be implemented.  
 
1.5.2 Magnetic cells 
The importance of magnetic-mechano actuation in stem cells differentiation, as well as the combination of 
magnetic functionalisation nanoparticles with osteogenic medium, cyclic magneto-mechanical stimulation 
and bone morphogenic protein, as a suitable tool for bone biomineralisation has been investigated (Santos et 
al. 2015; Gil & Mano 2014). It is well known that cells behaviour is affected by physical properties and 
chemical/ biochemical topography surface of scaffolds, as well as by mechanical stimulation. Regarding to 
the importance of mechanical stimulation in cells behaviour, MNPs labelled to the cells was investigated and 
an improvement on cells activity and functional tissue was formed (Gil & Mano 2014; Santos et al. 2015).   
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The most studied methodologies to produce magnetic cells were described as i) labelling magnetic particles 
in cells surface integrin or ii) by internationalization of MNPs into the cells by using fluid phase endocytosis, 
receptor-mediated endocytosis or phagocytosis (Gupta & Gupta 2005). By combining magnetic cells with 
external magnetic fields allowed to conduct the cells to a specific target and to control the delivery of 
biomolecules, drugs or growth factors; and is non-toxic and do not affect cell differentiation, proliferation, 
metabolic expression profile, reactive oxygen species formation and apoptosis rate (Wimpenny et al. 2012; 
Silva et al. 2012; Santos et al. 2015). Magnetite cationic liposomes were electrostatically interacted with 
human mesenchymal stem cells (hMSCs) and in vitro magnetic stimulation was assessed for sheet formation. 
This tissue was implanted into a cranial defect of F344 nude rats and after 14 days of implantation, 
significant bone was formed (Shimizu et al. 2007). El Haj group’s investigated the interaction of SPIONs 
with osteoblasts surface (in RGD receptors) and after 3 weeks an upregulation of osteopontin was showed 
(Wimpenny et al. 2012).  
 
1.5.3 Magnetic scaffolds 
Another strategy in bone tissue engineering is the use of magnetic scaffolds, by adding magnetic particles 
into the scaffold and combined with low-frequency pulsed electromagnetic fields, thus stimulation in bone 
regeneration was observed (Bock et al. 2010; Tampieri et al. 2014). SPIONS are the most common magnetic 
particles introduced into the scaffolds and were investigated into ceramic scaffolds (Panseri et al. 2013; 
Panseri et al. 2012), polymeric scaffolds (Mertens et al. 2014; Lopez-Lopez et al. 2015) or composite 
scaffolds (e.g. collagen/HAp, chitosan/HAp, among others) (Heidari et al. 2015). Various strategies were 
used to produce magnetic scaffolds, as by immersing in ferrofluids, incorporation of magnetic nanoparticles 
or magnetic cells into the scaffolds, among others (Bock et al. 2010). By applying an external magnetic field 
to superparamagnetic scaffolds the cells activity was enhanced by the compressive or tensile forces produced 
between nanoparticles and magnetic field (Gil & Mano 2014). In other words, the activation of magnetic 
field leads to switch on the single magnetic domain from MNPs, promoting an interaction between cells and 
scaffold, which might influence mechanotransduction pathway (i.e. cells translate physical stimuli into 
biochemical activity) (Gil & Mano 2014; Santos et al. 2015).   
Magnetic scaffolds response to an on/off demand by applying a magnetic field, highlighting their potential 
compared to the conventional ones. In one hand, the use of magnetic particles into the scaffolds improves 
cell adhesion, proliferation and differentiation by applying an external magnetic field, due to bone tissue 
capacity to identify the mechano-electrical conversion leading to improve cellular and metabolic activity, 
respect to bone differentiation (Singh et al. 2014). On the other hand, magnetic particles into the scaffolds 
were investigated as a non-invasively assess in vivo follow-up and monitor scaffold resorption by magnetic 
resonance imaging (MRI), leading to therapeutic and diagnostic application (Mertens et al. 2014; Skaat et al. 
2012; Perez et al. 2015). Take into account bone tissue composition, a porous scaffold composed by 
integrated superparamagnetic nanoparticles into HAp and HAp/tricalcium phosphate, were fabricated and 
were studied in the presence of Ros17/2.8 and MG63 cells, good biocompatibility, cell proliferation and 
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differentiation was showed. In vivo test accelerated BMP-2 expression and new bone-like tissue was formed 
(Wu et al. 2011). HAp/ collagen composite by direct incorporation of magnetic nanoparticles during HAp 
nucleation was investigated as a new concept to produce magnetic scaffolds. Cells are activated close to the 
scaffold and magnetization about 0.5 emu/g was obtained after applying an external magnetic field (Tampieri 
et al. 2011).  
As previously was described, one of TE strategies is to develop 3D complex systems with differentiated and 
proliferated cells into the scaffolds. Therefore this strategy can leads to a non-homogeneous cell distribution 
into the scaffold. One possible approach to overcome this drawback is the use of magnetic cells, which by 
magnetic forces enhance cells distribution into the scaffold structure (Skaat et al. 2012). Homogeneous 
internationalization and differentiation of magnetic cells into the scaffolds was improved by applying an 
external magnetic field and it efficiency was monitorised by MRI (Santos et al. 2015; Skaat et al. 2012; 
Sensenig et al. 2012). Nevertheless, polymeric scaffolds were investigated as a support for magnetic growth 
factors and suitable 3D framework for cell growth and proliferation was achieved (Skaat et al. 2012).  
M. Marcacci and co-authors, showed the potential of in vivo magnetic fixation in HAp/collagen magnetic 
scaffolds and controlled tissue regeneration was showed. As complementary technique, computational 
stimulation was investigated as a suitable tool to predict scaffolds movements (Panseri et al. 2013; Russo et 
al. 2012).  
In table 1, various examples of proposed magnetic devices to be applied in bone tissue engineering are 
summarized. 
 
Table 1. Examples of magnetic scaffolds investigated for bone tissue engineering.  
Material Template Study 
Cells/ 
Animal 
model 
Saturation 
Magnetization 
(emu/g) 
Remarks Ref. 
CaP coated γ -
Fe2O3 – BSA 
CaP coated γ -
Fe2O3 – CA  
Nanoparticles 
In 
vitro 
Human 
osteoblasts  
3.47 – 33.58 
CaP coated γ -
Fe2O3 – BSA: high 
osteoblasts density.   
(Pareta et 
al. 2008) 
SPIONs + DXM 
co-encapsulate in 
PLGA 
Microspheres  
(1 - 10µm) 
In 
vitro 
Human 
synovial 
fibroblasts 
Data not showed 
Excellent 
biocompatibility;  
Particles 
internalized 
through phagocytic 
process; 
Do not induce any 
inflammatory 
reaction.   
(Butoescu 
et al. 2009) 
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HAp/collagen 
(70:30 w/w) 
immersed in 
commercial 
ferrofluids 
Porous 
scaffolds 
obtained by 
freeze-dried  
In 
vitro 
hBMSC 13-15 
Preliminary results: 
scaffolds are able 
to support cell 
adhesion and 
proliferation in 
vitro. 
(Bock et 
al. 2010) 
γ-Fe2O3 MNP, HAp 
in PLA nanofibers 
Nanofibers 
produced by 
electrosping  
In 
vitro 
MC3T3-E1 
0.0492 
High osteoblasts 
cells proliferation 
and differentiation, 
compared to the 
control ones.  
(Meng et 
al. 2010) 
In vivo 
White rats, 
lumbar 
transverse 
defect 
Degradation rate of 
material 
complement by 
new bone 
formation à 
Applied SMF 
accelerated tissue 
repair; 
Good 
compatibility. 
(Meng et 
al. 2013) 
 
Fe5% -MBG & 
Fe10%-MGB 
(MGB – polymer 
P123 &  
polyurethane 
sponges) 
Porous 
scaffolds 
calcined at 
700°C 
In 
vitro 
BMSC 
5% ≈ 1 
10% ≈ 0.2 
MNPs - Enhances 
the mitochondrial 
activity and gene 
expression; 
Maintain sustained 
drug delivery.  
(Wu et al. 
2011) 
MNP (2, 1 & 
0.5%) in discs of 
HAp 
Porous discs 
immersed in 
colloid solution 
of MNP 
In 
vitro 
ROS 17/2.8 
MC3T3-E1 
2% - 0.94 
1% - 0.53 
0.5% - 0.24 
MNP - Stimulated 
cell adhesion, 
proliferation, and 
differentiation by 
itself; 
MNP with SMF – 
enhanced cell 
proliferation and 
differentiation.  
(Zeng et 
al. 2012) 
HAp/collagen 
(70/30 wt%) with 
nucleated 4wt% 
MNP &  
HAp/collagen 
Porous 
scaffolds 
obtained by 
freeze-dried 
In vivo Male rabbits Data not showed 
Histopathological 
screening: no 
inflammatory 
reaction due to 
MNPs; 
(Panseri et 
al. 2013) 
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1.5.4 Novel biocompatible magnetic nanoparticles: Fe-HA 
Some authors defends that magnetite nanoparticles present low stability (Marques et al. 2014; Hoffman-
Amtenbrink et al. 2009) and tends to aggregate due to strong magnetic dipole-dipole attractions; to avoid that 
and to improve colloidal dispersion and biocompatibility; the surface charge, surface topography and 
biocompatibility were modified by surface coating with hydrophilic polymers (e.g. dextran, chitosan, etc. …) 
(Chomoucka et al. 2010) or with bovine serum albumin, siloxanes and citric acid (Pareta et al. 2008; 
Marques et al. 2014).  
Nevertheless, a new concept to produce bioactive and bioresorbable biomimetic materials with intrinsic 
magnetization was investigated. HAp is a biocompatible, bioactive and bioreasorbable material and their 
crystal structure, allows the incorporation of different ions, such as iron sources to create iron-doped apatite 
(Fe-HA) with superparamagnetic properties (Sprio et al. 2012). Briefly, by adding simultaneously Fe2+ and 
Fe3+ ions, during the neutralization process of HAp, Ca2+ ions are partially substituted by iron ions into HAp 
lattice and material with superparamagnetic features is produced. The improvement of magnetic properties 
can be induced by the formation of minimal amounts of magnetite or maghemite (Tampieri et al. 2011; 
Tampieri et al. 2012; Panseri et al. 2012; Sprio et al. 2012; Sprio et al. 2010). Fe-HA showed bone-like 
composition and in vitro and in vivo tests indicated any cytotoxic effect in presence of rabbit osteoblasts cells 
after 24h of cell seeding, as well as biocompatible properties were showed with pilot rabbit investigations 
(Sprio et al. 2010; Panseri et al. 2012). On the other hand, different concentrations of Fe-HA material were 
tested in presence of Saos-2 human osteoblast-like cells without or under external magnetic field, during 7 
days. An improvement on cell activity in presence of static external magnetic field was observed, as well as, 
good biocompatibility from Fe-HA was obtained after 4 weeks implanted into critical size lesion of rabbit 
condyle (Panseri et al. 2012), while osteogenic differentiation of human mesenchymal stem cells was 
(70/30 wt%) 
immersed in 
ferrofluid 
Higher bone 
healing rate in 
scaffold nucleated 
with MNPs.  
Bioactive glasses + 
MNPs + SBF 
biomineralisation  
Scaffolds 
produced by 
Salt-leaching 
techniques 
(calcined 
during 
different 
timings)  
In 
vitro 
HeLa 
50’: 6.78 
70’: 3.72 
90’: 3.19 
110’: 1.96 
Good 
biocompatibility 
and cell adherence 
ability.  
(Wang et 
al. 2013) 
PCL + MNPs 
Nanofibrous 
produced by 
electrospun 
In 
vitro  
In vivo 
Osteoblasts 
Male 
Sprague-
Dawley Rats 
1.0 -11.2 
In vitro: improve 
cell adhesion; 
In vivo: Significant 
bone formation.  
(Singh et 
al. 2014) 
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obtained in presence of material composed by Fe-HA and PCL (Gloria et al. 2013). 
Fe-HA presented bone-like composition with nanocrystalline hydroxyapatite, cytocompatible, 
biocompatible, osteoinductive, osteocondutive, bioactivity and prompt their future use in biomedical 
applications as suitable tool for theranostic, drug delivery, heat mediator for hyperthermia treatment, contrast 
agent for magnetic resonance imaging or as magnetic nanocarriers, as a possible substitution of commercial 
iron oxide nanoparticles (Tampieri et al. 2011; Tampieri et al. 2012; Tampieri et al. 2016; Kaygili et al. 
2014; Kramer et al. 2013; Panseri et al. 2012; Sprio et al. 2010) 
Furthermore, by using a bio-inspired assembling/mineralization process (as previously reported as 
biomineralisation process), which mimics the cascade phenomena occurring in vivo during new bone tissue 
formation, heterogeneous nucleation of Fe-HA onto collagen type I matrix, was successful achieved 
(Tampieri et al. 2003; Tampieri et al. 2008; Tampieri et al. 2014). This process activates various 
physicochemical and morphological mechanisms that constrain the inorganic phase to nucleate in specific 
loci of collagen macromolecule, and limit the crystal growth to few nanometres with very low crystal 
ordering and specific orientation, similarly as occurring in the newly formed bone (Tampieri et al. 2008; 
Sprio et al. 2012). As a result of the above mentioned approach, the obtained hybrid construct exhibited high 
compositional and structural mimicry of bone tissue with excellent biocompatibility, osteogenic ability and 
intrinsic superparamagnetic properties enabling remote activation by magnetic signalling (Tampieri et al. 
2014). This approach opens the new proposed therapies boosting tissue regeneration in the patients with 
reduced endogeneous regenerative potential (Higashi et al. 1993; Kotani et al. 2002; Xu & Gu 2014). The 
ability of natural polymers such as collagen to expose negatively charged functional groups enabling the link 
of Ca2+ ions and subsequent heterogeneous nucleation of apatite nanophases, opens to the development of 
hybrid biomimetic materials with tailored mineralization extent by using various macromolecular matrices 
and could be tailored from cartilage to bone-like level (Tampieri et al. 2008). The bone-like and magnetic 
properties promotes the ability to be used in bone tissue regeneration and be activated by external magnetic 
field that can be promising on boost regeneration of extended bone or osteochondral regions (A.- Sprio; et al. 
2016; Tampieri et al. 2014; Gil & Mano 2014). 
 
1.6 Brief idea on regulatory guidelines and scaffold commercialization 
New innovative strategies have been investigated and proposed to develop novel devices for bone tissue 
regeneration, but still exhaustive bureaucracy processes have been applied in the commercialization of those 
devices (Pashuck & Stevens 2012; Mehta; 2008). In the book entitled “Biomaterials in the Design and 
Reliability of Medical Devices, 2002” edited by Michael N. Helmus, the main procedures to commercialize 
biomaterials and templates, for the different parts of the human body was showed. On the other hand, in the 
book entitled “Principles of tissue engineering, 3rd ed”, mainly in the chapters three and eighty-five, translate 
the key points on scaffolds commercialization (Russell & Bertram 2011; Hellman 2011). 
Prior to scaffolds implantation a wide range of protocols have been followed and to pass from research bench 
to clinical testing is important to point: i) the characterisation and evaluation of the raw materials (i.e. cells 
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and scaffold), ii) the manufacturing process (i.e. cellular processing and testing of biomaterial process, as 
well as interplay between cells and scaffolds) and then the actions related to iii) translational medicine (i.e. 
potentiality of the product in small or large animals). An exhaustive screening of in vitro and in vivo assays 
to test device-like products is available in ISO10993-1 (approved by FDA). The risk : benefit of new 
biomaterials must be compared to the materials available in the market, in terms of results reproducibility in 
vitro and in vivo that is fundamental in the decisions for human trials.   
In figure 4, a general pathway from lab to commercialization of devices was presented. The first step 
includes the lab research with special focus on research target (e.g. bone tissue, biological and biomechanical 
mechanisms of bone tissue) and the development of new approaches with cells and scaffolds. Followed by in 
vitro and in vivo studies, under regulatory guidelines (e.g. Centre for Devices and Radiological Health 
(CDRH) and Center for Biologics Evaluation and Research (CBER) from FDA departments that are 
responsible in the validation of biomaterials and cells, as a support for tissue regeneration). Then, new 
regulatory guidelines are applied in the clinical studies with humans, followed by business strategies and 
product commercialization. Actually, it is expected that tissue engineering strategies will bring to the market 
new devices in 8-10 years. An emerging knowledge from tissue engineering and regenerative medicine will 
bring new customized solutions to the patients (Russell & Bertram 2011).  
 
Figure 4. Step from research bench to scaffold commercialization.   
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Chapter 2. Materials and Methods 
	  
2.1 Application of biomineralisation process to obtain new hybrid biomaterials with 
superparamagnetic properties  
	  
2.1.1 Raw materials 
RCP, commercially available as CellnestTM, is characterised by molecular weight of 51.7 kDa and isoelectric 
point of ≈ 10.02, and was provided by Fujifilm Manufacturing Europe B.V. (The Netherlands). Calcium 
Hydroxide (Ca(OH)2, 95%), Phosphoric Acid (H3PO4, 85 wt%), Iron(II) chloride tetrahydrate (FeCl2.4H2O, 
99%) and Iron(III) chloride hexahydrate (FeCl3.6H2O) were purchased from Sigma Aldrich (U.S.A.), while 
nitric acid (HNO3, 65%) was purchased from Titolchimica (Italy). Ultrapure water (0.22 mS, 25 °C) was 
used in all the experiments. 
 
2.1.2 Biomineralisation Process 
Biomineralisation process was carried out in presence of Fe2+ and Fe3+ ions, with the purpose to provide ion 
substitution in apatite during the neutralization process. Firstly, RCP was dissolved in aqueous environment 
thermostated at 40 °C during stirring for 40 minutes and then RCP solution was added to an aqueous solution 
of H3PO4 and dropwise into a basic aqueous suspension of Ca(OH)2 containing FeCl2·4H2O and FeCl3·6H2O 
as sources of Fe2+ and Fe3+ ions, under constant heating and stirring, for two hours (Figure 5). All the 
obtained materials were freeze-dried (≈ 0.1 bar) for further physico-chemical characterisation. All the as-
used solutions were varied take into account the used Fe2+/Fe3+ molar ratio, Fe/Ca molar ratio and organic 
and inorganic ratio, but keeping the Ca/P molar ratio (1.67).  
 
 
Figure 5. Schematic design of biomineralisation process.  
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2.1.3 Morphological, chemical, thermal and magnetic characterisation 
Size distribution of RCP was evaluated by dynamic light scattering (DLS, Zetasizer Nano Series, Malvern, 
UK) and was measured by backscatter detection (λ = 630 nm, θ = 173°). 
The infrared spectra were collected in the wavelength range from 400 to 4000 cm-1, using KBr pellet 
technique with 2 cm-1 of resolution. The sample (∼2 mg) was mixed with ∼150 mg of anhydrous KBr and the 
powder pressed at 8000 psi into 7 mm diameter discs. The crystallinity index was measured by evaluating 
the ratio: (I603 + I563) / I588, where I is the intensity of the IR band recorded at the wavelength identified by the 
subscript (Surovell & Stiner 2001) (Weiner & Bar-Yosef 1990). 
The phase composition was determined by X-ray powder diffraction (XRD), performed by a D8 Advance 
Diffractometer (Bruker, Karlsruhe, Germany) using Cu-Kα radiation at 40kV and 40mA. XRD spectra were 
recorded in the 2θ range 10–80°, with a step size of 0.02° and a counting time of 0.5s. The Inductively 
coupled plasma optical emission spectrometry (ICP OES; Liberty200, Varian, Clayton South, Australia) was 
performed to determine the overall content of calcium (Ca), phosphorus (P) and iron (Fe) into the mineral 
phase of the different samples. Each type of material were prepared in triplicate by dissolving 20 mg of 
powder in 2 mL of HNO3 (65 wt%) and the volume of the solution was raised to 100 mL by adding 
deionized water and further analysed by ICP-OES. Predetermined concentrations of Ca, P, Fe elements were 
also prepared and used as standard calibration. Thermogravimetric analysis (STA 449C) was carried out to 
explore the thermal behaviour of the composites and to assess the amount of mineral phase. 10 mg of sample 
was placed into an alumina crucible and the experiment was conducted in air flux with heating ramp from 30 
°C to 1100 °C and heating rate of 10 °C/min. A susceptometer balance YSZ 01C/02C (Sartorius 
Mechatronics, Italy) was used to evaluate the magnetisation of pelletized materials under a field of 2700 A/m 
at a distance of 18 mm.  
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2.2 New bioactive bone-like microspheres with intrinsic magnetic properties obtained by bio-
inspired mineralisation process 
	  
2.2.1 Raw materials  
RCP was kindly provided by Fujifilm Manufacturing Europe B.V. (The Netherlands). Calcium hydroxide 
(Ca(OH)2, ≥95%), phosphoric acid (H3PO4, 85%), iron(II) chloride tetrahydrate (FeCl2.4H2O, ≥99%), 
iron(III) chloride hexahydrate (FeCl3.6H2O, 97%), sodium hydroxide (NaOH, ≥98%), 1,10-phenantroline 
(C12H8N2, ≥99%), sulphuric acid (H2SO4, 99.999%), corn oil, acetone (≥99.9%), potassium bromide (KBr, 
≥99%), phosphate buffered saline (PBS), dimethyl sulfoxide ((CH3)2SO, ≥99.9%), ethanol (≈ 96% (v/v)), 
were all obtained by Sigma Aldrich (St Louis, MO, USA), whereas nitric acid (HNO3, 65%) was purchased 
from Titolchimica (Italy). αMEM w/o ascorbic acid, fetal bovine serum (FBS) and penicillin-streptomycin 
were purchased from Thermo Fisher Scientific (Waltham, MA, USA). 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), calcein acetoxymethyl (calcein AM) and ethidium homodimer-1 
(EthD-1) were purchased from Invitrogen (Carlsbad, CA, USA). Ultrapure water (0.22 mS, 25 °C) was used 
in all the experiments. 
 
2.2.2 Reaction of RCP with calcium and iron ions 
The as-used divalent and trivalent ions (i.e. Ca2+, Fe2+ and Fe3+) in biomineralisation process were separately 
bound to RCP in aqueous media. Those reactions were prepared as a reference to be compared with 
biomineralised materials and to evaluate the involved chemical interactions. The amount of ions dispersed in 
the solution was defined on the basis of a 1:1 molar ratio with the free carboxylic groups available in the 
RCP matrix, which are derived from aspartic and glutamic acid (1 mol of RCP corresponds to 57 acids) 
(Bouwstra J., Sutter M., Kluijtmans S., Hennink W. 2010; Boer A., Urk H., Bouwstra J. 2012). 
Firstly, 15.5 mg of Ca(OH)2 was dispersed in 2 mL of deionized water at room temperature and 200 mg of 
RCP was dissolved in deionized water, in separated reaction vessel, at thermostated environment (i.e. 40°C). 
Calcium solution was dropped into RCP solution under vigorous magnetic stirring and continuously mixed at 
room temperature for 30 minutes to obtain a solution henceforth coded as RCP/Ca.  
Similar procedures were carried out to link Fe2+ and Fe3+ ions to RCP. Two solutions were prepared by 
dissolving 43 mg of FeCl2.4H2O and 29 mg of FeCl3.6H2O in 2 ml of deionized water and dropped in two 
reaction vessels containing the RCP solution, thus obtaining final materials henceforth coded as RCP/Fe2 
and RCP/Fe3, respectively.  
On the other hand, new reactions of RCP/Fe2 and RCP/Fe3 were performed and 0.1 M of NaOH was 
dropped to achieve the conditions of apatite crystallization (as obtained in the biomineralisation process), 
then the mixture was homogenized for 30 minutes. In all the as-mentioned reactions the final RCP 
concentration was 5 wt%. The resulting materials were freeze-dried at -40 °C under vacuum (≈ 0.1 bar) 
overnight, for future investigations. 
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2.2.3 Synthesis of hybrid mineralised materials  
Mineralised materials were synthesised by heterogeneous nucleation of Fe-doped hydroxyapatite on RCP 
matrix, by following the method showed in the section 2.1.2. However, slightly modification in the amount 
of reactants was performed. Briefly, an aqueous solution of RCP (0.003 M) was prepared and thermostated at 
40°C. An acid solution of H3PO4 (1.2 M) was prepared and dropped in the RCP solution, then poured 
dropwise into a basic aqueous suspension of Ca(OH)2 (0.8 M) also containing FeCl2·4H2O and FeCl3·6H2O 
as sources of Fe2+ and Fe3+ ions, to establish a Fe2+/Fe3+ molar ratio of 3:2. The process was carried out at a 
fixed temperature and under magnetic stirring, to achieve a nominal mineralization extent equal to 40 wt%. 
The overall ion content was set to achieve Ca/Pmol = 1.67 and Fe/Camol = 0.2 and the synthesis of materials 
were carried out at two different synthesis temperatures (i.e. 40 °C and 60 °C) (Figure 5). The as-obtained 
materials are henceforth coded as RCPFeHA40 and RCPFeHA60, respectively.  
Iron-free mineralised materials were synthesised at the same temperature conditions (i.e. 40°C or 60°C) and 
were used as a control in the chemical-physical characterisation, henceforth coded as RCPHA40 and 
RCPHA60, respectively.  
By the end, the as-obtained hybrid mineralised slurries were used to produce the microspheres by the 
emulsification process, as described in the section 2.2.4, or to be freeze-dried at -40 °C under vacuum (≈ 0.1 
bar) overnight, for further physicochemical investigations.   
 
2.2.4 Production of microspheres by emulsification method 
A water-in-oil emulsification process was established, to produce pure RCP and hybrid magnetic 
microspheres, starting from the previously obtained hybrid mineralised slurries (i.e. RCPFeHA40 and 
RCPFeHA60).  
The emulsification process comprises three different stages, i.e. i) microspheres production in pre-warmed 
oil; ii) microspheres jellification and iii) oil phase washing. In detail, 20 g of hybrid mineralised slurry was 
dropped in 45 g of pre-warmed corn oil and kept under mechanical stirring for 20 minutes. The solution was 
cooled, until microspheres jellification, and dropped into a 300 mL of chilled acetone and kept under 
mechanical stirring for 5 minutes, then maintained for 1 hour at room temperature, under mechanical stirring. 
The microspheres were left to sediment and acetone was carefully removed, then 300 mL of clean acetone 
was added and the microspheres were washed for 10 minutes. This step was repeated twice. The 
microspheres were filtered, dried overnight in an oven at 40 °C, and sieved to achieve a size distribution in 
the range 38 to 100 µm (Figure 6). For pure RCP microspheres, predetermined concentrated aqueous 
solution of RCP (≈ 5 – 36 wt%) was prepared and microspheres were obtained by the aforementioned 
method. DHT treatment was carried out by placing the dried microspheres in glass vials covered with 
aluminium foil and heated at 160 °C for 48 hours under vacuum.  
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Figure 6. Schematic design of emulsification process.  
	  
2.2.5 Physicochemical, morphological and magnetic characterisation 
The detailed protocols to perform FTIR, XRD and TGA analysis were showed in the section 2.1.3.  
The identification of functional groups of pure RCP and hybrid mineralised materials was made by Fourier 
Transform Infrared Spectroscopy (FTIR) (Avatar 320 FT-IR, Thermo Nicolet, Canada).  
The phase composition of the mineralised materials was obtained by X-ray powder diffraction (XRD, D8 
Advance, Bruker, Karlsruhe, Germany). Crystallographic data were then obtained by full profile refinement 
of the XRD pattern (TOPAS 5, Bruker, Germany).  
The overall content of calcium (Ca), phosphorus (P) and iron (Fe) was determined by inductively coupled 
plasma optical emission spectrometry (ICP-OES; Liberty200, Varian, Clayton South, Australia).  
A calorimetric assay with orthophenantroline was used to determine the amount of Fe2+ ions, by means of 
formation of a stable red-orange Fe (II) orthophenantroline complex [(C12H8N2)3Fe]2+
 in the pH range 4-5 to 
be detected by UV–Visible spectrophotometry (Lambda 35 UV/VIS Spectrometer; Perkin Elmer Instrument, 
USA) at 510 nm (Murti et al. 1970; Tampieri et al. 2012). Buffer solution (pH=4), 0.2 % of 1,10-
phenanthroline solution and 3M H2SO4 was previously prepared. 4 mg of RCPFeHA40 and RCPFeHA60 
were separately dissolved in 10 mL of deionized water with 0.1 mL of 3M H2SO4. The final solution to be 
investigated by UV-vis was: 500 µl of RCPFeHA40 or RCPFeHA60 solution, 500 µL of buffer solution 
(pH=4), 500 µL of 0.2 % of 1,10-phenanthroline solution and deionized water to the final volume of 5 mL. 
The concentration of Fe2+ was calculated by using a calibration curve obtained by 0.02 mg/ml of 
FeCl2.4H2O. The Fe3+ amount was calculated by the difference between the total iron amount (as obtained by 
ICP-OES analysis) and the Fe2+ amount (as obtained by the calorimetric assay).  
Simultaneous thermogravimetric (TGA) analysis (STA 449/C Jupiter, Netzsch, Germany) was carried out to 
explore the thermal behaviour of RCP and mineralised materials, particularly to assess the amount of the 
mineral phase in the final obtained materials.  
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A susceptometer balance YSZ 01C/02C (Sartorius Mechatronics, Italy) was used to evaluate the 
magnetisation of pelletized materials under a field of 2700 A/m at a distance of 18 mm. The obtained 
magnetisation was normalised by the mineral phase amount, obtained by TGA analysis. Deeper investigation 
was carried out by using a vibrating sample magnetometer (VSM) Lakeshore 735, in the range from -15 kOe 
to 15 kOe. A predetermined amount of sample was loaded into the sample holder and the experiments were 
carried out at room temperature. The results are presented with uncertainty of about ±2%. The potential of 
magnetic microspheres to be controlled in wet conditions was evaluated by using a neodymium magnet (1.2 
T).  
The morphology of the microspheres was analysed by using Scanning Electron Microscope (SEM) (FEI 
Quanta 600, USA) in low vacuum mode with an accelerating voltage of 10 kV and a working distance of 10 
mm. The effect of the incorporation of iron ions and the synthesis temperature on the morphology and 
ultrastructure of the nucleated hydroxyapatite nanocrystals was examined by using transmission electron 
microscopy (TEM: FEI Tecnai F20 microscope, USA), using an accelerating voltage of 120 kV. Energy 
dispersive X-ray analysis (EDX) was carried out to detect the presence of iron in the hydroxyapatite 
nanocrystals. For TEM investigations, the as-obtained mineralised slurries by biomineralisation process were 
washed three times with deionized water to remove the organic phase and freeze dried at -40 °C under 
vacuum (≈ 0.1 bar) overnight. The freeze-dried powder was dispersed in ethanol and placed on 
carbon/formvar coated-copper grid.  
 
2.2.6 Preliminary cytocompatibility test 
Mouse pre-osteoblast cell line, MC3T3-E1 Subclone 14 (ATCC cell bank, USA) was used for the biological 
study. In detail, MC3T3-E1 cells were cultured in αMEM without ascorbic acid, 10% Fetal Bovine Serum 
(FBS) and 1% penicillin-streptomycin (100 U/mL-100 µg/mL). Cell culture was kept at 37°C in an 
atmosphere of 5% CO2. Cells were detached from culture flasks by tripsinization, centrifuged and re-
suspended. Cell number and viability were assessed by trypan-blue dye exclusion test. 
For the experiment, cells were plated at a density of 5000 cells/cm2 in 96-well and 24-well plate. 24 hours 
after seeding, different concentrations of each microspheres group (10 µg/mL and 100 µg/mL; RCP, 
RCPFeHA40 and RCPFeHA60) were added to the cell culture. Microspheres, sterilized by 25 kGy γ-ray 
radiation prior to use and before being added to the cells were vortexed. All the cell-handling procedures 
were performed in a sterile laminar flow hood and all cell-culture incubation steps were performed at 37°C 
with 5% CO2. 
Cell viability was evaluated by quantification of cell metabolic activity using MTT and Live/Dead assay, 
after 1, 3 and 7 days. MTT reagent was prepared at 5 mg/mL in 1x PBS. Cells seeded in 96-well plate, were 
incubated with MTT reagent 1:10 for two hours at 37°C. Medium was removed and cells were incubated 
with 1 mL of dimethyl sulfoxide for 15 min. In this assay, the metabolically active cells react with the 
tetrazolium salt in the MTT reagent to produce a formazan dye that can be observed at λmax = 570 nm, using 
a Multiskan FC Microplate Photometer (Thermo Fisher Scientific, Waltham, MA, USA). This absorbance is 
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directly proportional to the number of metabolically active cells. Three samples per group was analysed at 
each time point. 
Live/Dead assay kit (Invitrogen, U.S.A.) was performed according to manufacturer's instructions. Briefly, 
the cells seeded on 24-well plates were washed with 1x PBS for five min and incubated with 
Calceinacetoxymethyl (Calcein AM) 2 µM plus Ethidium homodimer-1 (EthD-1) 4 µM for 15 min at 37°C 
in the dark, the samples were rinsed in PBS 1x (Papadopoulos et al. 1994). Images were acquired by an 
inverted Nikon Ti-E fluorescence microscope (Nikon Corporation, Tokyo, Japan). One sample per group 
was analysed at each time point. 
 
2.2.7 Statistical analysis  
Statistical analysis was performed using two-way ANOVA, followed by Tukey’s multiple comparison test, 
considered statistically significant when p≤0.05. Calculations were performed using Graph Pad Prisma 6 
software. Data is plotted as mean ± standard error of mean (Mean+SEM) of n. 3 samples per each group.  
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2.3 Effect of ions release from hybrid superparamagnetic microspheres on osteogenic 
differentiation of MC3T3-E1 
	  
2.3.1 Raw materials  
RCP was kindly provided by Fujifilm Manufacturing B.V. (The Netherlands). Calcium hydroxide (Ca(OH)2, 
≥95%), phosphoric acid (H3PO4, 85%), iron(II) chloride tetrahydrate (FeCl2.4H2O, ≥99%), iron(III) chloride 
hexahydrate (FeCl3.6H2O, 97%), sodium hydroxide (NaOH, ≥98%), corn oil, acetone (≥99.9%), potassium 
bromide (KBr, ≥99%), phosphate buffered saline (PBS), HEPES sodium salt (≥99.5%), acetic acid 
(≥99.85%), sodium acetate (≥99%), were all purchased from Sigma Aldrich (St Louis, MO, USA), whereas 
nitric acid (HNO3, 65%) was purchased from Titolchimica (Italy), and fluidMAG-CT from Chemicell 
(Germany, Berlin). Biological reactants were described in section 2.3.7. Ultrapure water (0.22 mS, 25 °C) 
was used in all the experiments. 
 
2.3.2 Preparation of RCP and RCPfluidMAG-CT solutions  
RCP and RCP combined with fluidMAG-CT (i.e. commercial magnetic nanoparticles, size 50 nm) were 
prepared. Briefly, 5g of RCP was dissolved in 12 mL of milli-Q water under magnetic agitation and 
thermostated at about 40ºC, and then 2 ml of fluidMAG-CT were dropped in RCP dissolution, for a complete 
involvement of magnetic nanoparticles in RCP matrix, under magnetic agitation for 30 minutes. The as-
obtained material is encoded as RCPfluidMAG-CT. RCP was produced by the as-mentioned method but the 
volume of magnetic nanoparticles was substituted by milli-Q water.  
 
2.3.3 Synthesis and functionalisation of mineralised slurries   
Iron free and iron containing mineralised slurries were obtained by biomineralisation process, as described in 
the section 2.1.2. Herein, slight modifications in the amount of the reactants were performed, as briefly 
described: an aqueous solution of RCP (≈0.006 M) was prepared and thermostated at 40°C. An acid solution 
of H3PO4 (≈ 3.9 M) was prepared and dropped in the RCP solution, then poured dropwise into a basic 
aqueous suspension of Ca(OH)2 (≈ 1.9 M) also containing FeCl2·4H2O and FeCl3·6H2O as sources of Fe2+ 
and Fe3+ ions, to establish a molar ratio of 3:2. The process was carried out at a fixed temperature and under 
magnetic stirring, to achieve a nominal mineralization extent (i.e. inorganic : organic fraction) equal to 40 
wt%. The overall ion content was set to achieve Ca/P = 1.67 and Fe/Ca = 0.2 and the synthesis of the slurry 
was carried out at 60°C. The as-obtained material was henceforth coded as RCPFeHA.   
Iron-free mineralised slurries were synthesised at 20°C and 60°C to obtain control hybrid mineralised 
materials with iron-free hydroxyapatite, henceforth coded as RCPHART and RCPHA, respectively. 
To the as-obtained iron-containing mineralised slurries predetermined concentrations of sodium citrate (i.e. 
0.55 M, 0.3 M, 0.06 M, 0.006 M and 0.0006 M) were investigated. Sodium citrate was added to the slurries 
and maintained under magnetic stirring for about 6h, at room temperature (≈ 20ºC). The functionalization 
time was selected by measuring the surface charge of the slurries at concentration of 0.55 M, by using ζ-
potential. 
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Therefore, functionalised slurries were dropped in pre-warmed corn oil for the production of microspheres, 
by using water-in-oil emulsification process, as presented in the section 2.2.4. 
 
2.3.4 Fabrication of microspheres by emulsification process 
A water-in-oil emulsification process was assessed to produce pure RCP, RCPfluidMAG-CT and hybrid 
microspheres (i.e. RCPHART, RCPHA and RCPFeHA). The used emulsification process was already 
described in the section 2.2.4. After drying process, microspheres were sieved to achieve a size distribution 
in the range 50 to 75 µm. Three different batches of each type of microspheres were produced. 
Dehydrothermal treatment (DHT) was carried out by placing the dried microspheres in glass vials covered 
with aluminium foil and heated at 160 °C for 48 hours under vacuum.  
 
2.3.5 Morphological and physicochemical characterisation 
Functionalised slurries and microspheres surface charge were evaluated by using ζ-potential (Zetasizer Nano 
analyzer (Malvern, UK). ζ-potential measurements through electrophoretic mobility were carried out with a 
using disposable folded capillary cells (DTS1061; Malvern, UK) at 25 °C. For functionalised slurries, 100 µl 
of slurry was diluted in 5 mL of milli-Q water and ζ-potential was evaluated at t = 0 and t = 30’, 1h30’, 3h 
and 6h. Microspheres surface charge was evaluated in HEPES buffer (i.e. 0.01 M; pH 7.4) at concentration 
of 1.2 mg/mL of microspheres. The ζ-potential average was calculated from three separate measurements 
(100 runs each) in each type of microspheres and the results were showed as Mean±SEM.  
The morphology of the microspheres was analysed by using Scanning Electron Microscope (SEM) (FEI 
Quanta 600, USA) in low vacuum mode with an accelerating voltage of 10 kV and a working distance of 10 
mm. Microspheres size distribution was evaluated by SEM micrographs and analysed by Image J software.  
The identification of functional groups of RCPFeHA and functionalised RCPFeHA was evaluated by Fourier 
Transform Infrared Spectroscopy (FTIR) (Avatar 320 FT-IR, Thermo Nicolet, Canada), by following the 
protocol described in the section 2.1.3.  
The phase composition of the all as-produced microspheres was obtained by X-ray powder diffraction (XRD, 
D8 Advance, Bruker, Karlsruhe, Germany), as presented in the section 2.1.3.  
The overall content of calcium (Ca), phosphorus (P) and iron (Fe) was determined by inductively coupled 
plasma optical emission spectrometry (ICP-OES; Liberty200, Varian, Clayton South, Australia), by 
following the method showed in 2.1.3. 
Simultaneous thermogravimetric (TGA) analysis (STA 449/C Jupiter, Netzsch, Germany) was carried out to 
explore the presence of citrate ions on functionalised RCPFeHA microspheres and measured as following the 
section 2.1.3. 
A susceptometer balance YSZ 01C/02C (Sartorius Mechatronics, Italy) was used to evaluate the 
magnetisation of pelletized materials (i.e. RCPfluidMAG-CT and RCPFeHA) under a field of 2700 A/m at a 
distance of 18 mm.  
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2.3.6 Microspheres degradation study  
Microspheres degradation tests were carried out under two different conditions that mimic i) the 
physiological (pH 7.4) and ii) the inflammatory (pH 5.0) environment. For physiological condition, 
osteogenic differentiation medium was prepared with DMEM (Gibco), 10% Fetal Bovine Serum (FBS), 1% 
penicillin-streptomycin (100 U/mL-100 µg/mL), 10 mM β-glycerophosphate and 50 µg/mL ascorbic acid. 
The inflammatory like condition was achieved by buffering the previous medium with sterile sodium 
acetate-acetic acid buffer solution, reaching pH 5.0. The as-prepared media were named as DMEM and 
DMEM-IM, respectively.  
Each type of microspheres were sterilised in PBS 1X by using autoclave (120ºC for 20 minutes). Then PBS 
1X was substituted by DMEM or DMEM-IM obtaining a final concentration of 30 mg/mL of microspheres. 
Three samples of each type of microspheres were investigated. DMEM or DMEM-IM only were used as 
controls. Microspheres degradation study was carried out in the incubator at 37°C in an atmosphere of 5% 
CO2, up to 28 days.  
Microspheres morphology was evaluated by SEM, after 7, 14, 21 and 28 days. Moreover, RCPHART and 
RCPFeHA at day 28 were washed four times with milli-Q water, freeze dried and stored for further FTIR 
and XRD characterisations. 
 
Ions dissolutions evaluation   
The elemental concentration of calcium and iron ions released from RCPfluidMAG-CT, RCPHART and 
RCPFeHA in DMEM and DMEM-IM was evaluated by ICP-OES. At predetermined time points (i.e. 12h, 
24h, 48h, 7 days, 14 days, 21 days and 28 days), both media (i.e. DMEM and DMEM-IM) were collected 
from microspheres by centrifugation (13300 rpm, for 12 minutes) and the released ions were investigated, as 
well as the differences on the pH by using pH meter with electrochemical sensor (XS instruments, Italy). 
DMEM and DMEM-IM were replaced at the as-mentioned time points. The retrieved media (0.6 mL) were 
digested with 1 mL of HNO3 (65 wt%) and the volume of the solution was raised to 3 mL by adding 
deionized water, and further analysed by ICP-OES. Predetermined concentrations of Ca and Fe elements 
were also prepared and used as standard calibration. The released ions were normalised to the total 
concentration of each element (i.e. Catotal and Fetotal) in 30 mg of microspheres. Three samples were used per 
material and the ions concentration was expressed as Mean ± standard error of the mean (SEM).  
 
2.3.7 Biological characterisation 
	  
2.3.7.1 Cell culture 
Mouse pre-osteoblast cell line, MC3T3-E1 Subclone 14 (ATCC cell bank, Manassas, VA, USA) was used 
for the biological investigation. In detail, MC3T3-E1 cells were cultured in αMEM without ascorbic acid 
(Gibco), 10% FBS and 1% penicillin-streptomycin (100 U/mL-100 µg/mL). Cell culture was kept at 37°C in 
an atmosphere of 5% CO2, later on the cells were detached from culture flasks by trypsinization, centrifuged 
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and re-suspended in cell medium. Cell number and cell viability were assessed by trypan-blue dye exclusion 
test. 
For the experiment, cells were plated at a density of 2500 cells/cm2 in osteogenic medium in 48-well plates 
for cell viability with predetermined concentration of each type of microspheres (i.e. 10 µg/mL, 100 µg/mL 
and 500 µg/mL); in 24-well plates for cell damage evaluation and cell morphology; in 6-well plates for gene 
expression and western blot analysis, 24 hours after cells seeding, different concentrations of each sterilised 
microspheres (i.e. 10 µg/mL and 100 µg/mL of RCP, RCPfluidMAG-CT, RCPHART and RCPFeHA) were 
added to the cell culture. All the cell-handling procedures were performed in a sterile laminar flow hood and 
all cell-culture incubation steps were performed at 37 °C with 5% CO2. 
 
2.3.7.2 Cell viability  
Cell viability as function of cell number based on metabolic activity was evaluated by XTT assay, following 
the manufacture’s protocol (Thermo Fisher Scientific, U.S.A.). Briefly, 6 mg of XTT was dissolved in 6 mL 
of osteogenic cell medium and then was added 15 µL of 10 mM of PMS solution. After, 75 µL of the as-
prepared solution was dropped in each well and incubated at 37 ºC in CO2 incubator for 2 hours and the 
absorbance was analysed at 450 nm by using a Multiskan FC Microplate Photometer (Thermo Fisher 
Scientific, USA). All the tested microspheres were prepared in various concentrations and the cell viability 
was analysed after 1, 3 and 7 days of cell seeding. Cells only and microspheres without cells were used as 
controls and the experiments were conducted in triplicates and plotted as Mean±SEM.  
 
2.3.7.3 Cell damage and cell morphology evaluation 
Apoptotic cells  
After 24h and 72h of incubation, cells were evaluated with Annexin V/Dead Cell Apoptosis Kit (Molecular 
Probes) according to manufacturer’s instructions. Briefly, cells were washed with cold PBS 1X, and 
incubated with 1X annexin-binding buffer, Alexa Fluor 488 annexin V and propidium iodide (PI) working 
solution for 15 minutes at room temperature following by DAPI staining for cell nuclei. Cells incubated with 
or without Doxorubicin  (0.54 µg/mL; DOX) were used as positive and negative control, respectively. One 
sample per group was analysed and images were acquired with an inverted Ti-E fluorescence microscope 
(Nikon). 
 
Reactive Oxygen Species (ROS) 
ROS formation at 24h and 72h was analysed by ROS indicator kit (carboxy-2,7-difluorodihydrofluorescein 
diacetate, carboxy-H2DFFDA, Molecular Probes), according to manufacturer’s instructions. Briefly, cells 
were incubated with ROS detection reagent for 15 minutes at 37°C, then this solution was removed and cell 
culture medium was added for 10 minutes at 37°C, before washing the cells with PBS 1X following by 
DAPI staining for cell nuclei. Cells incubated with or without 100 µM of hydrogen peroxide (H2O2) were 
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used as positive and negative control, respectively. One sample per group was analysed and images were 
acquired with an inverted Ti-E fluorescence microscope. 
 
Actin filament staining 
At day 3, cell morphology was evaluated by phalloidin staining. Cells were washed with PBS 1X for 5 min, 
fixed with 4% (w/v) paraformaldehyde for 15 minutes. Permeabilization was performed with PBS 1X with 
0.1% (v/v) Triton X-100 for 5 min. FITC-conjugated phalloidin (Invitrogen, U.S.A.) 38 nM in PBS 1X was 
added for 20 minutes at room temperature in the dark. For nuclear staining the cells were incubated with 300 
nM of DAPI for 5 min. Images were acquired by an Inverted Ti-E fluorescence microscope. One sample per 
group was analysed.  
 
Haematoxylin and Eosin Staining (H&E) 
After 3 days of cell culture, cells were washed with PBS 1X for 5 minutes, fixed with 4% (w/v) 
formaldehyde for 15 minutes, washed twice with PBS 1X for 5 minutes and stained with H&E. Briefly, the 
cells were incubated with Mayer’s haematoxylin for 7 minutes, then differentiated with tap water for 10 
minutes. Cells were then stained with eosin Y (0.25%) for 30 seconds, washed with milli-Q water and 
mounted. Images were acquired by an Inverted Ti-E fluorescence microscope. One sample per group was 
analysed.   
 
2.3.7.4 Western Blot 
After 7 days of culture the cells, cultured with 100 µg/mL of microspheres, were lysed in a 
Radioimmunoprecipitation buffer (RIPA buffer) supplemented with a proteinase inhibitor cocktail (Cell 
Signalling Technology, U.S.A.). Protein concentration in each cell lysate supernatant was determined by a 
colorimetric assay (Kit DC Protein Assay, Bio-Rad, U.S.A.). The protein sample were diluted in sample 
buffer (3:1), and loaded and separated in a 4–20% Mini-PROTEAN TGX stain-free protein gels (Bio-Rad, 
U.S.A.), using a Mini-PROTEAN electrophoresis cell kit (Bio-Rad, U.S.A.). The proteins were then 
transferred to nitrocellulose membranes by means of a Trans-Blot Turbo™ transfer system (Bio-Rad, 
U.S.A.), with the blots incubated thereafter for 30 min at room temperature in a blocking solution of 2.5% 
non-fat dry milk in PBS 1X. The membranes were incubated overnight at 4°C with primary rabbit antibody 
anti-alkaline phosphatase (ALP, Abcam, UK), anti-osteocalcin (LifeSpan BioSciences, U.S.A.) and anti-β-
actin (Cell Signaling Technology, USA) as internal control. Moreover rabbit antibody anti-LC3B-I and 
LC3B-II (Cell Signalling Technology, USA) was used to detect autophagy as cellular stress marker. Then 
membranes were incubated with a horseradish goat peroxidase-linked secondary antibody anti-rabbit (Bio-
Rad, U.S.A.) for 1h 30 min. An enhanced chemiluminescence kit (ECL, Bio-Rad, U.S.A.) was used to 
visualize the protein bands with ChemiDoc XRS+ (Bio-Rad, U.S.A.). In order to evaluate the relative protein 
expression, the ALP, osteocalcin and LC3B-I and LC3B-II band intensities were quantified by densitometry 
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using ImageLab Software and were then normalized over the signal of the corresponding bands of β-actin 
(i.e. loading control). 
 
2.3.7.5 Quantitative real-time polymerase chain reaction (qPCR)  
The gene expression profile of MC3T3-E1 cells, cultured for 7 days with 100 µg/mL of microspheres, was 
assessed by using qPCR. Cells only were cultured in osteogenic differentiation medium and were used as 
calibrator in order to obtain a relative quantification. Total RNA was harvested by using Tri Reagent, 
followed by the Direct-zol RNA MiniPrep kit (Zymo Research) according to manufacturer's instructions. 
RNA integrity was analyzed by native agarose gel electrophoresis and the quantification was performed by 
using the Qubit® 2.0 Fluorimeter together with the Qubit® RNA BR assay kit, according to the 
manufacturer's instructions (Invitrogen, U.S.A.). Total RNA (i.e. 500 ng) was reverse transcribed to cDNA 
using the High-Capacity cDNA Reverse Transcription Kit, according to manufacturer's instructions (Applied 
Biosystems, U.S.A.). The relative quantification of the expression of the genes, i.e. osteonectin (SPARC, 
Mn00486332-m1), osteocalcin (BGLAP, Mm00649782_gH), collagen I (COL I, Mm00483888_m1), 
osteopontin (OPN, Mm004336767) and glyceraldehydes-3-phosphate dehydrogenase (GAPDH, 
Mm99999915_g1), used as housekeeping gene, were performed by StepOneTM Real-Time PCR System 
(Applied Biosystems, U.S.A.). Data were collected using the OneStep Software (v.2.2.2) and relative 
quantification was performed using the comparative threshold (CT) method (ΔΔCT) where the relative gene 
expression level equals 2-ΔΔCt (Boanini et al. 2016; Livak & Schmittgen 2001). Experiments were performed 
in duplicate, using three technical replicates for each experiment and representative results were normalized 
to RCP. Error bars reflect one standard error of the mean of three technical replicates, as described elsewhere 
(Liu et al. 2013; Ivey et al. 2008).  
 
2.3.8 Statistical analysis 
Statistical analysis was performed by using GraphPad Prism 5 software. The unpaired t-test was used for 
ions release and two-way ANOVA, followed by Bonferroni post-tests was used for calcium absorption in 
DMEM. Data is plotted as Mean ± SEM of n. 3 samples per each group. 
Statistical analysis of biological tests was performed by using two-way ANOVA followed by Bonferroni 
post-tests for XTT analysis and data was plotted as mean ± SEM of n. 3 samples per each group. All the 
other biological results were evaluated by one-way ANOVA followed by Tukey’s multiple comparison test 
and data were plotted as mean ± SEM of n. 2 samples per each group. Results were considered statistically 
significant when p<0.05. 
 
	  
	  
	    48 
 
  
2.4 Effect of microspheres composition on differentiation of human mesenchymal stem cells  
	  
2.4.1 Materials  
RCP, RCPHART and RCPFeHA microspheres were previously prepared by emulsification process and 
crosslinked with DHT treatment, as described in section 2.2.4. In the following experiments, microspheres 
were sterilised by autoclave. Briefly, predetermined amount of microspheres were introduced in Eppendorf 
and covered with aluminium foil, then were introduced in glass vial and closed with aluminium foil, and 
sterilised in autoclave at 120°C for 20 minutes. Subsequently, the glass vials were opened into the sterile 
hood and the microspheres were left to dried for about 30 minutes.   
 
2.4.2 Microspheres characterisation  
The specific surface area of microspheres was measured by BET method (Brunauer, Emmett e Teller), using 
nitrogen adsorption (Sufer, Thermoscientific, U.S.A). Samples were previously degassed at 50°C under 
vacuum (about 3.0x10-3 torr) for 15 hours. 
	  
2.4.3 Cell culture  
Leftover bone samples from children undergoing facial reconstruction surgery were used to obtain hMSCs 
under umbrella agreements between patients and Dutch university hospitals for the use of waste materials 
(MEC2014-106, Erasmus MC Rotterdam). Three independent Donors coded as Donor 1, Donor 2 and Donor 
3 were investigated. hMSC’s were seeded at density of 5×10! cells per T175 flask in 20 mL of standard cell 
medium (i.e. Minimum Essential Medium alpha (α-MEM, Gibco by Life Technologies, U.S.A.), 
supplemented with 10% heat-inactivated fetal calf serum (FCS, Lonza), 50 µg/mL of gentamycin 
(Invitrogen, U.S.A.), 1.5 µg/mL fungizone (Invitrogen, U.S.A.), 5 ng/µL fibroblast growth factor-2 
(Instruchemie B.V., The Netherlands) and 0.1 mM of ascorbic acid (Sigma Aldrich, U.S.A.)) and were 
cultured at 37°C under humidified incubator and 5% of carbon dioxide (CO2). Cell medium was renewed 
every 3-4 days. Cells were detached, upon reaching near confluence (i.e. 80–90%), from culture flasks by 
trypsinization (0.25% trypsin/EDTA; Life Technologies, U.S.A.), centrifuged and re-suspended in standard 
cell medium. Cell number and cell viability were assessed by trypan-blue dye exclusion test. 
 
Cell seeding in monolayer  
hMSCs (P5) were re-suspended in standard cell medium and were cultured at density of 3000 cells/cm2 in 
12-well plate. Cells were left to adhere to the well plate for 24 hours, and then 500 µg of each type of 
microspheres were added on the top of the cells. The cell culture was kept for 7 days at 37°C under 
humidified incubator and 5 % of CO2. Samples were analysed by optical microscope and were treated with 
Live/Dead assay, for further cell viability evaluation (section 2.4.4).  
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Cell seeding strategy on microspheres  
Preliminary investigations were carried out in presence of hMSC’s (≤P8). The amount of cells seeded on the 
different microspheres was investigated in the range of 3500, 700 and 350 cells/cm2 and specific surface area 
of the microspheres was considered. On the other hand, 350 cells/cm2 were seeded in all tested microspheres 
take into account the specific surface area of RCP microspheres, thus equal cell number in all tested 
microspheres (Table 2).  
 
Table 2. Cells numbers used in the optimisation of cell seeding. (* Values obtained from specific 
surface area of microspheres; ** based on specific surface area of RCP microspheres).    
Microspheres 
(Ms) 
Specific surface area of 
microspheres, cm2/mg 
* 3500 cells/cm2 * 700 cells/cm2 
* 350 
cells/cm2 
** 350 
cells/cm2 
RCP 1352.8 2 367 400 473 480 236.740 
236.740 RCPHART 291.1 509 425 101 885 50.942 
RCPFeHA 1941.1 3 396 925 679 385 339.692 
 
The experiments were carried out with standard cell medium. Previous to cell seeding, for a completely 
interaction of the cells with all tested microspheres, the bottom of 6-well plate or 12-well plate were filled 
with 2 % of agarose and left to dried at room temperature. For the cell seeding, 500 µg of each type of 
microspheres were placed in eppendorf and predetermined amount of cells were seeded on the top of 
microspheres (Table 2). At density of 3500 cells/cm2, the cells were mixed with microspheres by inversion 
process at each 10 minutes until reaching one hour and then were transferred to the 6-well plate or 12-well 
plate and kept in culture for three days (Figure 7A).  
Moreover, for 700 and 350 cells/cm2 the seeding strategy was slightly modified. Briefly, 500 µg of each type 
of microspheres were introduced in eppendorf and predetermined amount of cells were seeded on the top of 
microspheres (Table 2), then cells and microspheres were mixed by inversion at each 10 minutes until one 
hour of seeding. Subsequently, cells and microspheres were left to sediment and standard cell medium was 
collected and replaced three times, completing another hour (Figure 7B). After 2 hours of seeding, cells and 
microspheres were placed in the well plates covered with agarose. Cell culture was kept at 37 ºC under 
humidified incubator and 5 % of CO2. Triplicates of microspheres were prepared and the results were 
showed as mean of standard deviation (Mean±SD).    
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Figure 7. Cells seeding strategy for 3500 cell/cm2 (A) and for 700 and 350 cells/cm2 (B). 
 
Osteogenesis   
hMSCs from the Donor 1, Donor 2 and Donor 3 (P4) were seeded in all tested microspheres at density of 
236.740 cells in 500 µg of microspheres in eppendorfs, by following the previous seeding method (Figure 
7B). Cells and microspheres were transferred to 6-well plate or 12-well plates (previous covered with 2% of 
agarose) in standard cell medium. After 24 hours of incubation, standard cell medium was replaced by 
osteogenic induction medium (i.e. high-glucose DMEM (Invitrogen, U.S.A.) with 10% of FCS, 50 µg/mL 
gentamycin (Invitrogen), 1.5 µg/mL fungizone (Invitrogen, U.S.A.), 10 mM glycerol 2-phosphate (Sigma 
Aldrich, U.S.A), 0.1 µM dexamethasone (Sigma Aldrich, U.S.A) and 0.1 mM ascorbic acid (Sigma Aldrich, 
U.S.A)). The as-obtained combination of microspheres and cells were encoded as 3D templates, from RCP, 
RCPHART and RCPFeHA. For the controls, cells were seeded in 6-well or 12-well plate at density of 3000 
cells/cm2. Osteogenic induction medium was replaced twice a week. The samples were harvested at the latest 
point prior to detachment of the cells monolayer and might varied between 17 days to 21 days, depending on 
the Donor.    
 
2.4.4 Cell viability and proliferation  
DNA assay 
At predetermined time points, samples were collected, introduced into eppendorf’s and were washed once 
with PBS. For the digestion of the samples a papain buffer containing 0.2 M of sodium phosphate monobasic 
(≥99.0%, Sigma Aldrich, U.S.A) and 0.01 M of ethylenediaminetetraacetic acid disodium salt dehydrate 
(Sigma Aldrich, U.S.A) was prepared and freshly was added 0.01 M of cysteine HCL (Sigma Aldrich, 
U.S.A) and 250 µg/mL of papain (Sigma Aldrich, U.S.A). Defined volume of papain solution (300 µL) was 
dropped in the samples and incubated overnight at 60 ºC, then the samples were vortex and incubated for 
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more one hour at 60ºC. DNA assay with ethidium bromide was used to determine the DNA amount in the 
samples. Samples and calibration curve (0 – 1.25 µg of Deoxyribonucleic acid sodium salt from calf thymus 
(DNA)) were pipetted in Duplo in 96-well plate (50 µL), then 100 µL of heparin solution (8.3 IU/mL dilution 
in PBS, Leo Pharmaceutical Products, Denmark) and 50 µL of Ribonuclease type III-A solution (0.05 
mg/mL dilution in PBS, Sigma Aldrich, U.S.A) were added to each well, and incubated at 37ºC for 30 
minutes. After incubation, 50 µL of ethidium bromide (25 µg/mL dilution in PBS, Thermo Fisher Scientific, 
U.S.A.) were placed in each well and the plate was read on the Wallac Victor (excitation 340 nm and 
emission 590 nm). The results were expressed Mean±SD in the same Donor and were plotted as Mean±SD 
from three independent Donors (n=3).   
The percentage of cells adhere on the microspheres (CellMS, %) were calculated, as follow:  
𝑪𝒆𝒍𝒍𝑴𝒔 = 𝑫𝑵𝑨𝒒𝟖.𝟓 𝑵°𝒔𝒆𝒆𝒅         ×𝟏𝟎𝟎                                       
Equation 1. Percentage of cells adhered on the microspheres.  
	  
Where as, 𝐷𝑁𝐴𝑞 was the DNA quantified by the DNA assay and was expressed in pg; 8.5 was the DNA 
amount in each cell, pg (Dormer et al. 2012) and 𝑁°!""# was the initial cells number seeded in each type of 
microspheres.   
 
DAPI staining 
3D templates were placed in 24-well plate and 1 mL of formalin (4%) was added to fix the cells for one hour 
at room temperature. 3D templates were washed three times with PBS; were stained 5 minutes with DAPI 
solution (5 mg/mL) and were washed three times with PBS. The images were acquired by using fluorescent 
microscope Zeiss Axiovert 200M, with Axiovert software (Germany).  
 
Live & Dead assay 
Live/Dead® viability/cytotoxicity kit for mammalian cells (Life Technologies, U.S.A.) was performed 
according to manufacturer's instructions. Briefly, the cell medium was recovered from RCPFeHA 3D 
template (in 24-well plate) or from cells seeded on 12-well plates and were washed once with saline solution 
(i.e. 0.9% of NaCl in milli-Q water), then were incubated with Live/Dead solution composed by 
Calceinacetoxymethyl (Calcein AM) and Ethidium homodimer-1 (EthD-1) (e.g. 1 mL of saline solution with 
1 µL of Calcein AM and 1.5 µL of EthD-1), wrap with aluminium foil and incubated for 40 minutes at 37°C 
in an humidified atmosphere and 5% of CO2. Live/Dead solution was removed and samples were washed 
twice with saline solution. Samples were kept in saline solution during the viability analysis with fluorescent 
microscope Zeiss Axiovert 200M, with Axiovert software (Germany). Three samples per group were 
analysed and an example of each group was showed. 
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2.4.5 Calcium assay 
The decrease of calcium concentration in the osteogenic induction medium was evaluated over the course of 
the experiment. At predetermined time points, cell medium was collected from the cell culture and analysed 
by calcium assay. Briefly, 10 µL of cell medium or standard curve were pipetted in Duplo in 96-well plate. 
α-MEM was prepared with known concentration of calcium (i.e. 0 - 3mM) and was used as standard curve. 
For the detection of the calcium, two distinct solutions were prepared: Solution I) 1 M of ethanolamine 
buffer (pH 10.6) and Solution II) 0.35 mM O-cresolphthalein complexone, 19.8 mM 8-hydroxyquinoline and 
0.6 M hydrochloric acid. Those solutions were mixed in the proportion of 1:1 and 100 µL was pipetted in 
each well. The absorbance was measure at 595 nm with Versamax (Molecular Devices). The results were 
expressed as Mean±SD from three independent Donors (n=3) or as Mean±SD in each Donor.  
 
2.4.6 Gene expression 
RNA isolation and DNA synthesis 
Samples were transferred to 1.5 mL eppendorf, washed once with PBS and were snap freezing with liquid 
nitrogen. RNA was isolated from the 3D templates or cells monolayer by homogenizing samples with a 
Eppendorf-potter in 350 µL of Trizol (Thermo Fisher Scientific, U.S.A.). The total RNA was extracted by 
adding 70 µL of chloroform (Sigma Aldrich, U.S.A) and three phases after centrifugation were formed. RNA 
was collected from the top layer and equal volume of 70% v/v of ethanol (Sigma Aldrich, U.S.A) was added. 
The RNA was purified by using RNeasy Mini Kit with RNeasy MinElute spin columns (Quiagen, The 
Netherlands), following the manufacturer’s instructions and total RNA was quantified by spectrophotometry 
(NanoDrop 2000, Thermo Scientific, The Netherlands) at wavelength of 260 and 280 nm. 300 ng of RNA 
was reverse transcribed into complementary DNA (cDNA) by using RevertAid First Strand cDNA Synthesis 
kit (Thermo Fisher scientific, U.S.A.), according to the manufacturer’s protocol.   
 
Quantitative PCR 
Osteogenic gene transcriptions were quantified on Bio-Rad CFX thermal cycler (Bio-RAD, U.S.A). 
Thermocycler conditions comprised an initial holding at 95°C for 10 min, followed by one step at 95°C for 
15 s and 60°C for 60 s for 40 cycles. For gene expression tests, three different housekeeping genes were 
evaluated, such as Ubiquitin C (UBC), Glyceraldehyde-3-phosphate dehydrogenase (GADPH) and Beta-2-
microglobulin (B2M), while the investigated osteogenic genes were Gamma-carboxyglutamic acid-
containing protein (BGLAP), Collagen type I (COL I), Integrin-binding sialoprotein (IBSP), Alkaline 
phosphatase (ALPL) and Osteonectin (SPARC).  
UBC and B2M mRNA levels were analyzed with qPCR™ Mastermix Plus for SYBR® Green I (Eurogentec, 
Nederland B.V., The Netherlands), while GADPH, BGLAP, COL I, IBSP, ALPL and SPARC, TaqMan 
Master Mix (Applied Biosystems, U.S.A.) was applied, according to the manufacturer’s instructions. The as-
corresponding primers were described in Table 3. (Groeneveldt et al. 2014; Leijs et al. 2012; Verseijden et 
al. 2009). The CT values of the housekeeper genes GADPH, B2M and UBC were averaged by using 
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geometric averaging of every sample. This average is the best keeper index (BKI) for every single sample. 
All separate CT values were corrected to the BKI by using the 2−ΔCT formula (Leijs et al. 2012). Values were 
represented as Mean±SD for samples from three independent Donors (n=3) or were plotted as Mean±SD in 
each Donor.  
 
Table 3. Primers sequences used to define the osteogenic expression of the genes.  
 Forward Reverse 
H
ou
se
ke
ep
in
g 
ge
ne
s 
GADPH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC 
UBC ATTTGGGTCGCGGTTCTTG TGCCTTGACATTCTCGATGGT 
B2M 5’-TGCTCGCGCTACTCTCTCTTT-3’ 
5’-TCTGCTGGAT 
GACGTGAGTAAAC-3’ 
O
st
eo
ge
ni
c 
ge
ne
s ALPL GACCCTTGACCCCCACAAT GCTCGTACTGCATGTCCCCT 
BGLAP GAAGCCCAGCGGTGC CACTACCTCGCTGCCCTCC 
IBSP TGCCTTGAGCCTGCTTCC GCAAAATTAAAGCAGTCTTCATTTTG 
COL I CAGCCGCTTCACCTACAGC TTTTGTATTCAATCACTGTCTTGCC 
SPARC ATCTTCCCTGTACACTGGCAGTTC CTGGGTGTGGGAGAGGTACC 
 
2.4.7 von Kossa staining 
Cells monolayer were washed once with PBS and fixed with 4% of formaldehyde for one hour, then washed 
several times with distilled water and milli-Q water and stained with von Kossa staining. Briefly, cells were 
incubated with 5 % of silver nitrate (AgNO3, ≥ 99.5%, Sigma Aldrich, U.S.A) and incubated in light desk up 
to 60 minutes. Cells were washed once with milli-Q water and counterstained with thionin solution (0.4% 
thionin in 0.01 M aqueous sodium acetate, (Sigma Aldrich, U.S.A)) for 5 minutes. By the end, the samples 
were dehydrate in 70% (10 s), 96% (1 s) and 100% (1 minute) of ethanol (Vector Laboratories, U.S.A.).  
 
2.4.8 Preparation of histology samples  
Samples were fixed in 4% formaldehyde (Klinipath) in PBS, embedded in 2% w/v agarose (Eurogentec, 
Belgium) and subsequently processed in paraffin for light microscopy. The samples were cut into 5 µm 
sections by using a microtome (Leica RM 2135).    
   
Haematoxylin and Eosin staining  
Pre-treated paraffin sections were deparaffinise in Xylene (2 times, 5 minutes each) and in 100% (2 times, 5 
minutes each), 96% (1 time, 5 minutes) and 70% (1 time, 5 minutes) of ethanol, then were washed twice with 
distilled water for 3 minutes each. Sections were transferred to haematoxylin solution (Sigma Aldrich, 
U.S.A) for 20 seconds and washed with running tapwater for 10 minutes, then were immersed in eosin Y 
solution (2% in 50% of ethanol and 0.5 mL of glacial acetic acid, Merck, Germany) during 45 seconds. By 
the end, the sections were introduced in 70 % of ethanol (10 seconds) and dehydrate one minute in each step, 
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in 96% and 100% of ethanol and two times in o-xylene (Sigma Aldrich, U.S.A). The stained sections were 
mounted with Depex mounting medium (Merck, Germany) and analysed on optical microscope.   
 
Thionin Staining 
The pre-treated paraffin sections were stained with 0.04% thionin (Gurr, Essex, UK) in 0.01 M aqueous 
sodium acetate pH 4.5 for up to 15 minutes, and then the sections were counterstained for 5 min with a 0.1 % 
solution of fast green in water for 5 minutes (Bulstra et al. 1993; Bos et al. 2001). The stained samples were 
evaluated by using optical microscope.  
 
2.4.9 Statistical analysis  
Cell seeding strategies and gene expression were statistically analysed by one-way ANOVA by Tukey’s 
Multiple Comparison Test. The calcium content was evaluated by two-way ANOVA by Bonferroni posttests. 
The p value < 0.05 was considered statistically significant.  
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2.5 Superparamagnetic microspheres as a sustained carrier for rhBMP-2 delivery 
	  
2.5.1 Materials  
Recombinant human bone morphogenetic protein-2 (rhBMP-2) and fluorescent recombinant human bone 
morphogenetic protein-2 (texas red rhBMP-2) were kindly furnished by Fraunhofer Institute for Interfacial 
Engineering and Biotechnology (Germany).    
Porous microspheres (≈ 1 µm) composed by collagen type I like peptide (RCP) were kindly provided by 
Fujifilm Manufacturing Europe B.V. (The Netherlands) and coded as RCPporous.  
Non-mineralised and mineralised microspheres (i.e. pure RCP, RCPfluidMAG-CT, RCPHART and 
RCPFeHA) were obtained by the as-mentioned emulsification process, as described in the section 2.2.4.   
 
2.5.2 Assessment of rhBMP-2 release from microspheres  
2.5.2.1 Microspheres characterisation  
Predetermined amount of microspheres were placed in warm solution of agarose (2 wt%) and left to solidify, 
then were introduced in sample holder and embedded with H-OCT compound (Histo-Line Laboratories, 
Italy). Sliced samples (30 µm thickness) were obtained by using a microtome cryostat (5000 MC, Histo-Line 
Laboratories, Italy) and the morphology of microspheres’ cross-sections were analysed by using Scanning 
Electron Microscope (SEM) (FEI Quanta 600, USA) in low vacuum mode with an accelerating voltage of 10 
kV and a working distance of 10 mm. RCPFeHA was analysed by using Field Emission Scanning Electron 
microscopy (FE-SEM, Zeiss Sigma) and Ca, P and Fe distribution was evaluated by microanalysis with 
Energy dispersive spectroscopy (EDS; Oxford X-Act with 10 mm2 silicon drifted detector (SDD)). The 
results were evaluated by INCA microanalysis Suite software.  
Microspheres and rhBMP-2 surface charge were evaluated by using ζ-potential (Zetasizer Nano analyzer 
(Malvern, UK). ζ-potential measurements through electrophoretic mobility were performed in disposable 
folded capillary cells (DTS1061; Malvern, UK) at 25 °C. Microspheres surface charge was evaluated in 
HEPES buffer (i.e. 0.01 M; pH 7.4) at concentration of 1.2 mg/mL of microspheres, while 12 µg/mL of 
rhBMP-2 was evaluated. The ζ-potential average was calculated from three separate measurements (100 runs 
each) in each type of microspheres. The results were showed as Mean±SEM.  
The contact angle measurements of the as-investigated microspheres were carried out by optical contact 
angle system stabilized with camera (Contact angle, Drop shape analyser with IDS camera, Kruss GmbH, 
Germany). Briefly, a pellet of each sample was obtained by pressing ≈ 150 mg of microspheres (100 mbar) 
and deionized water droplets (2 µL) were carefully dropped onto the pelletized microspheres. Contact angle 
was captured and calculated by applying fitting method (tangent) with approximation by using Kruss 
advance software. The results were showed as Mean±SEM. The effect of surface morphology and 
microspheres composition on water adsorption was also evaluated for about 12 minutes, and the results were 
showed as Mean±SD.  
Predetermined amount of microspheres in PBS were placed in 24-well plate at 37°C for 24 hours to swell. At 
each time point (i.e. 1h, 3h, 6h, 9h and 24h) the swollen microspheres were observed by inverted Nikon Ti-E 
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microscope (Nikon Corporation, Tokyo, Japan) and analysed by Image J. The swelling percentage (Sw, %) 
was calculated according to the following equation, 
 𝑺𝒘 = 𝑫𝒔𝑫𝒅 − 𝟏 ×𝟏𝟎𝟎            
Equation 2. Percentage of swelling capacity of microspheres.  
	  
(where, 𝐷! and 𝐷! are the diameter of the swollen and dried microspheres, respectively). The data was 
obtained by assuming a spherical shape and measuring the area of microspheres (acquired by Image J) and 
translate to microspheres diameter. The results were showed as Mean±SEM.  
Data of total porosity (i.e. the volume percentage of pores) of RCPFeHA microspheres was determined by 
mercury intrusion porosimetry and was executed into the range between 0 and 200 MPa (Pascal 140/240 
series porosimeter, Thermo Finnigan, U.S.A.).  
The chemical interaction of microspheres with rhBMP-2 was evaluated by Fourier Transform Infrared 
Spectroscopy (FTIR) (Avatar 320 FT-IR, Thermo Nicolet, Canada), as presented in section 2.1.3.  
The specific surface area (SSA) of RCP, RCPfluiMAG-CT, RCPHART and RCPFeHA was measured by 
BET method (Brunauer, Emmett e Teller) by using nitrogen adsorption (Sufer, Thermoscientific, U.S.A) and 
were previously degassed at 50°C under vacuum (about 3.0x10-3 torr) for 15 hours. 
 
2.5.3 In vitro loading and release of rhBMP-2   
In vitro rhBMP-2 loading 
rhBMP-2 was loaded to the all tested microspheres by adsorption method and the experimental setup was 
adapted from (Mumcuoglu et al. 2016). Briefly, in 1.5 mL eppendorf LoBind tubes 50 µL or 75 µL of 
predetermined concentration of rhBMP-2 were pipetted on top of 15 mg of dry non-mineralised 
microspheres (i.e. RCP and RCPfluidMAG-CT) and mineralized microspheres (i.e. RCPHART and 
RCPFeHA), respectively. Soluble rhBMP-2 was used as a control. All the as-prepared samples were 
overnight incubated at 4 °C to allow the completely adsorption of rhBMP-2 on microspheres during the 
swelling process.  
 
In vitro release of rhBMP-2  
The used release medium was Dulbecco’s Modified Eagle’s Medium (DMEM), supplemented with 1 % 
bovine serum albumin (BSA) and 1 % penicillin-streptomycin (100U/mL - 100µg/mL). After overnight of 
rhBMP-2 adsorption, predetermined volume of release medium was added on top of swollen microspheres 
(i.e. 950 µL in RCP and RCPfluidMAG-CT and 925 µL in RCPHART and RCPFeHA) to obtain a final 
concentration of 900 ng/mL or 400 ng/mL of rhBMP-2. Samples were incubated at 37 °C, under three 
different conditions: agitation (≈100rpm), static and pulsed electric magnetic field (PEMF).  
At given time points up to 14 days, the release medium was collected after centrifugation at 3000 rpm for 5 
min and was replaced by fresh release medium (900 µL). After 14 days of release assay, 900 µL of urea 
solution (6 M) was added to the microspheres and were incubated 4 hours at 37 °C. This supernatant was 
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collected by centrifugation and dialyzed with cellulose membrane (3500 D, Medicell Membranes Ltd, UK), 
for 3 days at 4 °C. milli-Q water was replaced twice a day for the completely removal of the salt. Meanwhile, 
all the microspheres were washed twice with PBS and the supernatant was collect for further analysis. Then, 
microspheres and soluble rhBMP-2 were digested by using predetermined concentration of collagenase 
solution in DMEM (i.e. 1 mg/mL, 2 mg/mL, 5 mg/mL and 10 mg/mL) and 900 µL was added to the 
microspheres and incubated two days at 37°C. All the supernatants were further analysed by sandwich 
enzyme-linked immunosorbent assay (ELISA) development kit specific for rhBMP-2 (PeproTech, USA), as 
described below.  
 
Enzyme-linked immunosorbent assay (ELISA)  
The detection of rhBMP-2 was investigated by using sandwich ELISA technique, according to the 
manufacturer's protocol. Briefly, the used 96-well plate was prepared with a known quantity (0.50 µg/mL) of 
bound antibody to capture the rhBMP-2, then the non-specific binding sites were blocked with solution of 
bovine serum albumin (1 %) and unknown released rhBMP-2 was added to the plate. A specific detection 
antibody (1 µg/mL) was added to “sandwiches” the rhBMP-2, then enzyme-linked secondary antibodies 
were applied to bind detection antibody and unbounded conjugates (antibody-enzyme) were washed off. By 
the end, substrate was added and was enzymatically converted to a color and color development was 
monitored with an ELISA plate reader at 405 nm and 620 nm (Gan & Patel 2013). The concentration of 
unknown released rhBMP-2 was quantified relative to a rhBMP-2 standard calibration curve (ranging from 
47 to 3000 pg/mL) run on the same plate, while the percentage of released rhBMP-2 was calculated respect 
to the positive control (soluble rhBMP-2, at concentration 900 or 400 ng/mL).  
Three samples of each group and controls were investigated and the amount or percentage of rhBMP-2 
released was expressed as Mean±SEM.  
 
2.5.4 Loading efficiency of microspheres and interaction with rhBMP-2 
Quantitative efficiency  
In order to evaluate the loading efficiency of all the tested microspheres, predetermined concentration of 
rhBMP-2 was adsorbed on 15 mg of microspheres and was kept overnight at 4°C.  
Further, to the microspheres was added milli-Q water to obtain a final concentration of 900 ng/mL of 
rhBMP-2 and then washed three times with milli-Q water. At each washing step the milli-Q water was 
collected by centrifugation (3000 rpm, 5 minutes) and the non-adsorbed rhBMP-2 was evaluated by ELISA 
development kit. The percentage of loading efficiency (LE, %) of 15 mg of microspheres were calculated, as 
follow:  𝑳𝑬 = 𝑺𝒐𝒍𝒓𝒉𝑩𝑴𝑷𝟐!𝑺𝒖𝒎𝒏𝒂𝒅𝒔  𝒓𝒉𝑩𝑴𝑷𝟐𝑺𝒐𝒍𝒓𝒉𝑩𝑴𝑷𝟐 ×𝟏𝟎𝟎         
Equation 3. Calculation of loading efficiency of microspheres.  
	  
(where, 𝑆𝑜𝑙!!!"#! is soluble rhBMP-2 and 𝑆𝑢𝑚!"#$  !!!"#! is sum of non-adsorbed rhBMP-2 found in each 
washing step). The as-showed data were acquired from triplicated samples and presented as Mean+SEM.  
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rhBMP-2 interaction with microspheres  
To evaluate the interaction of rhBMP-2 with all tested microspheres, the previous washed samples were 
freeze-dried (0.1 mbar) and evaluated by FTIR analysis, following the protocol showed in the section 2.1.3. 
The relevant vibration modes were analysed by deconvolution and curve fitting technique (Fit by Sum with 
Lorentzian curve) by using MagicPlot Student 2.5.1 software.    
 
Qualitative efficiency  
To further identify the rhBMP-2 adsorption efficiency from RCP, RCPfluidMAG-CT, RCPHART and 
RCPFeHA, predetermined concentration of texas red rhBMP-2 was adsorbed by the microspheres overnight 
at 4°C. Meanwhile, empty microspheres, used as control and solution of rhBMP-2 was substituted by milli-Q 
water. Further, predetermined amount of milli-Q water was added to the microspheres to reach a final 
rhBMP-2 concentration of 900 ng/mL. Non-adsorbed rhBMP-2 was removed by centrifugation and washed 
three times with milli-Q water. Fluorescent images from empty microspheres, microspheres with 900 ng/mL 
of rhBMP-2 and washed microspheres were acquired by Inverted Ti-E fluorescence microscope (Nikon) with 
properly filter (i.e. Excitation of 557 nm and emission of 576 nm).  
 
2.5.5 In vitro rhBMP-2 bioactivity assay 
rhBMP-2 bioactivity was investigated by using C2C12 BRE-Luc bioassay cell line. To generate the BMP 
reporter cell line, C2C12 cells were stably transfected with pGL3(BRE)-luciferase reporter construct, as 
reported in (Herrera & Inman 2009; Brum et al. 2015) and were denominated as C2C12 BRE-Luc cell line.  
C2C12 BRE-Luc cell line were incubated in complete growth medium (i.e. Dulbecco's modified Eagle's 
medium without phenol (DMEM) containing 10 % of fetal calf serum (FCS), 1 % penicillin-streptomycin 
(100 U/mL-100 µg/mL) and 1 mM Sodium Pyruvate, then 200 µg/mL of Geneticin (G418, Thermo Fisher 
Scientific, USA) was added after 4 hours of platting the cells. Cell culture was kept at 37°C under humidified 
incubator and in an atmosphere of 5% CO2. Cells were detached from culture flasks by tripsinization, 
centrifuged (i.e. 10 minutes at 250 g) and re-suspended. Cell number and viability were assessed by trypan-
blue dye exclusion test. 
For the rhBMP-2 reporter assay, new investigations on rhBMP-2 release were carried out at final 
concentration of 900 ng/mL, by following the adsorption assay as mentioned in section 2.5.3. Therefore, the 
used release medium was growth medium of C2C12 BRE-Luc cell line and the experiments were performed 
at 37 °C in an atmosphere of 5% CO2. C2C12 BRE-Luc cell line (≤P19) were seeded into white-walled 96-
well culture plates at a density of 10 000 cells per well in 50 µL of complete growth medium. After 30 min, 
50 µL of growth medium with released rhBMP-2 from RCP, RCPHART and RCPFeHA, growth medium 
with soluble rhBMP-2 for the controls (900 ng/mL), as well as standard calibration curve with soluble 
rhBMP-2 (900 ng/mL to 1.6 ng/mL), were added to the well plate in duplicate and incubated for 24 hours at 
37°C in an atmosphere of 5% CO2. Furthermore, lysis reconstitution buffer and lyophilized luciferin (Steady 
Lite Plus, Perkin Elmer Inc., USA) were combined and 100 µL of the as-prepared solution was added to each 
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well. The plate was shaken for 15 minutes in the dark and then luminescence signal generated by luciferin 
was measured 6 seconds by using a Wallac VICTOR Multilabel reader (Perkin Elmer, USA). 
On the other hand, the percentage of rhBMP-2 bioactivity (BB, %) was calculated by using the following 
equation:  𝑩𝑩,% =    𝑳𝒖𝒄𝒂𝒄𝒕𝑹𝒆𝒍𝒓𝒉𝑩𝑴𝑷!𝟐 ×𝟏𝟎𝟎                                  
Equation 4. Calculation of rhBMP-2 bioactivity.  
	  
Where, 𝐿𝑢𝑐!"# was defined as luciferase activity obtained by the assay with C2C12 BRE-Luc cell line and 
the amount of released rhBMP-2 (ng) calculated by the ELISA sandwich method was denominated as 𝑅𝑒𝑙!!!"#!!. The results were presented in percentage and as Mean±SEM of triplicates.  
 
2.5.6 Optimisation of rhBMP-2 adsorption from microspheres  
rhBMP-2 release studies from RCP, RCPHART and RCPFeHA were performed by following two strategies: 
i) the specific surface area was used to define the amount of microspheres and the concentration of rhBMP-2 
and ii) equal amount of microspheres with equivalent concentration of rhBMP-2 adsorbed on the 
microspheres were investigated (Table 4). The as-mentioned rhBMP-2 concentrations were adsorbed by the 
microspheres at 4°C and predetermined volume of cell medium was added to obtain a final concentration of 
900 ng/mL. After 1 day of releasing studies, the supernatant was collected by centrifugation and evaluated in 
presence of C2C12 BRE-Luc cell line. For the selection of the best-in-class rhBMP-2 adsorption strategies, 
the results were presented as luciferase activity (RLU), from Mean±SEM of triplicates.  
 
Table 4. Parameters used in both strategies of rhBMP-2 release, (SSA: rhBMP-2 adsorption take into 
account the specific surface area of the microspheres; No SSA: rhBMP-2 adsorption without consider 
specific surface area).  
Microspheres 
SSA No SSA 
Weight of 
microspheres, 
mg 
Initial 
concentration of 
rhBMP-2 to be 
adsorbed, µg/mL 
Volume of 
rhBMP-2 
solution, µL 
Weight of 
microspheres, 
mg 
Initial 
concentration of 
rhBMP-2 to be 
adsorbed, 
µg/mL 
Volume of 
rhBMP-2 
solution, µL 
RCP 3.23 83.65 10.76 15 18 50 
RCPHART 15 12 75 15 12 75 
RCPFeHA 2.25 80.2 11.25 15 12 75 
 
2.5.7 In vitro rhBMP-2 release under pulsed electromagnetic field (PEMF) 
rhBMP-2 was adsorbed by RCPHART, RCPfluidMAG-CT and RCPFeHA and a final concentration of 400 
ng/mL was achieved. The releasing studies were performed in static and under pulsed electric magnetic field 
(PEMF).  
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PEMF is composed by polymethylmethacrylate tube carrying a home-made eppendorf support and two 
solenoids (i.e., Helmoltz coils, the planes of which were parallel). The generated magnetic field and the 
induced electric field were perpendicular and parallel to the samples, respectively. Eppendorf’s were 
horizontally introduced into the home-made support and were 5 cm distant from each solenoid plane (Figure 
8). A Biostim SPT pulse generator (Igea, Carpi, Italy) was used to power the solenoids. According to the 
position of the solenoids and the characteristics of the pulse generator, the electromagnetic stimulus had the 
following parameters: intensity of the magnetic field equal to 2.0 ± 0.2 mT, amplitude of the induced electric 
tension equal to 5 ± 1 mV, frequency of 75 ± 2 Hz, and pulse duration of 1.3 ms. The rhBMP-2 adsorption 
and releasing studies were followed by the previous protocol, as showed in section 2.5.3. 
 
 
Figure 8. Pulsed electric magnetic field used on rhBMP-2 release. 
	  
2.5.8 Statistical analysis  
The significant differences of rhBMP-2 adsorption strategies and the effect of porosity on rhBMP-2 release 
were analysed with two-way ANOVA by Bonferroni’s multiple comparison tests. The significant differences 
on rhBMP-2 release, the effect of microspheres composition on rhBMP-2 release and percentage of rhBMP-
2 bioactivity were evaluated by one-way ANOVA with Tukey’s multiple comparisons. 
Values of p<0.05 were accepted as statistically significant.  
 
Solenoids 
	   	   	  
Sample 
holder 
Generated magnetic field 
	   	  
Induced 
electric field 
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2.6 Preliminary investigations on Scaffold fabrication 
	  
2.6.1 Scaffolds fabrication  
As showed in the section 2.1.2, biomineralisation process was assessed to produce mineralised biomaterials 
with superparamagnetic properties. For the fabrication of the scaffolds the as-prepared slurries of RCP/FeHA 
(60/40) at 40, 50 and 60 °C were used to produce the scaffolds. Biomineralised slurries were placed in 48 
well plate (i.e. 1 mL per each well), then the material was frozen at -20°C, then the samples were introduced 
in pre-cooled freeze-drying and the cycle of drying was performed for 48 hours under vacuum (≈ 0.1 bar), 
and a final porous structure was achieved. Scaffolds were crosslinked under vacuum by DHT at 160 °C for 
48 hours. 
 
2.6.2 Scaffold characterisation  
Morphological characterisation 
The as-produced scaffolds were cut in longitudinal cross-section and were analysed by using Scanning 
Electron Microscope (SEM) (FEI Quanta 600, USA) in low vacuum mode with an accelerating voltage of 10 
kV and a working distance of 10 mm.  
 
Swelling tests 
Swelling extent was determined by conventional gravimetric method, in order to observe the water 
absorption ability of the scaffolds, where the swollen and dried weight of the scaffolds were considered. 
Crosslinked scaffolds with ≈ 0.04 g in weight were used and swelling tests were performed in PBS (pH 7.4) 
under incubator with agitation (≈ 100 rpm), at 37°C. After 1h, 3h, 18h and 24h, swollen samples were 
weighted. RCP/HA (60/40, 40°C) scaffold was used as a control sample. The swelling percentage (S, %) of 
the scaffolds was calculated as follow:  𝑺 = 𝑾𝒔!𝑾𝒅𝑾𝒅 ×𝟏𝟎𝟎               
Equation 5. Calculation of swelling capacity of the scaffolds.  
  
Where as 𝑊! was the weight of the swollen scaffold and 𝑊! was the weight of the dried scaffold. Three 
samples of each group were analysed and the results were showed as Mean±SEM. 
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Chapter 3. Results 
3.1 Application of biomineralisation process to obtain new hybrid biomaterials with 
superparamagnetic properties  
	  
3.1.1 Collagen I based recombinant peptide 
Biomineralisation investigations were carried out in presence of an innovative biomaterial produced by 
fermentation process and without animal sources and has been commercialized as Cellnest®, by Fujifilm 
Manufacturing Europe B.V. (The Netherlands). The as-mentioned biomaterial is recombinant peptide based 
on human collagen type I, α I chain, (RCP) and was designed and addressed to new devices for bone tissue 
regeneration. RCP is enriched of RGD motif (i.e. arginine – glycine – aspartate) and presented promising 
properties, such as high cellular adhesiveness, safety, biocompatible, biodegradable and bioabsorbable and 
can be formulated in scaffolds, microspheres, among others (Van Boxtel 2013; Boer A., Urk H., Bouwstra J. 
2012; Mumcuoglu et al. 2016; Ramírez-Rodríguez et al. 2016; Patrício; et al. 2017). The recombinant 
peptide has an extremely uniform molecular weight distribution of approximately 51 kD, 571 amino acid in 
length and size distribution about 10 nm (Figure 9A, 9B). 
 
 
Figure 9. Composition of RCP (A) and size distribution profile of RCP (B).   
 
3.1.2 Development of materials with magnetic and bone-like properties 
Biomineralisation process adapted by (Sandri et al. 2010; Tampieri et al. 2003) was used to synthesise 
biomimetic biomaterials by mediation of neutralisation process and nucleation of hydroxyapatite 
nanocrystals into collagen fibrils was obtained. 
Herein, the biomineralisation of RCP was investigated by following the as-mentioned methodology. RCP is 
a small molecule, water-soluble and does not form fibres by varying the pH, as in the case of collagen type I. 
During the biomineralisation process for a completely involvement and interaction with mineral phase, 
biomineralisation synthesis was kept under stirring for 2 hours and for the formation of low crystalline 
hydroxyapatite with magnetic properties, several parameters were evaluated, as showed below.  
 
Effect of synthesis temperature and Fe2+/Fe3+ molar ratio mineralised with low content of FeHA 
The effect of synthesis temperature on phase composition and magnetic properties were evaluated in 
biomineralised materials synthesised with low amount of inorganic phase (10 wt%) and the synthesis 
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parameters were presented in Table 5. Iron-containing hybrid biomaterials were synthesised at 25 ºC and at 
40 ºC and iron-free biomineralised material was synthesised at 40 ºC. 
 
Table 5. Parameters used in the biomineralisation process.   
Sample 
Biomineralisation 
temperature (ºC) 
Fe/Ca, mol % Fe2+/Fe3+, mol RCP/FeHA, wt% 
RCP/FeHA (90/10; 3:2; 25) 25 
20 
3:2 
90/10 RCP/FeHA (90/10; 3:2; 40) 40 3:2 
RCP/FeHA (90/10; 5:4; 40) 40 5:4 
RCP/HA (90/10) 40 --- --- 90/10 
 
Biomineralised materials presented a diffraction peak at about 20 θº, which reflects the presence of RCP in 
the biomineralised materials. High hydroxyapatite crystallinity without formation of new phases was showed 
in RCP/HA, while low synthesis temperature (i.e. 25 ºC) promotes the formation of very low crystalline 
hydroxyapatite, as showed in RCP/FeHA (90/10; 3:2; 25). By increasing the synthesis temperature and 
changing the Fe2+/Fe3+ molar ratio the crystallininty was increased. By comparing RCP/FeHA with RCP/HA 
low crystalline hydroxyapatite was obtained, probably due to the presence of iron ions into apatite lattice 
(Figure 10).   
 
Figure 10. XRD pattern of the as-produced biomaterials. a) RCP; b) RCP/HA (90/10); c) RCP/FeHA 
(90/10; 3:2; 25); d) RCP/FeHA (90/10; 3:2; 40); e) RCP/FeHA (90/10; 5:4; 40). 
	  
Magnetic properties of the as-synthesised biomaterials were evaluated with susceptometer balance and no 
magnetisation was detected. Moreover, by placing those materials in contact with neodymium magnet, very 
low magnetisation was presented.  
The production of biomineralised biomaterials was showed, although very low magnetisation was 
demonstrated. The following step was to increase the amount of mineral phase and to evaluate the effect on 
magnetic properties.   
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Effect of organic and inorganic ratio  
As follow the previous results, Fe2+/Fe3+ molar ratio (3:2), Fe/Ca molar ratio (20 mol%) and temperature (40 
ºC) was maintained and the mineral content in the mineralised materials was changed. The effect of mineral 
content on phase composition was evaluated by FTIR and XRD analysis. FTIR spectrum were showed in 
Figure 11A and the main vibration modes of RCP (i.e. Amide I, II and III) and formation of hydroxyapatite 
(i.e. vibration modes of phosphate groups) and the presence of carbonate vibration bands (at 873 cm-1), were 
presented, thus indicating the formation of carbonate-substituted hydroxyapatite, which is similar to natural 
bone apatite (Figure 11B). FTIR spectra can also be used to evaluate the calcium phosphate crystallinity 
index or splitting factor (SF) on biomineralised materials. The results showed that the biomineralised 
samples presented low splitting factor compared to the calcium phosphate (i.e. splitting factor = 3.29), due to 
the poorly-crystalline apatite formed during the biomineralisation process (Table 6). 
Previous results were also confirmed by XRD analysis (Figure 11C). Low crystalline apatite was formed in 
all the synthesised materials as assigned by the planes at (002 (25°); 211(31°); 300(32°) (ref. code: 00-
0090432). Biomineralised materials with 80 wt% of mineral amount presented small diffraction peak at 
35.423 2θ° that might be related with the formation of secondary phase, such as iron oxide (e.g. magnetite or 
maghemite) (reference code: 00-019-0629). The phase composition of RCP/FeHA (60/40) was similar with 
bone tissue (Figure 11D).  
 
 
Figure 11. (A) FTIR spectrum and (C) XRD pattern of the as-produced biomaterials, #) Calcium 
phosphate, 40 ºC; a) RCP/FeHA (60/40); b) RCP/FeHA (40/60); c) RCP/FeHA (30/70); d) RCP/FeHA 
(20/80), (* iron oxide pattern with reference code: 00-019-0629;   calcium phosphate hydroxide with 
reference code: 00-0090432); B) Typical infra-red spectra and XRD pattern (D) of bone tissue (Boskey 
2007; Vallet-Regi & Gonzalez-Calbet 2004). 
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The as-synthesised biomaterials presented low-crystalline apatite similar to bone tissue composition and the 
presence of Ca, P, Fe (wt%), Ca/P (mol) and Fe/Ca (mol%) were evaluated by ICP-OES (Table 6). By 
increasing the mineral ratio in the hybrid biomaterials, slightly increase of Ca, P and Fe was showed, while 
Fe/Ca ratio was closer to the theoretical one, i.e. 20 mol%. 
The mineral amount on the different samples was evaluated by using thermogravimetric analysis, and no 
significant different were showed with theoretical ones (Table 6).  
Magnetic properties of the as-obtained biomaterials were evaluated by susceptometer balance (Table 6), and 
an improvement on magnetic properties was showed, mainly in RCP/FeHA (20/80). The high magnetisation 
in RCP/FeHA (20/80) was suggested by the formation of secondary phase, as showed by XRD results.  
 
Table 6. Splitting factor, quantitative evaluation of different elements, mineral amount and 
magnetisation of biomineralised materials. (values obtained by: ♯ ν4 phosphate group analysed by 
FTIR; ¥ ICP-OES; ** TGA analysis; § Susceptometer balance; * (Dorozhkin 2011)).  
  Bone * 
RCP/FeHA 
(60/40) 
RCP/FeHA 
(40/60) 
RCP/FeHA 
(30/70) 
RCP/FeHA 
(20/80) 
♯ Splitting factor --- 2.276 2.393 2.327 2.524 
¥ Ca (wt%) 34.8 12.08±0.41 17.62±0.58 23.37±0.43 18.81±0.77 
¥ P (wt%) 15.2 4.26±0.10 7.28±0.17 7.92±0.18 6.29±0.22 
¥ Fe (wt%) --- 3.14±0.10 5.55±0.15 6.05±0.11 4.8751±0.23 
Ca/P (molar)  1.71 2.19±0.18 1.87±0.15 2.28±0.13 2.31±0.25 
(Fe+Ca)/P (molar) --- 2.60±0.20 2.29±0.17 2.70±0.15 2.74±0.27 
Fe/Ca  (mol %) --- 18.65±1.70 22.61±1.94 18.57±0.95 18.60±2.30 
Fe/(Ca+Fe)  (mol %) --- 0.16±0.01 0.18±0.01 0.16±0.01 0.16±0.02 
** RCP/FeHA, wt% --- 54/46 36/64 26/74 16/84 
§ Magnetisation, 
emu.g-1 
--- 0.005±0.00 0.0185±0.02 0.015±0.00 0.18±0.02 
 
Effect of Fe2+/Fe3+ molar ratio and Fe/Ca molar ratio 
RCP/FeHA (60/40) showed similar composition with bone tissue, while RCP/FeHA (20/80) presented high 
mineral content and magnetisation values. Take into account this result an improvement on magnetic 
properties were performed on RCP/FeHA (60/40) synthesised at 40 ºC and Fe/Ca molar ratio (i.e. 20 and 45) 
and Fe2+/Fe3+ molar ratio (3:2 and 5:4) were evaluated (Table 7).  
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Table 7. Parameters used in the biomineralisation process.   
Sample 
Biomineralisation 
temperature (ºC) 
Fe/Ca, mol % Fe2+/Fe3+, mol RCP/FeHA, wt% 
RCP/FeHA (20; 3:2) 
40 
20 
3:2 
60/40 
RCP/FeHA (45; 3:2) 45 
RCP/FeHA (20; 5:4) 20 
5:4 
RCP/FeHA (45; 5:4) 45 
 
The effect of Fe2+/Fe3+ molar ratio and Fe/Ca molar ratio on phase composition and magnetic properties were 
evaluated. FTIR spectra indicated the presence of RCP in all the as-synthesised biomaterials, as assigned by 
the main amide groups (i.e. Amide I, Amide II and Amide III). In RCP/FeHA (20; 5:4) and RCP/FeHA (45; 
5:4) a strange configuration of phosphate groups (i.e. ν3 and ν4) was showed (Figure 12A). By XRD analysis 
the mineral phase was investigated and narrow diffraction peaks in that materials, suggested the formation of 
unreacted iron chloride (Figure 12B). A very low crystalline hydroxyapatite was formed in RCP/FeHA (45; 
3:2) and non-magnetisation was detected with susceptometer balance. The results suggested that by 
increasing the Fe/Ca molar ratio or Fe2+/Fe3+ molar ratio do not improves the magnetic properties.  
 
 
Figure 12. (A) FTIR spectrum and (B) XRD pattern of the as-produced biomaterials, #) Calcium 
phosphate, 40 ºC; a) RCP/FeHA (20; 3:2); b) RCP/FeHA (20; 5:4); c) RCP/FeHA (45; 3:2); d) 
RCP/FeHA (45; 5:4), (  calcium phosphate hydroxide with reference code: 00-0090432). 
 
Effect of temperature  
Regarding to the previous results, magnetic properties were not improved. The hybrid biomaterial that 
showed relevant properties was RCP/FeHA (3:2, 20) with 40 wt% of mineral phase. The following 
investigation was based on keeping the optimised parameters and the synthesis temperature was changed. In 
this study, iron-containing biomaterial was synthesised at 40 ºC, 50 ºC and 60 ºC. Phase composition was 
evaluated by FTIR and XRD analysis. The presence of organic and inorganic phase was evident by the 
assignment of the main peaks of RCP and calcium phosphate formation (Figure 13A). Splitting factor 
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indicates an increase of crystallinity degree from 2.17, 2.45 to 2.46 for materials synthesised at 40, 50 and 60
ºC, respectively. By increasing the synthesis temperature the crystallinity of the biomineralised materials 
was increased, as showed by the XRD pattern (Figure 13B). A new diffraction peak was presented in the 
material synthesised at 60 ºC (Figure 13B*), suggesting that by increasing the synthesis temperature induces 
the formation of secondary phase, as iron oxides (e.g. magnetite or maghemite). Magnetite tends to form by 
increase of temperature during the synthesis process (Tampieri et al. 2012). Magnetic properties were also 
investigated, 0.005 emu.g-1, 0.007 emu.g-1 and 0.17 emu.g-1 were obtained in the materials synthesised at 40 
ºC, 50 ºC and 60 ºC, respectively.  
 
 
Figure 13. (A) FTIR spectrum and (B) XRD pattern of the as-produced biomaterials, a) RCP/FeHA, 
40 ºC; b) RCP/FeHA, 50 ºC; c) RCP/FeHA, 60 ºC; (  calcium phosphate hydroxide with reference 
code: 00-0090432; * iron oxide diffraction peaks with reference code: 00-019-0629).  
 
Regarding to the as-mentioned results, in the following section was presented the production of two iron 
containing mineralised materials (40 wt% of mineral extend; Fe/Ca (20 mol%); Fe2+/Fe3+ (3:2)). On the other 
hand, the effect of single ions into RCP matrix and the effect of iron in apatite lattice, by using as a control 
RCP mineralised with hydroxyapatite with the same synthesis conditions were presented.  
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3.2 New bioactive bone-like microspheres with intrinsic magnetic properties obtained 
by bio-inspired mineralisation process 
	  
3.2.1 Physicochemical and morphological characterisation of mineralised and non-
mineralised materials 
Compositional and crystallographic analysis  
The XRD analysis of pure RCP and the as-obtained hybrid mineralised materials, reported the presence of 
an amorphous phase that can be ascribed to RCP, as identified by a broad diffraction peak located in the 
2θ region 10-30 (Figure 14). In the mineralised compounds a nanocrystalline hydroxyapatite phase was 
also detected, in agreement with the JCPDS card number: 09-0432 (Figure 14), without any evidence of 
other calcium phosphate crystalline phases. The full profile analysis of the XRD spectra reported smaller 
crystallites in RCPFeHA40 and RCPFeHA60 materials, when compared to iron-free materials (i.e. 
RCPHA40 and RCPHA60), as well as a slight distortion of the lattice, particularly an increase of the a 
axis and a decrease of c axis (Table 8), thus resulting in a slight lattice volume expansion (∼ 0.2%) in 
comparison with iron free RCPHA materials. Besides, RCPFeHA60 exhibited an additional diffraction 
peak at 2θ ≈ 35.4 (Figure 14 e), indicating the formation of magnetite as secondary phase (in agreement 
with the JCPDS card number: 01-079-0417). Semi-quantitative phase analysis reported an amount of 
about 8% of iron oxide formed in RCPFeHA60.  
 
 
Figure 14. XRD pattern of RCP (a) and of the as-obtained mineralised materials: b) RCPHA40; c) 
RCPFeHA40; d) RCPHA60 and e) RCPFeHA60. Iron oxide formation in RCPFeHA60 is indicated 
by Ø .   
 
Figures 15A-B show FTIR spectra obtained from RCP and mineralised materials. RCP shows large 
absorption band in the wavelength region 3600-2600 cm-1 assigned to the OH- stretching of water 
molecules and at ≈ 3074 cm-1 could be attributed to the N-H stretching for amide A. Then, three main 
peaks attributed to the amide groups (i.e. ≈ 1637 cm-1 for Amide I, 1550 cm-1 for Amide II, 1240 cm-1 for 
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Amide III) were detected, as well as an absorption band at 1390 cm-1, ascribed to the carboxylic group 
COOH- (Figure 15B). Besides, in Figures 15A–B the characteristics vibration modes generated by the 
phosphate group present in the hydroxyapatite phase (i.e. ν1 and ν3 stretching at ≈ 960 cm-1 and ≈ 1030-
1100 cm-1, respectively, and ν4 bending modes at ≈ 603-565 cm-1) were detected (Gomez-Morales et al. 
2013; Yang et al. 2005). 
 
 
Figure 15. FTIR spectra of mineralised materials. a) RCP; b) RCPHA40; c) RCPHA60; d) 
RCPFeHA40 and e) RCPFeHA60. A: full pattern, B: a detail evidencing the position of the 
absorption bands related to amide, carboxylic groups and phosphate groups.  
	  
Narrower phosphate bands were associated to iron-free materials (i.e. RCPHA40 and RCPHA60) and, 
also, to iron-containing materials (i.e. RCPFeHA60) synthesised at higher temperature (Figure 15B and 
splitting factors in Table 8). The partial replacement of phosphate ions by carbonate (in B position, i.e. the 
phosphate site) in the HA phase was confirmed by the presence of absorption bands in the FTIR spectra 
of mineralised materials attributed to the ν2 stretching modes at 875-870 cm-1 (Addison et al. 2015), 
which were the only ones visible, as the ν3 bending modes of carbonate, located at ∼ 1450, 1420-1400 cm-
1, were overlapped by the absorption bands generated by the organic matrix (Sprio et al. 2012; Gaihre et 
al. 2008).  
 
Table 8. Splitting factor (SF) and cell parameters of mineralised materials. 
 
SF a (Å)  c (Å)  c/a 
Vol 
(Å3)  
Dav (nm)  D300 (nm)  D002(nm)  
RCPHA40 2.63 9.422 6.910 0.733 531.3 13.7 11.3 ± 0.9 22.4 ± 1.1 
RCPHA60 2.95 9.424 6.905 0.733 531.1 17.1 15.8 ± 0.6 25.1 ± 0.7 
RCPFeHA40 2.17 9.445 6.889 0.729 532.3 11.6 11.6 ± 4.5 23.1 ± 1.2 
RCPFeHA60 2.46 9.450 6.890 0.729 532.9 11.3 17.8 ± 1.3 23.1 ± 1.3 
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FTIR spectra recorded on the hybrid materials showed a slight shift of the adsorption band corresponding 
to carboxylic group and a higher intensity of the amide II band, if compared to pure RCP. In particular, 
the carboxylic group band shifted from 1390 cm-1 detected in RCP sample to 1402 cm-1 (RCPHA40) and 
1411 cm-1 (RCPHA60). In RCPFeHA40, the vibration modes of carboxylic groups were detected at 1411 
cm-1 and 1386 cm-1, while in RCPFeHA60 were ascribed at 1413 cm-1, and 1384 cm-1 (Mercado et al. 
2014).  
Further investigation of the interaction between the organic RCP matrix and the inorganic phase was 
carried out by reacting RCP with well-defined amounts of relevant cations used on biomineralisation 
process (i.e. Ca2+, Fe2+ and Fe3+). Figures 16A – 16B show the FTIR spectra of RCP/Ca, RCP/Fe2 and 
RCP/Fe3 materials, as obtained by assembling RCP in presence of Ca2+, Fe2+ and Fe3+ ions, respectively. 
Both RCP and RCP/Ca solutions were characterised by basic pH (≈ 10 and 12, respectively); chemical 
interactions in RCP/Ca were evidenced by an intensity increase and shift of both amide I and II bands 
(Figure 16A-B and Table 9), possibly induced by the linking with calcium ions. On the other hand, 
RCP/Fe2 and RCP/Fe3 were characterised by an acidic pH (i.e. pH = 6 and 3, respectively), consequently 
in order to reproduce the synthesis conditions of iron-containing mineralised RCP, the pH was adjusted to 
neutral values by addition of NaOH. In such conditions the band shift in Amide I and II was negligible 
(Table 9), moreover take also into account the previous results from mineralised materials, we 
hypothesised that amide and COOH- groups resulted significantly involved in the biomineralisation 
process, as sites for heterogeneous nucleation of the apatite nanophase.  
 
 
Figure 16. A) FTIR spectra of RCP and mineralised materials. B) a detail on absorption bands 
relevant for linking the inorganic phase. a) RCP; b) RCP/Ca; c) RCP/Fe3; d) RCP/Fe2. 
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Table 9. FTIR wavenumber obtained for amide I, amide II and carboxylic group in RCP, RCP/Ca, 
RCP/Fe3, RCP/Fe2 and in RCP/Fe3 and RCP/Fe2 with adjusted pH. 
 Wavenumber, cm-1 
 
RCP RCP/Ca RCP/Fe3 RCP/Fe2 
RCP/Fe3, 
Adjusted pH 
RCP/Fe2, 
Adjusted pH 
Amide I 1637 1634 1630 1627 1635 1635 
Amide II 1537 1542 1532 1534 1537 1537 
Carboxylic group 1390 1391 1409 1409 1398 1407 
 
The elemental composition of mineralised materials was investigated by ICP-OES (Table 10). The results 
showed higher Ca/P molar ratios, if compared to the value typical of stoichiometric hydroxyapatite (i.e. 
1.67). The (Fe+Ca)/(P+CO32-) molar ratio of RCPFeHA60 decreased in comparison with Ca/(P+CO32-) 
molar ratio of RCPHA60, thus confirming the partial replacement of Ca2+ by iron ions in the structure of 
the mineral nanophase. The overall amount of Fe detected in RCPFeHA40 and RCPFeHA60 was close to 
the amount introduced in the reaction vessel. However, a decrease of Fe2+/Fe3+ molar ratio was detected, 
ascribed to the reduction of the weight percentage of Fe2+. This result suggested a rapid oxidation of Fe2+ 
to Fe3+, during the synthesis process.     
 
Table 10. Chemical features of mineralised materials (results obtained by: * ICP-OES; ** UV-VIS). 
 
* Ca 
 (wt%) 
* P  
(wt%) 
* Fe 
 (wt%) 
Ca/(P+CO32-
) (mol) 
Fe/Ca 
(mol) 
(Fe+Ca)/(P+
CO32-)(mol) 
** Fe2+ 
(wt%) 
Fe3+ 
(wt%) 
RCPHA40 13.6±0.1 4.7±0.0 --- 1.91±0.0 --- --- --- --- 
RCPHA60 13.9±0.1 3.3±0.0 --- 2.30±0.0 --- --- --- --- 
RCPFeHA4
0 
13.1±0.0 4.7±0.0 4.2±0.0 --- 0.23±0.0 2.19±0.0 0.10 4.05 
RCPFeHA6
0 
13.3±0.0 4.4±0.0 3.9±0.0 --- 0.21±0.0 1.91±0.0 0.58 3.28 
 
Figures 17A – 17C show the thermal behaviour of pure RCP and hybrid mineralised materials and 3 
different temperature ranges characterised by weight loss were identified. In the lowest temperature range 
(≈ 25°C – 120°C (a)) the weight loss was ascribed to the evaporation of water. Following, weight loss 
ascribed to RCP decomposition initiated at about 250°C (b) and completed at about 700°C (Figure 17A). 
However, careful analysis of the TG profile revealed different onsets of the degradation process in the 
various investigated materials, i.e. ≈ 250°C (RCP), ≈ 260°C (RCPHA40), ≈ 265°C (RCPHA60), ≈ 285°C 
(RCPFeHA40) and ≈ 300°C (RCPFeHA60)  (Figure 17A – 17C). On the other hand, the presence of the 
mineral phase induced the complete decomposition and elimination of the RCP matrix already at 550 °C 
(Figures 17B, 17C). Further, weight loss detected in the range 700–1100 °C can be ascribed to the 
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evaporation of carbonate ions and hydroxyl incorporated in the apatitic structure during the synthesis 
process (Mercado et al. 2014).  
As a result of complete RCP degradation, the presence of the mineral phase uniformly distributed in the 
whole mineralised material was evident, as shown by SEM image in Figure 17D.  
The synthesis of the mineralised materials was carried out to induce a mineralisation extent of 40 wt%; in 
this respect the TG analysis reported that the amount of mineral phase in the final materials ranged 
between approximately 38 – 43 wt% (Figure 17B, 17C).  
 
 
Figure 17. Weight loss of RCP (A) and mineralised materials in absence (B) and presence of iron 
(C). D): SEM micrograph of 3D network of the mineral nanophase in RCPFeHA60, as obtained 
after complete decomposition of RCP, at 700 °C, (Scale bar: 200 nm). 
 
Morphological and ultrastructural evaluation by TEM 
Figure 18 shows the TEM micrographs and SAED images of hydroxyapatite nanophase obtained upon 
bio-inspired mineralisation of RCP in different conditions. In all the synthesised materials, TEM analysis 
showed the formation of nano-crystalline hydroxyapatite with similar morphology. In addition, in 
RCPFeHA60 dark spots with size about ≈ 5-25 nm were detected (Figure 18D, assigned with black 
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arrows), in close connection with the hydroxyapatite nanocrystals; such spots were identified as iron 
oxide nanoparticles, nucleated onto the HA nanophase, likely due to the higher temperature adopted 
where the formation of iron oxide such as magnetite was favoured (Tampieri et al. 2012). The EDX 
analysis of RCPFeHA40 and RCPFeHA60 is shown in Figure 18E and the presence of iron even in 
absence of the dark spots in RCPFeHA40, indicated the effective incorporation of iron into the 
hydroxyapatite structure.      
 
 
Figure 18. TEM micrographs of mineralised materials, RCPHA40 (A), RCPFeHA40 (B) and TEM 
micrograph with SAED image of RCPFeHA60 (C); Examples of iron oxide nanoparticles, identified 
with black arrows, formed on hydroxyapatite nanocrystals of RCPFeHA60 (D), (Scale bar: 20 nm); 
Energy dispersive X-ray (EDX) analysis of RCPFeHA40 and RCPFeHA60 (E). 
 
3.2.2 Characterisation of microspheres 
The as-obtained mineralised slurries were engineered into microspheres by water-in-oil emulsification 
process and crosslinked by DHT. Several factors affected the production of well-dispersed hybrid 
microspheres, such as slurry/oil ratio, solution volume, mechanical stirrer velocity, cooling temperature 
and RCP concentration. Herein, mechanical stirring velocity, cooling temperature and RCP concentration 
were investigated. Emulsification process was applied to RCPFeHA60 slurry in three distinctive steps (as 
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mentioned in the methods section). In the first step, dropping of mineralised slurry in pre-warmed oil, 
associated to various mechanical stirring velocities were studied, from 520 to 975 rpm (Figure 19A to 
19D). In all the tested mechanical stirring velocity, well dispersed microspheres were obtained. At higher 
stirring velocities smaller microspheres were obtained, but coalescence phenomena occurred leading to 
agglomeration into clusters of heterogeneous shape (Figure 19C, 19D), whereas less agglomerated 
microspheres were produced at 520 rpm (Figure 19A). Further investigations on emulsification process 
were carried out by correlating the cooling temperature (2nd step: microspheres jellification) with RCP 
concentration, in the hybrid mineralised materials (≈ 5 – 11 wt%). The results indicated that the formation 
of well-dispersed microspheres is associated with the gelling kinetics of the slurry/oil phase and the RCP 
concentration in the slurry. In this respect, the initial RCP concentration played a relevant role, depending 
on the presence of mineralizing ions. In fact, when preparing pure RCP solutions the concentration of 
RCP had to be increased from 5 to about 36 wt% in order to obtain well dispersed RCP microspheres; 
moreover RCP microspheres were successfully obtained when in the second step of emulsification (i.e. 
microspheres jellification) 5.5 °C was used; whereas in the case of hybrid microspheres the RCP ratio 
was ≈ 11 wt% and a lower cooling temperature was required, i.e. about 2 °C (Figure 19E).  
In order to validate the emulsification process efficiency, the as-obtained microspheres were separated 
into batches of different size by sieving in the range size of 38 – 50 – 75 – 100 µm and SEM micrographs 
showed the production of microspheres with well-defined size, i.e. 45.5 ± 0.4, 68.0 ± 0.7 and 88.3 ± 0.6 
µm, respectively. Figures 19F – 19H show SEM images of RCP and iron doped hydroxyapatite 
microspheres in the range size of 50 – 75 µm. The pure RCP microspheres presented a smooth surface 
(Figure 19F), whereas the hybrid microspheres exhibited a rougher surface, due to the presence of 
homogenously distributed inorganic nanoparticles (Figure 19G, 19H). 
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Figure 19. Hybrid microspheres obtained by varying the mechanical stirring velocity, 520 rpm (A), 
650 rpm (B), 715 rpm (C) and 975 rpm (D). As-optimised microspheres obtained at 520 rpm and at 
low cooling temperature, i.e., microspheres jellification (E). Detail surface morphology and shape of 
pure RCP (F) and hybrid microspheres: RCPFeHA40 (G) and RCPFeHA60 (H), (Scale bar are: 50 
µm (A, B, C, D, E) and 10 µm (F, G, H)). 
 
As RCP is a readily water-soluble biomaterial, DHT was used as a crosslinking method to obtain 
microspheres with enhanced stability in aqueous media. In order to evaluate the effect of DHT on RCP, 
crosslinked RCP microspheres were characterised by FTIR and TGA (Figure 20A, 20B). In the FTIR 
spectrum, a slight decrease of amide and carboxylic peaks intensity (in particular amide I and III) was 
found, whereas an intensity increase for amide II was obtained (Figure 20A*). Those results suggest the 
formation of intermolecular crosslinking, involving the amide groups and providing a more hydrophobic 
structure, leading to a high stability when exposed to physiological conditions (Gomes et al. 2013; 
Drexler & Powell 2011; Haugh et al. 2009). The thermal properties of crosslinked RCP were not 
significantly altered by the DHT treatment (Figure 20B). 
  
 
Figure 20. FTIR spectra (A) and TGA profile (B) of DHT crosslinked RCP microspheres compared 
to non-crosslinked microspheres. 
	  
The developed hybrid microspheres RCPFeHA60 are endowed with magnetic properties; in fact, also in 
cell medium suspension they can be easily attracted from a magnet (neodymium permanent magnet 1.2 
T), even at distance of 1 cm. (Figure 21A, 21B).  Moreover, the magnetic properties of RCPFeHA40 and 
RCPFeHA60 were evaluated by using a susceptometer balance and vibrating sample magnetometer 
(VSM). Different magnetisation values were obtained by susceptometer balance for RCPFeHA40 (0.004 
emu/g) and for RCPFeHA60 (0.17 emu/g). Regarding to the high magnetisation obtained in 
RCPFeHA60, a deeper investigation was performed by VSM, with magnetic field from -15 kOe to 15 
kOe. The VSM results indicated that the magnetisation of the RCPFeHA60 microspheres increased with 
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the magnetic field, until reaching saturation, and a specific magnetisation of 1.65 emu/g was obtained 
(Figure 21C). 
 
 
Figure 21. RCPFeHA60 microspheres in cell medium in absence (A) and in presence of neodymium 
magnet (B) and specific magnetisation of RCPFeHA60 obtained by VSM (C).  
	  
3.2.3 In vitro cell analysis 
Two hybrid microspheres groups (i.e. RCPFeHA40 and RCPFeHA60) with defined magnetic properties 
and composed by low crystalline hydroxyapatite without and with formation of iron oxide, during the 
synthesis process, were investigated focusing on cells viability and proliferation. A preliminary in vitro 
cytocompatibility study was performed to evaluate any effect of the magnetic RCP microspheres on pre-
osteoblastic cell behaviour using not magnetic RCP microspheres as control. Cell viability was 
investigated by MTT test and Live/Dead assay (Figure 22 and 23). 24 hours after MC3T3-E1 cell 
seeding, two concentrations of microspheres (10 µg/mL and 100 µg/mL) were added to the culture 
medium. Quantification of metabolically active cells was performed for each time point. MTT test results 
demonstrated an increase in cell proliferation from day 1 to day 7 for all the samples highlighting the 
absence of cytotoxicity (Figure 22). The only statistically significant difference among the groups were 
identified with the lower microspheres concentration at day 7 (Figure 22).  
The cell cultures were also analysed for cell viability with the Live/Dead assay based on the simultaneous 
determination of live and dead cells with two probes, Calcein and EthD-1, that measure recognized 
parameters of cell viability: intracellular esterase activity and plasma membrane integrity, respectively. A 
very high ratio of viable cells were seen with no significant differences among the group at each time 
point confirming the absence of cytotoxicity induced by the magnetic RCP microspheres at both 
concentrations (Figure 23).  
 
	  
	  
  
77 
 
  
 
Figure 22. Analysis of cells proliferation by the MTT assay, after 1, 3 and 7 days of MC3T3-E1 cell 
culture with RCP, RCPFeHA40 and RCPFeHA60 microspheres at concentration of microspheres 
of 10 µg/ml (A) and 100 µg/ml (B). (**p≤0.01; ****p≤0.0001; n = 3). 
	  
 
Figure 23. Cell viability analysed by the Live/Dead assay after 1, 3 and 7 days of cell culture with 
100 µg/ml microspheres.  Calcein AM stains for live cells in green, EthD-1 stains for dead cells in 
red, (scale bar: 200 µm). 
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3.3 Effect of ions release from hybrid superparamagnetic microspheres on osteogenic 
differentiation of MC3T3-E1 
	  
3.3.1 Physical, chemical and thermal characterisation of RCPFeHA functionalised with Sodium 
Citrate  
RCPFeHA microspheres in presence of cell medium tend to agglomerate, by forming a lump of 
microspheres (Figure 24A) and a new strategy was adopted (Figure 24B). RCPFeHA slurry was 
functionalised with sodium citrate at different concentrations (i.e. 0.55 M, 0.3 M, 0.06 M, 0.006 M and 
0.0006 M) and microspheres stability in cell medium was achieved by the surface charge and repulsive 
interaction between microspheres. Firstly, the effect of sodium citrate (with concentration of 0.55 M) into 
biomineralised slurry was evaluated by ζ-potential at predetermined time points. By increasing the 
functionalisation time, a negative charge on biomineralised slurry was improved by the adsorption of citrate 
ions on the surface of mineral phase, and suitable surface charge for electrostatic repulsion was obtained at 
1h 30 min of functionalisation (Table 11).  
 
Table 11. Effect of sodium citrate on surface charge of RCPFeHA slurry. 
RCPFeHA slurry  ζ-potential, mV 
t = 0, no citrate 12.3±0.36 
t = 30’ -13.23±0.21 
t = 1h30 -17.2±0.99 
t = 3h -18.8±0.71 
t = 6h -14.4±1.08 
 
Taken into account this result, RCPFeHA slurry was functionalised with sodium citrate at various 
concentrations during 1h 30 min and microspheres were produced by emulsification process (Figure 24C -
24G). Results indicated that by using high concentration of sodium citrate (i.e. 0.55 M), microspheres with 
size of 1 mm were produced (i.e. aggregation of small microspheres formed huge particles), while by 
decreasing the concentration of sodium citrate, smaller aggregates of microspheres were formed. Regarding 
to the Figure 24F, well dispersed microspheres were produced, thus indicating that successful 
functionalisation with sodium citrate was obtained with concentration of 0.006 M. Functionalised 
microspheres were crosslinked by DHT and microspheres were stable in presence of osteogenic 
differentiation medium for at least 7 days (i.e. no microspheres aggregation) (Figure 24H). 
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Figure 24. Effect of sodium citrate concentration on as-fabricated RCPFeHA microspheres. A) 
Microspheres without sodium citrate in osteogenic differentiation medium (Scale bar: 100 µm); B) 
Designed set-up of RCPFeHA slurry functionalisation with sodium citrate; RCPFeHA microspheres 
obtained with different concentrations of sodium citrate: C) 0.55 M; D) 0.28 M; E) 0.06 M; F) 0.006 
M; G) 0.0006 M. Well dispersed microspheres functionalised with 0.006M in presence of osteogenic 
differentiation medium (H), (Scale bar: 200 µm). 
 
The effect of sodium citrate (concentration of 0.006 M) on the microspheres was analysed by FTIR, XRD 
and TGA analysis (Figure 25). FTIR and XRD indicated the formation of poor crystalline and B-type 
carbonate hydroxyapatite (Figure 25A, 25B). FTIR spectra (Figure 25A) showed the presence of the main 
vibration peaks of RCP (i.e. amide I, amide II, amide III and carboxylic groups) and calcium phosphate (i.e. 
phosphate and carbonate assignments) formation in both type of microspheres (i.e. in functionalised and 
crosslinked functionalised microspheres) (Patrício; et al. 2017). On the other hand, by the introduction of 
sodium citrate differences were showed in the FTIR spectra. Carboxylic stretching vibrations of citrate were 
reported at 1755, 1600, 1450 and 1387 cm-1 (Mitsionis et al. 2010; Cheraghipour et al. 2012). Moreover, in 
functionalised microspheres a new peak was detected at 1755 cm-1 (Figure 25A*), which was attributed to 
C=O vibration from -COOH group of sodium citrate, while other vibration modes were overlapped by RCP 
matrix. XRD patterns showed the formation of low crystalline hydroxyapatite (in agreement with the JCPDS 
card number: 09-0432) with presence of small amount of iron oxide (e.g. magnetite or maghemite). Thermal 
investigations provide the decomposition profile of RCPFeHA, functionalised RCPFeHA and crosslinked 
functionalised RCPFeHA. In RCPFeHA microspheres, the weight loss below to ≈ 140°C was assigned to the 
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evaporation of the adsorbed water molecules, followed by degradation of RCP matrix until ≈ 600 °C, then 
evaporation of carbonate and hydroxyl ions from apatitic structure was detected up to 1000 °C. In 
functionalised RCPFeHA (i.e. RCPFeHANa3Cit) and crosslinked functionalised RCPFeHA (i.e. 
RCPFeHANa3Cit DHT = 48h), slight differences on the thermogram were assigned by the weight loss (≈ 7 
wt%) at ≈ 400 °C to 600 °C, indicating the degradation of citrate ions into the microspheres, followed by 
evaporation of carbonate ions (≈ 600 °C – 1000 °C) (Figure 25C).   
 
 
Figure 25. Chemical and thermal features of functionalised RCPFeHA microspheres, by FTIR (A); 
XRD (B) and TGA analysis. a) Non-functionalised RCPFeHA microspheres; b) Functionalised 
RCPFeHA microspheres and cosslinked by DHT (c).  
	  
3.3.2 Phase composition, morphological characterisation, microspheres size distribution and 
magnetic properties   
XRD pattern of all the as-produced microspheres was presented in figure 26. In RCP and RCPfluidMAG-
CT, typical broad diffraction peak (10 – 30 Ө°) from the polymeric phase was showed. RCPHA and 
RCPFeHA were synthesised at 60 °C and in both hybrid biomaterials low crystalline hydroxyapatite was 
formed, while RCPHART was synthesised at 20°C and very low crystalline hydroxyapatite was obtained. 
Low intensity and slight shift of diffraction peak at 26 Ө° in RCPFeHA was showed, indicating the partial 
replacement of Ca ions for Fe ions into hydroxyapatite lattice (Figure 26e).  
In RCPfluidMAG-CT, the as-introduced superparamagnetic nanoparticles into RCP matrix was confirmed 
by the diffraction peak at 35.66 Ө° (in agreement with the JCPDS card number: 01-079-0417), while in 
RCPFeHA the as-used synthesis temperature induced the formation of secondary phase, as iron oxide (e.g. 
magnetite or maghemite) and was assigned in the same diffraction signal.  
The elements composition of RCPfluidMAG-CT and mineralised microspheres were presented in Table 12. 
The differences on (Fe+Ca)/(P+CO32-) mol ratio for RCPFeHA, compared to Ca/P molar ratio of 
stoichiometric hydroxyapatite (≈ 1.67), can be related to the incorporation of foreign ions into the apatite 
lattice.  
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Figure 26. XRD pattern of the as-obtained microspheres: RCP (a); RCPfluidMAG-CT (b); RCPHART 
(c); RCPHA (d); RCPFeHA (e). (Iron oxide formation is indicated by *) 
	  
Emulsification process was assessed to produce the microspheres and were separately sieved in the range of 
50 – 75 µm and analysed by SEM (Figure 27). All the as-obtained microspheres presented spherical shape, 
with the exception of RCPHA. The high crystallinity of RCPHA and low viscosity of the biomineralised 
slurry, might indicate a non-successful microspheres fabrication (Figure 27C). RCP and RCPfluidMAG-CT 
offered smooth surface, while in RCPHART and in RCPFeHA roughness surface by the homogeneous 
distribution of mineral on the microspheres was obtained. RCP, RCPfluidMAG-CT, RCPHART and 
RCPFeHA microspheres size distribution was evaluated by using the SEM micrographs and analysed by 
Image J software. Microspheres size distribution and respective Gaussian size distribution were showed in 
Figure 28 and similar microspheres size was obtained, ranging from ≈ 67 µm to 70 µm. 
 
 
Figure 27. SEM micrographs from the as-produced microspheres: A) RCP; B) RCPfluidMAG-CT; C) 
RCPHA; D) RCPHART; E) RCPFeHA, (Scale bar is 200 µm and in the figure inserts is 20 µm).  
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Figure 28. Size distribution and respective microspheres size obtained by Gaussian distribution. A) 
RCP; B) RCPfluidMAG-CT; C) RCPHART; D) RCPFeHA.  
 
Prior to microspheres production RCPFeHA and RCPHART slurries were functionalised with sodium citrate 
at concentration of 0.006 M and microspheres were obtained by emulsification process. The surface charge 
of microspheres were analysed in HEPES buffer solution (pH 7.4) and low surface charge of all produced 
microspheres was showed and dispersed microspheres in osteogenic differentiation medium were obtained 
Table 12. In RCPFeHA, the surface charge in the functionalised microspheres was slightly improved from 
2.17 ± 0.63 mV to 5.39 ± 0.12 mV.  
 
Table 12. Microspheres composition, ζ-potential and chemical elements of microspheres. (*obtained by 
ICP-OES) 
Composition of 
microspheres  
Code  
ζ-potential, 
mV 
* Ca, mol * Fe, mol 
Ca/(P+CO32-), 
mol 
(Fe+Ca)/(P+ 
CO32-), mol 
Collagen type I based 
Recombinant Peptide 
RCP 1.53±0.21 --- 0.021±0.00 --- --- 
Collagen type I based 
Recombinant Peptide 
prepared with 
commercial 
superparamagnetic 
nanoparticles 
RCPfluid
MAG-CT 
2.195±0.78 --- --- --- --- 
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Collagen type I based 
Recombinant Peptide 
mineralised with 
hydroxyapatite 
nanophase 
RCPHART 3.345±0.05 0.51±0.00 --- 2.03±0.03 --- 
Collagen type I based 
Recombinant Peptide 
mineralised with iron 
doped hydroxyapatite 
RCPFeHA 5.86±0.11 0.48±0.04 0.09±0.01 --- 2.31±0.02 
 
fluidMAG-CT are iron oxide nanoparticles commercially available for Magnetic Resonance Imaging (MRI) 
diagnostic. RCPfluidMAG-CT microspheres with certain amount of iron oxide nanoparticles were produced 
and was defined as control to the as-synthesised and produced RCPFeHA microspheres. By susceptometer 
balance the magnetic properties were evaluated and RCPfluidMAG-CT and RCPFeHA showed similar 
magnetisation values, i.e. 0.22 emu/g and 0.26 emu/g, respectively.  
 
3.3.3 Microspheres degradation studies under physiological and inflammatory mimicking 
conditions  
RCP, RCPfluidMAG-CT, RCPHART and RCPFeHA were immersed in two different DMEM: DMEM (pH 
7.4) and DMEM-IM (pH 5), and the degradation studies were evaluated over the course of 28 days. 
Microspheres morphology was analysed by SEM micrographs at 7, 14, 21 and 28 days and microspheres 
were not degraded in presence of both conditions (Figure 29 and 30). After 28 days at pH 7.4, small 
microspheres with wrinkled structure were obtained and RCPFeHA showed a porous surface. Polymeric 
microspheres showed high stability at pH 5, although the solubility of the mineral phase of RCPHART and 
RCPFeHA was clearly evident by the wrinkled structure. 
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Figure 29. SEM micrographs of microspheres, after immersion in physiological mimicking conditions, 
over the course of 28 days. A) RCP; B) RCPfluidMAG-CT; C) RCPHART; D) RCPFeHA, (Scale bar: 
20 µm); (Note: 7D: 7 days; 14D: 14 days; 21D: 21 days; 28D: 28 days). 
	  
 
Figure 30. SEM micrographs of microspheres, after immersion in mimicking inflammatory conditions, 
over the course of 28 days. A) RCP; B) RCPfluidMAG-CT; C) RCPHART; D) RCPFeHA, (Scale bar: 
20 µm); (Note: 7D: 7 days; 14D: 14 days; 21D: 21 days; 28D: 28 days). 
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pH of both controls media (i.e. DMEM and DMEM-IM) and the media used in the degradation studies with 
all the tested microspheres were evaluated at each predetermined time points (i.e. 12h, 24h, 48h and 7, 14, 21 
and 28 days). By comparing the obtained pH (i.e. 7.4 and 5) in the controls or in the media with RCP or 
RCPfluidMAG-CT, non-significant differences were detected (Figure 31). In physiological mimicking 
conditions (DMEM, pH 7.4), higher pH (≈ 7.6) on RCPHART and an increase of the pH (from ≈ 7.2 to 7.5) 
on RCPFeHA, were obtained in the first 48h of experiment, then a pH plateau from 7 days to 28 days were 
presented (≈ 7.4). During 28 days in inflammatory mimicking conditions, a slight increase on the pH of the 
media in contact with RCPHART and RCPFeHA was observed, probably due to the ion exchange or ion 
release from both microspheres (Figure 31).  
 
 
Figure 31. pH changes in DMEM (pH 7.4) and DMEM-IM (pH 5) in presence of microspheres and 
controls (Mean±SEM).  
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Calcium and iron ions have been showed an inductive effect on osteogenesis (Tampieri et al. 2014; Tampieri 
et al. 2016; B.- Sprio; et al. 2016). Regardless, ions release was investigated after incubation of 
RCPfluidMAG-CT, RCPHART and RCPFeHA, at predetermined time points in physiological and 
inflammatory mimicking conditions. DMEM was a medium enriched of calcium ions (≈ 1.05 mM) and the 
percentage of adsorbed calcium at each time point was normalised to the total calcium in the replaced 
medium (Figure 32A), while released ions were normalised to the total amount of ions in 30 mg of 
microspheres (Table 12). Higher pH values from DMEM in presence of RCPHART, was reflected in higher 
calcium absorption (about 80% of calcium absorption at each time point) until 7 days of experiment, 
followed by a decrease to ≈ 16% at day 21. From day 21 to 28, slight increase was showed, maybe due to the 
solubility of the microspheres. In RCPFeHA, over the course of the experiment about ≈ 50 to 90% of 
calcium was adsorbed, reaching the saturation after 7 days in presence of DMEM. Meanwhile, about 0.13 
mM of Fe ion was released from RCPFeHA. Regarding to the Fe release from RCPFeHA in both conditions, 
significant differences on Fe ion release was presented (p < 0.05), indicating the exchange of iron ion to the 
adsorbed calcium ion in DMEM (Figure 32B). In inflammatory mimicking conditions, a cumulative calcium 
release was presented without significant differences between RCPHART and RCPFeHA (Figure 32C). For 
RCPfluidMAG-CT in both media, extremely statistically significances on Fe release were showed (p ≤ 
0.001) (Figure 32D). 
  
 
Figure 32. Percentage of calcium adsorbed from DMEM at pH 7.4 (A); Cumulative Fe release of 
RCPFeHA (B); Cumulative Ca release at pH 5 (C) and Cumulative Fe release from RCPfluidMAG-
CT (D); (* p<0.05; ** p≤0.01; *** p≤0.001).  
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The composition of RCPHART and RCPFeHA microspheres, after 28 days in mimicking conditions (i.e. 
physiological and inflammatory) were analysed by FTIR and XRD tests (Figure 33). As showed in FTIR 
spectrum, organic and inorganic phase were presented in RCPHART and RCPFeHA, as observed by the 
vibration assignments in amide and phosphate groups, respectively (Figure 33A). In RCPHART and 
RCPFeHA, no additional phases formed along 28 days in presence of DMEM or DMEM-IM. In RCPFeHA, 
lower intensity of diffraction peak at 35.66 Ө° was showed, corroborating the iron release, over the course of 
28 days (Figure 33B, 33C).  
 
 
Figure 33. A) FTIR spectrum of RCPHART after 28 days in pH 7.4 (a) and in pH 5 (b) and of 
RCPFeHA after 28 days in pH 7.4 (c) and in pH 5 (d); (B) XRD pattern of RCPHART before (a) and 
after 28 days at pH 7.4 (b) and pH 5 (c) and of RCPFeHA (C), before (d) and after 28 days at pH 7.4 
(e) and pH 5 (f).   
 
3.3.4 Biological characterisation 
Cell viability 
Cell viability was evaluated at predetermined time points and results from XTT test showed an increase on 
cell viability over the time of the experiment, even at high concentration of microspheres (Figure 34). 
Statistically significant differences were identified among the groups and in all the tested concentration of 
microspheres (p<0.05; p<0.01; p<0.001). At concentration of 500 µg/mL higher statistically significant 
differences were showed among the tested groups, without cytotoxic effect on the cells.  After 7 days of cell 
seeding with the microspheres at 100 µg/mL, equivalent cell viability among the groups was showed and this 
concentration was selected for the further investigations on gene expression and western blot.  
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Figure 34. Cell viability in presence of all tested microspheres (*p<0.05; **p<0.01; ***p<0.001).  
 
Cell damage and cell morphology evaluation 
In order to evaluate the early stage of apoptosis due to the presence of the microspheres in the culture 
(Koopman et al. 1994), the cellular protein annexin V, commonly used to detect apoptotic cells, was 
investigated at day 1 and after 3 days with an assay that also highlight the presence of necrotic cells. As 
showed in figure 35, all the polymeric and hybrid microspheres tested in both concentrations, do not induce 
cell apoptosis and necrosis. The cells cultured in standard conditions represented the negative control (Figure 
35A), while cells grown in presence of 1 µM doxorubicin were used as positive control (Figure 35B). 
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Figure 35. The effect of microspheres on cells apoptosis/necrosis, at two concentrations: 10 µg/mL and 
100 µg/mL and at two experimental time points (Day 1 and Day 3). Apoptotic cells in green, necrotic 
cells in red, cell nuclei in blue. Negative control (A) and positive control (B), (Scale bar: 50 µm). 
 
A further evaluation was performed to verify if the proposed microspheres could induce the production of 
reactive oxygen species (ROS), as index of cell damage (Stark 2005). The results indicated that for all the 
microspheres at both concentrations and experimental time points, very low level of ROS were produced 
(Figure 36), proving that the released ions do not induce oxidative stress on the cells. MC3T3-E1 cells grown 
in standard condition were used as negative control (Figure 36A), while cells treated with 100 µM of 
hydrogen peroxide were used as positive control (Figure 36B).  
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Figure 36. The effect of microspheres on ROS production, at two concentrations: 10 µg/mL and 100 
µg/mL and at two experimental time points (Day 1 and Day 3). (Negative control (A) and positive 
control (B)), (Scale bar: 50 µm). 
 
Cell morphology was analysed by phalloidin staining and H&E staining. The organization of the cytoskeletal 
structure of actin filaments is an essential element in maintaining and modulating cellular morphology and 
cell structural integrity (Radulovic & Godovac-Zimmermann 2011). The morphological analysis made by 
phalloidin staining showed MC3T3-E1 cells well spreaded in the well plate surface without any difference 
among the group (Figure 37A). These results were confirmed also by H&E staining and in bright field 
images (Figure 37B-C) the cells were well adhered to the surface of well plate and surrounding the 
microspheres. Cells showed the typical polygonal shape proving that the microspheres did not induce any 
macroscopic negative effects to the cell culture. 
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Figure 37. Morphological analysis of MC3T3-E1 cultured at day 3, in presence of 100 µg/ml of 
microspheres, evaluated by phalloidin staining (green: actin filaments, blue: cell nuclei) (A) and 
haematoxylin and eosin staining (B), (Scale bar: 20 µm). C) Bright-field images of RCPFeHA acquired 
at day 1 and day 7 of cell culture, (Scale bar: 50 µm).  
 
Western Blot Analysis  
Western blot analysis was performed to evaluate the protein expression of ALP and BGLAP and autophagy 
regulators (LC3B-I and LC3B-II), after 7 days of cell culture in presence of all tested microspheres 
(concentration of 100 µg/mL). The results were normalised by the expression of β-Actin (Figure 38). For 
all the tested microspheres, ALP and BLAP were expressed without any significant differences among the 
groups. A slight increase of LC3B-I and LC3B-II, even with any significant differences, was showed in 
presence of RCPfluidMAG-CT and RCPFeHA microspheres compared to cells only group.  
 
 
Figure 38. Western blot analysis for the expression of osteogenic proteins ALP (A) and BGLAP (B) 
and autophagy marker C) LC3B-I (graph above) and LC3B-II (graph below). β-Actin was used as an 
internal control.  
 
Osteogenic gene expression profile 
The effect of microspheres composition at 100 µg/mL on the expression of the osteogenic genes (COL I, 
SPARC and BGLAP) was evaluated by qRT-PCR (Figure 39). An overall trend in up-regulation of these 
genes in presence of all hybrid microspheres respect to RCP group was showed. Although no statistical 
significant differences were detected, BGLAP, a marker of late osteogenic differentiation, seems to be 
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upregulated in all the tested group. Instead, RCPFeHA exerted, even weakly, higher inductive effect in the 
expression of COL I and SPARC compared to RCPfluidMAG-CT and RCPHART. 
 
 
Figure 39. Relative quantification (2−ΔΔCt) of osteogenic related genes expression after 7 days of 
MC3T3-E1 culture with all the tested microspheres.   
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3.4 Effect of microspheres composition on differentiation of human mesenchymal stem 
cells  
	  
3.4.1 Cell viability  
Optical micrographs indicated great affinity of the cells to the all type of microspheres after 7 days of cell 
culture (Figure 40A). The effect of microspheres composition on cell viability, cell vitality and cytotoxicity 
were also evaluated by using the Live/Dead assay after 7 days of cell culture (Figure 40B – 40E). By 
comparing the images with cell monolayer without microspheres, high density of green cells was observed in 
all the tested microspheres, demonstrating high cell viability and non-cytotoxic effect on the cells. 
Microspheres were observed in red and non-dead cells were surrounding the microspheres, as showed at high 
magnification (Figure 40 D, E). Great cell affinity to the microspheres composed by hydroxyapatite or iron 
hydroxyapatite nanophase (i.e. RCPHART and RCPFeHA) was presented.  
 
 
Figure 40. Bright-field images (A) and Live (B) & dead (C) cells obtained after 7 days of cell culture in 
presence of hMSCs, (Scale bar: 200 µm). Live & Dead cells surrounded to RCPHART (D) and 
RCPFeHA (E) microspheres.  
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3.4.2 Optimisation of cell seeding 
Prior to the investigations in the effect of microspheres composition on osteogenic differentiation of hMSCs, 
cell-seeding strategy was optimised for 500 µg of microspheres. Preliminary studies on the amount of cell 
seeding were based on 3500 cells/cm2 and specific surface area of each type of microspheres. After three 
days of cell culture, high percentage of cells was attached to the agarose and a 3D template was formed. The 
percentage of cells attached to the microspheres was calculated based on DNA extracted from the cells 
attached to the microspheres and normalised by the nominal amount of DNA in each cell (8.5 pg/cell) 
(equation 1) (Dormer et al. 2012). Regarding to the high amount of used cells, in one hand low percentage of 
cells was attached to the different type of microspheres, with statistically significant differences for 
RCPFeHA (p<0.05) (Figure 41A). On the other hand, this low percentage was reflected in high amount of 
cells adhering to the microspheres as showed by haematoxylin and eosin staining (H&E) (Figure 41B). 
Afterwards, the amount of cells seeded on the microspheres was decreased based on 700 cells/cm2 and 
specific surface area of microspheres. Optical micrographs showed the formation of 3D templates for RCP 
and RCPFeHA, while in RCPHART disperse microspheres and cells were presented, after one day of culture 
(Figure 41 C, D, E). 
 
 
Figure 41. Cell seeding at density of 3500 cell/cm2 ((A) Percentage of cells adhere to the microspheres 
after 3 days of cell culture and (B) H&E staining on RCPFeHA); Optical micrographs from cells (700 
cells/cm2) in presence of RCP (C), RCPHART (D) and RCPFeHA microspheres (E), (Scale bar: 200 
µm).  
 
New cell seeding strategy was implemented by reducing the amount of cells (i.e. 350 cells/cm2) and based on 
specific surface area (SSA) of each type of microspheres (i.e. different cell number seeded in the 
microspheres) or SSA of RCP (i.e. equal cell number seeded in the microspheres). hMSCs (P8) were used 
in all the tested microspheres and DNA assay, DAPI staining and Live/Dead assay were performed, 
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after 24h of cell seeding.  
Non-adherent cells to the microspheres, during the cell seeding were avoided by using the washing steps. 
Equivalent DNA quantity with statistical significant differences for RCPFeHA (p<0.05) was presented 
by seeding the equal cell number. Cell seeding based on specific surface area was translated in 
differences on DNA amount, with extremely significant statistics differences between all the tested 
groups (p<0.0001) (Figure 42A, 42B). Take into account the DNA amount in one cell (≈ 8.5 pg/cell) 
(Dormer et al. 2012; Phuong N. Dang et al. 2016), about half of the number of cells were adhered to all 
the tested microspheres and in both cell-seeding strategies. By using the equal cell number, 3D 
templates were obtained after 24h of cell seeding, while by take into account the specific surface area 
on cells number, dispersed microspheres was showed in RCPHART, as showed by DAPI staining 
(Figure 42C, 42D). Cell nuclei were marked in blue and cells were visualised on the surface of each 
type of microspheres (Figure 42C, 42D). Meanwhile, 3D template of RCPFeHA was stained with 
Live/Dead and great cell viability, stained in green, was showed in the surface of the microspheres 
(Figure 42E). The results suggested that the specific surface area of each type of microspheres do not 
improve the cell adhesion, thus the use of equal cell number was showed to be the most suitable 
methodology for the cell seeding. 
 
Figure 42. DNA amount obtained from equal cell seeding number (A) and different cell seeding 
number (B). Cell nuclei were stained with DAPI, in equal cell seeding number (C) and different cell 
seeding number (D). Live/Dead staining of RCPFeHA after 24 hours of cell culture (E).  
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3.4.3 In vitro osteogenic differentiation of human mesenchymal stem cells  
Cell Content 
To analyse the amount of cells adhere to the microspheres and the influence of microspheres composition on 
cell content and consequently on cell proliferation, DNA content was quantified at predetermined time points 
(i.e. 2h, 1 day, 3 days, 7 days and in the end of the experiment). Similar cell seeding efficiencies in all tested 
microspheres, without significant differences among the groups, was showed after 2h of cell seeding (Figure 
43A).  At day 1, slight decrease in the DNA content was showed for RCPFeHA, due to the cell seeding in 
presence of the Donor 1, although delicate recovery on day 3 and day 7 was presented (Figure 43A, 43B). 
During the time in culture, no statistically significant differences were noted in the DNA content extracted 
from the cells in contact with all tested microspheres (n=3). Variability on DNA content was showed among 
the Donors (Figure 43B).  
 
Figure 43. (A) hMSCs DNA content in all tested microspheres, over the course of the experiment 
(n=3), (CellS: cell seeding after 2 hours; ExpF: end of experiment 21 days or 17 days, depending on the 
Donor); DNA values obtained from independent Donors (B), (Plot values represent Mean ± SD). 
 
Calcium content  
3D templates (i.e. hMSCs with all tested microspheres) were kept in culture for 17 or 21 days in osteogenic 
induction medium and the calcium content was quantified in presence of all the tested Donors. The values of 
calcium in the medium were compared with cells monolayer, used as a control. In presence of RCP, no 
significant reduction of calcium from osteogenic induction medium was presented, while in RCPHART and 
RCPFeHA compared to RCP low calcium values in the medium were detected (Figure 44A). In order to 
evaluate the effective trend of the results on calcium absorption from the cells or microspheres, individual 
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Donors were analysed (Figure 44B). In the Donor 1, from day 3 to day 14, no significant differences on 
calcium content were showed between microspheres, while at day 18 a decrease of calcium content was 
reflected from RCPHART, RCPFeHA and cell monolayer with statistically significant differences for 
RCPHART (p<0.05). In the Donor 2, at day 14 low calcium content in the medium was showed in presence of 
cell monolayer with very statistically significant differences with all tested microspheres (p<0.001). 
Controversial results were showed in the Donor 3, the decrease on calcium content was showed in RCPHART 
and RCPFeHA with very statistically significant differences at day 17 (p<0.001) (Figure 44B). 
The calcium content in osteogenic induction medium in presence of microspheres without cells was also 
evaluated. In RCP, no significant differences on calcium uptake were presented, while in mineralised 
microspheres (i.e. RCPHART and RCPFeHA) very statistically significant differences on calcium content 
were obtained (p<0.01; p<0.001), due to ion exchange between microspheres and osteogenic induction 
medium (Figure 44C). By comparing mineralised microspheres in presence of cells and without cells, high 
calcium content in cell medium in presence of cells was showed, suggesting the calcium uptake from the 
cells.  
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Figure 44. (A) Calcium content in osteogenic induction medium, over the course of the experiment 
with 3D templates (i.e. hMSCs and respective microspheres RCP, RCPHART and RCPFeHA) and in 
all tested Donors, (*p≤0.05; **p<0.01; ***p<0.001, respect to cell monolayer). B) Calcium content in 
osteogenic induction medium, over the course of the experiment with microspheres (RCP, RCPHART 
and RCPFeHA), (*p≤0.05; **p<0.01; ***p<0.001, respect to osteogenic induction medium (ost. ind. 
medium)). 
  
Gene Expression  
The calcium in osteogenic induction medium was quantified in all tested microspheres and cells monolayer. 
As showed previously, mineralised microspheres slightly uptake the calcium from the cell medium, thus for 
the gene expression the samples were harvested after calcium drop in cell monolayer. Osteogenic 
differentiation of hMSCs were evaluated by the expression of important genes, such as early markers of 
osteogenic differentiation (i.e. ALPL, COL I and IBSP) and late marker of osteogenic differentiation (i.e. 
BGLAP), as well as Osteonectin (SPARC), by real-time PCR.  
The as-obtained results showed a very low expression of the osteogenic genes, mainly BGLAP and ALPL in 
all tested microspheres, without statistically significant differences. Moreover, good levels of osteogenic 
differentiation were presented in COL I and SPARC (Figure 45A). Figure 45B demonstrated the expression 
of COL I and SPARC obtained separately in the different Donors among the tested microspheres and high 
variability between Donors was showed. High induction of osteogenesis was acquired with Donor 1 and 2, 
while lower expression was showed with the Donor 3. Regarding to the Donor 1, high expression of COL I, 
and IBSP with statistically significant differences and slight expression of SPARC in presence of RCPFeHA 
compare to RCP and RCPHART was showed (p<0.05, p<0.01) (Figure 45B, 45C).     
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Figure 45. A) Osteogenic gene expression levels obtained in presence of RCP, RCPHART and 
RCPFeHA. Gene expression levels of COL I, SPARC (B) and IBSP (C) obtained in presence of RCP, 
RCPHART and RCPFeHA in the different Donors, (*p<0.05; ** p<0.01; ***p<0.001).  
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von Kossa staining 
The evidence of osteogenic differentiation of all hMSCs donors exposed to osteogenic factors was evaluated 
in the end of the experiment. Optical micrograph showed the presence of calcium deposits, as indicated by 
the white arrows (Figure 46A). On the other hand, by von Kossa staining the advanced osteogenesis was 
investigated and in the Donors 1 and 2 was confirmed by the formation of calcium deposits (i.e. stained in 
black), while low mineralisation extend was developed by the Donor 3 (Figure 46B, 46C, 46D).    
 
 
Figure 46. A) Optical micrographs of calcium deposits as indicated with white arrow and von Kossa 
staining of osteogenic differentiated of hMSCs, (B) Donor 1; (C) Donor 2; (D) Donor 3, (Scale bar: A) 
200 µm and B, C, D) 100 µm).   
 
Haematoxylin & Eosin Staining and Thionin staining   
After 21 days of cell culture, RCP, RCPHART and RCPFeHA were stained with haematoxylin & eosin. The 
sections obtained from RCP, showed disperse microspheres and cells, while in presence of mineralised 
microspheres (i.e. RCPHART and RCPFeHA) high compact structure was obtained. In both mineralised 
microspheres, cells nuclei were stained in purple and the produced extracellular matrix or collagen fibers 
from cells were stained in pink (Figure 47A, 47B, 47C). In Figure 47D, the interaction of cells with 
microspheres was showed with clear evidence of cells nuclei and extracellular matrix. 
RCPFeHA was stained with thionin after 21 days of cell culture. Cells nuclei and cytoplasm were visualized 
in blue and violet-purple, respectively and great density of cells was surrounding the microspheres. 
Meanwhile, at high magnification the as-observed purple color from the cells might suggest the formation of 
glycosaminoglycan in presence of RCPFeHA microspheres (Figure 47E, 47F).   
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Figure 47. Haematoxylin and Eosin staining of representative sections of hMSCs cells cultured in 
osteogenic induction medium with RCP (A), RCPHART (B) and RCPFeHA (C, D) microspheres. E and 
F) Thionin staining of hMSCs cells cultured in osteogenic induction medium on RCPFeHA, (Scale bar: 
100 µm (A, B, C, E) and 50 µm (D, F)). 
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3.5 Superparamagnetic microspheres as a sustained carrier for rhBMP-2 delivery 
	  
3.5.1 Microspheres properties  
Surface topography, electrostatic interactions, hydrophobic interactions, hydrogen bond and surface 
chemistry of microspheres were described as the main factors involved in adsorption of protein (i.e. rhBMP-
2) (Huang et al. 2016; King & Krebsbach 2012). Regarding to that, surface morphology, surface charge, 
wettability, swelling and specific surface area of all as-produced microspheres were analysed.   
Microspheres were cut and cross-sections were evaluated by SEM. By the cross-section analysis, all the as-
produced microspheres presented a dense structure. Smooth internal morphology in RCP was presented, 
while in RCPfluidMAG-CT slight roughness surface was obtained by the incorporation of magnetic 
nanoparticles in RCP matrix (Figure 48A, 48B). Mineralised microspheres showed an internal roughness 
surface, due to the homogeneous distribution of mineral (Figure 48C, 48D). The distribution of Ca, P and Fe 
was mapped and analysed in RCPFeHA, by EDS microanalysis. The micrographs presented a homogeneous 
distribution of all the tested elements, indicating a well interaction of organic and inorganic matrix, as well as 
a production of homogeneous microspheres (Figure 48E, 48F, 48G).  
 
 
Figure 48. SEM micrographs from the as-fabricated microspheres; A) RCP; B) RCPfluidMAG-CT; 
C) RCPHART; D) RCPFeHA and Ca (E); P (F) and Fe (G) distribution, as well as EDS microanalysis 
on RCPFeHA microspheres (H), (Scale bar: 20 µm).  
 
The surface charge of all tested microspheres was evaluated and higher surface charge in RCPHART and 
RCPFeHA was presented. The wettability of the microspheres was evaluated and the contact angle of RCP 
and RCPfluidMAG-CT were lower than RCPHART and RCPFeHA (Table 13). Moreover, the water 
adsorption was evaluated in presence of RCPHART and RCPFeHA, for about 12 minutes. In both 
microspheres the water was slowly adsorbed, reaching a final contact angle of 42.27±1.76 and 49.06 ± 0.11, 
respectively, suggesting that mineralized microspheres were hydrophobic (Figure 49).  
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The effect of microspheres morphology and composition on swelling properties was analysed (equation 2) 
and the dense structure of RCP and RCPfluidMAG-CT microspheres allowed lower uptake of PBS, while 
RCPFeHA showed higher swelling properties, due to the presence of micro-porous with total porosity of 
69.15%, as measured by mercury porosimetry (Table 13). The specific surface area of the microspheres was 
also evaluated and higher specific surface area was showed in RCPFeHA microspheres, while RCPHART 
presented lower specific surface area. RCP and RCPfluidMAG-CT presented similar specific surface areas 
(Table 13).   
 
Table 13. Physical properties of microspheres, (obtained by: §zetasizer system; ♯contact angle system; 
*optical micrographs and analysed by Image J software; **BET equipment).  
Microspheres 
§Zeta Potential, 
mV 
♯ Wettability, º *Swelling, % 
** Specific surface 
area, m2/g 
RCP 1.53 ± 0.12 89.87 ± 4.13 16.45 ± 1.62 135.28 
RCPfluidMAG-CT 2.19 ± 0.55 75.67 ± 0.92 18.47 ± 1.82 121.60 
RCPHART -4.21 ± 0.86 111.4 ± 0.26 21.22  ± 1.76 29.11 
RCPFeHA 5.86 ± 0.07 111.9 ± 0.37 43.25 ± 2.27 194.11 
 
 
Figure 49. Variance of contact angle during the time for RCPHART and RCPFeHA (A). Representative 
water drop on RCPFeHA in the beginning (B), after 360 seconds (C) and in the end of the experiment. 
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3.5.2 Effect of specific surface area of microspheres on rhBMP-2 release   
Preliminary investigations on rhBMP-2 release were evaluated in presence of C2C12 BRE-Luc cell line. As 
reported previously, RCPHART showed lower specific surface area comparing to RCP and RCPFeHA 
microspheres, with 4.7 and 6.7 of fold change of difference, respectively. Two rhBMP-2 adsorption 
strategies were adopted by take into account or no the specific surface area of the tested microspheres.     
After one day of rhBMP-2 release, the supernatant was collected by centrifugation and analysed in presence 
of C2C12 BRE-Luc cell line. This cell line is genetically modified with BMP responsive element-luciferase 
construct that in presence of BMP, the luciferase gene is expressed (Herrera & Inman 2009). Therefore, the 
use of this test can indicate the bioactivity of released rhBMP-2, which is important on cellular response 
(Figure 50A, 50B).  
In both tested strategies the rhBMP-2 released from all the microspheres was bioactive, as indicated by the 
luminescence signal generated by the luciferin. Moreover, independently of the strategy a trend on luciferin 
signalling was observed. Take into account the specific surface area of each type of microspheres, very 
statistical significant differences among the tested microspheres were presented (p<0.001) (Figure 50B). 
Additionally, high luciferase activity from rhBMP-2 released by RCP microspheres was showed, while low 
luciferin signal for RCPFeHA microspheres with very statistically significant differences (p<0.001) in both 
strategies was presented (Figure 50B). Furthermore, the following investigations were carried out on equal 
amount of microspheres loaded with equivalent concentration of rhBMP-2.  
 
 
Figure 50. C2C12 BRE-Luc cell line in presence of released rhBMP-2 (A) and (B) Luciferase activity 
after 1 day of released rhBMP-2 from all tested microspheres (SSA: rhBMP-2 adsorption take into 
account the specific surface area; No SSA: rhBMP-2 adsorption without consider specific surface 
area), (* p<0.05; *** p<0.001). 
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3.5.3 Effect of microspheres composition on: Loading efficiency and interaction with rhBMP-2 
rhBMP-2 loading efficiency 
All the tested microspheres were washed three times with milli-Q water and evaluated by ELISA 
development kit. High amount of non-adsorbed rhBMP-2 was obtained from the first and second washing 
steps. The percentage of loaded rhBMP-2 in all the microspheres was presented in figure 51 (equation 3). 
Low percentage of rhBMP-2 was loaded from RCP and RCPfluidMAG-CT, while statistical significant 
differences and higher percentage of rhBMP-2 was loaded from RCPFeHA microspheres (99.4 ± 0.03 %; 
p<0.05).  
 
Figure 51. Loading efficiency of rhBMP-2 in all tested microspheres, (* p<0.05). 
 
Loading efficiency by using fluorescent rhBMP-2 
Empty microspheres and loaded microspheres with red texas rhBMP-2 were analysed by fluorescence 
microscopy at equal exposure time (Figure 52). Low fluorescent background was presented from empty 
RCP, RCPHART and RCPFeHA microspheres, while high fluorescence was showed for RCPfluidMAG-CT 
microspheres, probably due to the presence of magnetic nanoparticles into RCP matrix (Figure 52A). The 
presence of rhBMP-2 was detected by the high red fluorescence among the tested microspheres, at 
concentration of 900 ng/mL (Figure 52B). After washing steps, the fluorescent in the samples was 
maintained, particularly detected in the surface of the microspheres, indicating the high affinity and loading 
efficiency (Figure 52C). Moreover, with the presented technique was difficult to evaluate the localisation of 
the rhBMP-2 (i.e. inner or outer of the microspheres).   
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Figure 52. Fluorescence microscope images from microspheres without rhBMP-2 (A), with 900 ng/mL 
of rhBMP-2 (B) and after washing steps, (Scale bar: 20 µm). 
 
Chemical evaluation of interaction of rhBMP-2 with microspheres  
The interaction of rhBMP-2 with microspheres was evaluated by FTIR analysis. rhBMP-2 presented the 
typical vibration modes of proteins, with mainly assignments at 1600, 1560, 1200 cm-1, for Amide I, Amide 
II and Amide III, respectively and assignments in the range of 980 – 1130 cm-1 (Figure 53), that can be 
assigned to -COC and -CO stretching  (Figure 53 A*) (Jeevithan et al. 2014). In RCP and RCPfluidMAG-CT 
with adsorbed rhBMP-2, no significant differences were obtained on the vibration modes of the FTIR 
spectra, while deeply investigation was performed with mineralised microspheres (i.e. RCPHART and 
RCPFeHA). Three types of adsorption functional groups from rhBMP-2 (i.e. −𝑂𝐻;   −𝑁𝐻!;   −𝐶𝑂𝑂!) are 
showed to interact with hydroxyapatite nanophase (Dong et al. 2007), thus positive charge rhBMP-2 binds to 
the phosphate groups of hydroxyapatite layer (Gomez-Morales et al. 2013; Huang et al. 2016). Most of the 
investigations on rhBMP-2 are on Amide I and Amide II (Gilde et al. 2012; Schwartz et al. 2006), moreover 
the hybrid composition of microspheres limited the evaluation of interactions with rhBMP-2 in that region. 
Therefore, slightly differences on the stretching phosphate vibration mode (ν3) were presented (i.e. 1106 and 
1036 cm-1) (Figure 53F, 53I). In RCP spectra, six assignments were presented, while seven assignments were 
obtained for rhBMP-2 by the deconvolution of the FTIR peaks (Figure 53B, 53C). A narrower phosphate 
peak was showed in RCPHART and RCPFeHA without rhBMP-2. By the deconvolution of the peaks in range 
of 830 to 1190 cm-1 indicates the possible interaction of rhBMP-2 with RCPHART and RCPFeHA (Figure 
53F, 53I). In fact, the presence of rhBMP-2 in RCPHART was identified by the formation of broad phosphate 
	  
	  
  
107 
 
  
group, mainly by the shift of 1026.1 to 1014.4 cm-1 and the formation of larger peak at 1065.6 cm-1 (Figure 
53E, 53F). In RCPFeHA, the modification in the phosphate region was presented by the shift of the peak 
from 1018.5 to 1024.9 cm-1 and the broad peak at 111.7 cm-1 (Figure 53H, 53I). 
 
 
Figure 53. FTIR vibration peaks of RCP and rhBMP-2 (A) and respective deconvolution peaks (B) 
and (C); RCPHART without and with rhBMP-2 (D) and deconvolution of phosphate peaks without 
rhBMP-2 (E) and in presence of rhBMP-2 (F); RCPFeHA without and with rhBMP-2 (G) and 
deconvolution of phosphate peaks without rhBMP-2 (H) and in presence of rhBMP-2 (I). (Orange 
trace line: Fit by Sum; Black line: FTIR spectra; blue lines: deconvolution peaks).  
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3.5.4 rhBMP-2 release kinetics 
The rhBMP-2 release kinetics was evaluated under dynamic conditions (agitation, 100 rpm) and the effect of 
porosity and microspheres composition on rhBMP-2 release was investigated.  
 
Effect of porosity on rhBMP-2 release  
For this study, porous microspheres (RCP porous, 1 µm) with rhBMP-2 loading efficiency (i.e. 71.65 ± 3.87 %) 
were used as a comparative model to the as-produced dense RCP microspheres. In vitro release tests showed 
that RCP porous and RCP microspheres were able to release the rhBMP-2 over the time of the experiment 
(Figure 54), while an initial burst release was presented. After 24h, the rhBMP-2 cumulative release was 
about 65 % and 93 % for RCP porous and RCP microspheres, respectively. Moreover, after 3 days, rhBMP-2 
was completely released from dense RCP microspheres, while in RCP porous microspheres a slower and more 
controlled release over the time of the experiment (i.e. 83 % in 14 days) was detected with extremely 
statistical differences on rhBMP-2 release (p<0.0001).  
 
 
Figure 54. Cumulative release of rhBMP-2 in percentage from RCPporous and RCP microspheres, (in 
all the points of the graph statistically differences of p<0.0001). 
 
Effect of microspheres composition on rhBMP-2 release  
RCP dense microspheres and two types of mineralised microspheres (i.e. RCPHART and RCPFeHA) were 
investigated as rhBMP-2 carriers. As mentioned previously, a burst release for RCP microspheres was 
presented, while sustained release of rhBMP-2 from mineralised microspheres was experienced. After 1h of 
rhBMP-2 release, extremely significant differences on rhBMP-2 release was showed (i.e. between RCP and 
RCPHART; between RCP and RCPFeHA; **** p<0.0001), while very significant differences between 
RCPHART and RCPFeHA was presented (** p<0.01). About 57 % and 24 % of rhBMP-2 were respectively 
released from RCPHART and RCPFeHA microspheres, during 14 days of experimental investigations. Over 
the course of the experiment, extremely statistically significant differences were presented between all the 
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tested microspheres (p<0.0001) (Figure 55A). Therefore, for RCP microspheres 900 ng of rhBMP-2 were 
released at day 3, while 400 ng and 200 ng were delivered by RCPHART and RCPFeHA, respectively after 
14 days of investigations (Figure 55B).      
 
 
Figure 55. Cumulative release of rhBMP-2 in percentage (A) and in ng (B), from RCP, RCPHART and 
RCPFeHA microspheres.  
	  
3.5.5 Evaluation of non-released rhBMP-2 
After 14 days of rhBMP-2 release studies, microspheres were treated with urea and collagenase, in order to 
evaluate the residual attached rhBMP-2 to the microspheres. Predetermined concentrations of collagenase 
were investigated (i.e. 1 mg/mL; 2 mg/mL; 5 mg/mL and 10 mg/mL) and 10 mg/mL was selected as suitable 
concentration to degrade the microspheres and mineral nanophase was maintained (Figure 56). For RCP porous 
microspheres, almost all the rhBMP-2 was recovered, while in mineralised microspheres about 30 % and 15 
% of rhBMP-2, was obtained respectively from RCPHART and RCPFeHA. From those results, was 
hypothesised that the rhBMP-2 linked to RCP was obtained after degradation of RCP with collagenase, 
while residual rhBMP-2 was linked to the mineral phase in the microspheres. Besides, the results suggested 
that rhBMP-2 presented higher chemical interaction with iron containing mineralised microspheres, as 
showed previously with FTIR analysis.  
 
  
Figure 56. SEM micrographs of RCPHART (A) and RCPFeHA (B) microspheres, after 14 days of 
rhBMP-2 releasing studies, urea treatment and degradation with 10 mg/mL of collagenase, (Scale bar: 
50 µm). 
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3.5.6 rhBMP-2 bioactivity  
After one hour of releasing studies, the released medium was collected by centrifugation and predetermined 
volume was added to the C2C12 BRE-Luc cell line, as well as quantified by ELISA sandwich method and 
the results were showed as percentage of rhBMP-2 bioactivity (equation 4). High rhBMP-2 bioactivity was 
showed from all the tested microspheres, while statistically significant differences on rhBMP-2 bioactivity 
was showed for RCPFeHA compared to RCP microspheres (p<0.05) (Figure 57). 
 
 
Figure 57. Percentage of rhBMP-2 bioactivity from RCP, RCPHART and RCPFeHA, (* p<0.05). 
 
3.5.7 Tailored release of rhBMP-2 by using PEMF 
The effect of external magnetic fields on rhBMP-2 release was evaluated in presence of RCPHART, 
RCPfluidMAG-CT and RCPFeHA under pulsed electric magnetic field (PEMF). rhBMP-2 was adsorbed by 
the tested microspheres and a final concentration of 400 ng/mL was achieved and the releasing studies were 
performed without (static, NO PEMF) and under PEMF. In agreement with the previous results, all the tested 
microspheres were able to release rhBMP-2 over the time of the experiment. As was expected for RCPHART 
any significant differences in releasing profile at both condition was presented (Figure 58A). Meanwhile, the 
effect of magnetic properties on delivery of rhBMP-2 was analysed in RCPfluidMAG-CT and RCPFeHA. 
Any significant differences were showed in the rhBMP-2 releasing profiles from RCPfluidMAG-CT at both 
conditions (i.e. No PEMF or PEMF), suggesting that rhBMP-2 was not linked with magnetic nanoparticles 
but only on the surface of the microspheres (i.e. RCP matrix), thus no improving on releasing profile with 
PEMF was showed (Figure 58B). Therefore, in RCPFeHA slight increase on rhBMP-2 release in presence of 
PEMF was showed without statistically significant differences (Figure 58C). The explanation of this result 
might be correlated by the use of low magnetic field and low magnetisation from RCPFeHA (1.65 emu/g).      
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Figure 58. Cumulative release of rhBMP-2 in percentage of RCPHART (A), RCPfluidMAG-CT (B) and 
RCPFeHA (C) in presence or without PEMF.  
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3.6 Preliminary investigations on Scaffold fabrication 
	  
3.6.1 Bone-like scaffolds with superparamagnetic properties  
Phase composition of the scaffolds was showed in the section 3.1.2. By keeping the mineral amount of 40 
wt%, and by increasing the temperature of biomineralisation process material crystallinity and magnetic 
properties were improved. Herein, biomineralised slurries synthesised at 40 ºC, 50 ºC and 60 ºC were used to 
produce iron-free and iron containing mineralised scaffolds, by freeze-drying process. The effect of synthesis 
temperature on scaffold structure and morphology was analysed by SEM.  
Scaffolds and SEM micrographs from longitudinal cross-section of the scaffolds were showed in Figure 59A, 
59B. From macroscopic point of view, the scaffold composed by the slurry synthesised at 60 °C showed 
weak 3D structure, compared to the other scaffolds synthesised at different temperature. By SEM 
micrographs, scaffolds presented internal and external porous structure, although in the bottom part small 
porous were obtained. RCP/FeHA, 60 °C exhibited heterogeneous and undefined porous structure. By 
analysing the porous detail of the scaffolds, in RCP/HA scaffolds synthesised at 40 °C, heterogeneous 
distribution of the mineral was presented. In RCP/FeHA scaffolds mineralised at 40 °C, homogeneous 
mineral distribution inside of the porous was showed, compared to the ones synthesized at 50 °C and 60 °C. 
The heterogeneous structure of the scaffolds and non well-defined shape of the porous does not allowed to 
evaluate the porous size. The results suggested that morphological structure of the scaffolds were probably 
affected by the induced crystallinity promoted by the synthesis temperature and resulted in fragile scaffolds 
above a critical extent of mineralization.  
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Figure 59. Scaffolds produced by using the mineralised slurries and freeze-drying process (A) and 
SEM micrographs from bottom, middle and top of the scaffolds, cut as demonstrated in A*, (B); (a) 
RCP/HA; b) RCP/FeHA, 40ºC; c) RCP/FeHA, 50ºC; d) RCP/FeHA, 60ºC, (Scale bar: bottom, middle 
and top: 100 µm and porous detail: 10 µm).   
	  
The mineral content in the scaffolds was quantified by using the thermogravimetric curve obtained by TGA 
and higher mineral content was showed by using high synthesis temperature (≈ 49.3%), while similar 
mineral amount with theoretical one was showed in RCP/FeHA, 40ºC (≈ 46%) (Figure 60A).  
	  
	  
	    114 
 
  
The effect of scaffold morphology and mineral content on adsorption of PBS was assessed by swelling tests 
(equation 5). After 1h of swelling tests, scaffolds absorbed higher amount of medium and then an osmotic 
equilibrium in the samples, until 24h was obtained (Figure 60B). RCP/FeHA (i.e. 40 and 50 °C) scaffolds 
presented higher swelling behaviour compared to RCP/HA. High mineral content in RCP/FeHA, 60ºC was 
reflected in low swelling properties (Figure 60C). 
   
 
Figure 60. A) Thermogravimetric curve of iron containing mineralized scaffolds, obtained by TGA; B) 
Swelling properties up to 24h of soaking. C) Maximal swelling properties of the mineralised materials.  
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Chapter 4. Discussion  
	  
4.1 Application of biomineralisation process to obtain new hybrid biomaterials with 
superparamagnetic properties  
Preliminary investigations were carried out to produce new hybrid biomaterials with superparamagnetic and 
bone-like properties. As described in Tampieri et al. 2012, various parameters were investigated in the 
synthesis of FeHA to produce bone-like apatite with magnetic properties and by increasing the synthesis 
temperature an enhancement on magnetic properties were obtained.  
Fe/Ca molar ratio, Fe2+/Fe3+ molar ratio, organic / inorganic ratio and synthesis temperature were 
investigated. By varying Fe2+/Fe3+ molar ratio and Fe/Ca molar ratio magnetic or bone-like properties were 
not improved. On the other hand, in the case of those mineralised materials, the increase of mineral phase up 
to 80 wt% does not significantly improve the magnetic properties. Moreover, the as-obtained results 
indicated that by using RCP/FeHA with 40 wt% of mineral phase, Fe2+/Fe3+ molar ratio (3:2), Fe/Ca (20 
mol%) and by applying various synthesis temperature, bone-like and superparamagnetic properties were 
achieved.  
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4.2 New bioactive bone-like microspheres with intrinsic magnetic properties obtained by bio-
inspired mineralisation process 
The application of bio-inspired processes for the synthesis of smart, highly bioactive materials is a relatively 
recent approach that in the last decade has been successfully followed, particularly in the pH-driven 
assembling and mineralisation of natural polymeric matrices such as collagen, with bone-like apatitic nano-
phases. Such approach generated hybrid bone and osteochondral scaffolds with high biomimesis and 
regenerative ability (Tampieri et al. 2014; Tampieri et al. 2008; Sprio et al. 2012; Kon, Filardo, et al. 2010; 
Kon, Delcogliano, et al. 2010), and a number of novel biomaterials with smart properties for applications in 
medicine (Ramírez-Rodríguez et al. 2016; Campodoni et al. 2016). 
The main features of biomineralisation processes is the ability to transfer information from the 
macromolecular template to the nucleating inorganic phase; such information consists in an ensemble of 
physico-chemical, morphological and ultrastructural control mechanisms that control the crystallization 
pathway of the inorganic phase and limit its growth (Sprio et al. 2012; Bouwstra J., Sutter M., Kluijtmans S., 
Hennink W. 2010; Boer A., Urk H., Bouwstra J. 2012).  
In the present work, the biomineralisation process was translated to a hydrosoluble bioengineered collagen 
derived polypeptide matrix (RCP) obtained by an animal-free yeast fermentation process. The collagen I 
derived recombinant peptide is by design enriched with cell-binding RGD motifs, thus being able to support 
cell adhesion, proliferation and differentiation, in the form of hydrogel, scaffolds or microspheres (Bouwstra 
J., Sutter M., Kluijtmans S., Hennink W. 2010; Boer A., Urk H., Bouwstra J. 2012; Van Boxtel 2013). The 
biomineralisation process was applied to achieve the heterogeneous nucleation of Fe2+/Fe3+-doped 
hydroxyapatite onto the RCP matrix. The synthesis process was optimised on the basis of previous studies on 
the nucleation and crystallization of intrinsically superparamagnetic apatite phases, for which precise 
substitution extent with divalent and trivalent iron ions into the apatite structure was required (Tampieri et al. 
2012; Tampieri et al. 2014). In this respect XRD, TEM and spectroscopic analyses confirmed the doping of 
the apatite lattice with both ion species during the biomineralisation process. Two different synthesis 
temperatures were used (i.e. 40 °C and 60 °C) to investigate the effect on the inorganic phase formation, 
crystal growth and magnetic properties, by using RCP mineralised with stoichiometric apatite in the same 
conditions (i.e. RCPHA), as a control material. As an effect of iron substitution, RCPFeHA exhibited lower 
crystallinity than RCPHA, and a lattice distortion consistent with selective doping of the Ca crystal sites with 
both Fe2+ and Fe3+ ions, and also carbonation in B site, was observed by FTIR analysis. The results 
confirmed that the synthesis temperature and the presence of foreign ions into hydroxyapatite lattice strongly 
influenced the crystallinity of the mineral phase; besides, a further control level, imparted by the 
macromolecular template (RCP) was evident when comparing with Fe-doped HA obtained in the present 
work with one obtained by wet synthesis at the same conditions without any templating matrix (Tampieri et 
al. 2012). 
In order to study the early stages of RCP biomineralisation process, deeper investigation was carried out by 
studying the chemical interaction of divalent (i.e. Ca2+ and Fe2+) and trivalent (i.e. Fe3+) ions with RCP amide 
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and carboxylic groups and both are the main functional active groups for the coordination of different ions, 
like was reported in the biomineralisation of collagen or gelatin (Sprio et al. 2012; Mercado et al. 2014; 
Wang et al. 2015; Choi et al. 2013).   
Besides, a clear trend was identified, where the band shift was stronger in the iron-containing materials, and 
also in the ones prepared at higher temperatures. This finding confirms the role of exposed iron ions in 
mediating the biomineralisation process, particularly in inducing a stronger bond with the organic matrix by 
a specific and preferential link to the carboxylic group, together with calcium ions. On the other hand, the 
detected shifts of amide groups might suggest the formation of new chelate bonds between Ca or Fe ions and 
C=O bonds from RCP, that however seemed active only at acidic pH conditions. In fact, when the 
experiment was carried out at neutral pH the vibration modes of amide I and II were similar to those of pure 
RCP. This behaviour reflects the gelatin-like character of RCP macromolecule, particularly in respect to the 
interaction with iron (Gaihre et al. 2008; Yonezawa et al. 2008; Wang et al. 2015; Choi et al. 2013).  
The low crystallinity detected in the nucleated inorganic phase, particularly in RCPFeHA synthesised at 40 
°C, likely reflected a poor ordering in the coordination of Fe ions in the apatite structure thus inducing very 
low magnetization values; on the other hand an increase of synthesis temperature promoted the 
crystallization of iron oxide, as detected by XRD and TEM and the establishment of higher magnetisation, 
by means of superparamagnetic-like behaviour and single magnetic domain, as obtained by the trend of the 
magnetisation curve and the low coercive force (Hc).  
An emulsification process was optimised to produce RCP and hybrid microspheres and a dehydrothermal 
treatment (DHT) was used as method to crosslink and improves the microspheres stability in physiological 
conditions. Mechanical stirring velocity, cooling temperatures and RCP concentration, were the most 
relevant parameters to be controlled and well-dispersed hybrid microspheres with defined size and 
composition were obtained. DHT physical treatment is one of the methods used to crosslink gelatin or 
collagen scaffolds (Vandelli et al. 2004; Haugh et al. 2009; Prasertsung I. & Damrongsakkul S. 2010) and in 
crosslinked RCP microspheres, intermolecular bonds were formed and confirmed by both FTIR and thermal 
analysis.    
Preliminary biological study with murine pre-osteoblast cells investigated the effect of microspheres 
composition, polymeric or hybrid iron-containing, on cell behaviour. Cell viability showed no significant 
difference between materials at the highest microspheres concentration. The small amount of iron oxide 
formed in RCPFeHA60 did not compromise the cells viability, after 7 days of culture in vitro.   
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4.3 Effect of ions release from hybrid superparamagnetic microspheres on osteogenic 
differentiation of MC3T3-E1 
Calcium phosphate biomaterials presented interesting chemical and physical cues to be doped with relevant 
ions to mimic bone tissue composition (Boda et al. 2016). Recently, an innovative magnetic hydroxyapatite 
was synthesised by adding two iron sources (i.e. Fe2+ and Fe3+) into the HAp lattice and interesting chemical 
and physical properties and inductive effect on cell behaviour were showed (Panseri et al. 2012; Tampieri et 
al. 2014; Panseri et al. 2016). By using a biomineralisation process, RCP matrix was mineralised with 
Fe2+/Fe3+ doped hydroxyapatite and iron-containing microspheres with superparamagnetic cues were 
achieved (RCPFeHA). The effect of ions release and microspheres composition on osteogenic differentiation 
of MC3T3-E1 was evaluated, as well as the release of ions was proposed as therapeutic purposes for bone 
tissue regeneration.    
Both mineralised microspheres (i.e. RCPHART and RCPFeHA) presented bone-like composition and 
microspheres aggregation in cell medium was improved by the functionalisation with citrate ions, that 
complex the calcium or the iron ions (present in the mineral phase of the slurries) and non-agglomerated 
microspheres in cell medium were obtained. Moreover, a partial replacement of calcium ions for iron ions in 
RCPFeHA was showed, without significant modifications on materials composition.  
Further, the beneficial effect of calcium and iron release from RCPHART, RCPfluidMAG-CT and RCPFeHA 
microspheres was investigated as a potential use to enhance bone regeneration. Calcium and iron ions are 
relevant on bone metabolism and essential on cell growth and functionality. Calcium ion plays a key role in 
the polarization of macrophages from M1 (inflammatory) to M2 (regeneration), supporting the homeostasis 
and bone regeneration, while iron deficiency increases the risk of osteoporosis (Wang et al. 2016; Boda et al. 
2016; Perez et al. 2015; Toxqui & Vaquero 2015).  
Microspheres were immersed in two different mimicking conditions (i.e. physiological or inflammatory), 
over the course of 28 days, and microspheres morphology, ions release, differences in the pH and phase 
composition were evaluated. In physiological mimicking conditions, the concentration of calcium in DMEM 
with RCPHART and RCPFeHA was decreased, suggesting an uptake of Ca ion from the DMEM, mainly up 
to 7 days of immersion, and a precipitation of calcium/phosphate onto microspheres surface, as proved by 
the XRD analysis performed after 28 days immersed in DMEM. On the other hand, an increase of iron 
release on mimicking physiological conditions was showed, probably due to the iron ion exchange with 
calcium ion from DMEM. Some investigations have been corroborate the importance of adding extracellular 
Ca ion and osteogenic differentiation of human bone marrow stromal cells (hBMSCs) was enhanced (Zhang 
et al. 2014), although an increase of the number of death MC3T3-E1 cells was showed (Tsang et al. 2011). 
The dissolution of the as-produced superparamagnetic microspheres can make available Ca and Fe ions and 
can be defined as promising device for new effective applications in bone tissue engineering. In the blood the 
pH can be affected by the presence of tumour, inflammation and fractures, thus cellular responses are 
affected and reduced (Nakamura et al. 2016; Arnett 2010). Regarding to that, microspheres properties were 
evaluated under mimic inflammatory conditions. RCP and RCPfluidMAG-CT showed good morphologic 
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surface after 28 days of experiment, while from RCPfluidMAG-CT, RCPHART and RCPFeHA ions were 
released. Calcium solubility was similar from both mineralised microspheres and low iron was released from 
RCPFeHA. In acidic environment, the resorption activity of osteoclasts is increased and the deposition of 
alkaline mineral in bone is reduced by osteoblasts, promoting the mineral homeostasis (Nakamura et al. 
2016; Arnett 2010). The released ions from RCPFeHA could help or stimulate the surrounding inactivated 
osteoclasts to differentiate and to be activated, as well as improving osteoclasts formation in vivo (Nakamura 
et al. 2016).   
The effect of non-mineralised and mineralised microspheres on cell viability, cell morphology and their 
ability on promoting osteogenic differentiation of MC3T3-E1 were evaluated. All the tested microspheres 
were cytocompatible, without apoptotic activation or reactive oxygen species production, until 3 days of cell 
culture. Therefore, the staining of actin filaments showed cell adhesion and spreading, that are relevant on 
interaction with biomaterials for further activities like cell migration, proliferation, differentiation and 
extracellular matrix production (Lin et al. 2013). 
Real-time PCR analysis of osteogenic markers (i.e. BGLAP, COL I, and SPARC) was performed for 
evaluation of osteogenic differentiation promoted by microspheres composition. BGLAP is secreted by 
osteoblasts, as well as is the main noncollagenous compound of bone matrix deposition and mineralisation 
(Lin et al. 2013). Interestingly, an up-regulation of the genes was showed from all the tested microspheres. 
COL I is defined as an early osteogenic marker and is important on bone matrix formation (Lin et al. 2013). 
COL I expression was up-regulated in all the tested microspheres and slightly higher in RCPFeHA. SPARC 
gene encodes an important protein for collagen in bone tissue to become calcified (Rosset & Bradshaw 
2016). SPARC expression was higher up-regulated in RCPFeHA. The as-mentioned expression levels of the 
genes suggested that all the microspheres have the ability to stimulate osteogenic differentiation of murine 
pre-osteoblasts cells, probably due to the calcium deposition in the microspheres surface (Zhang et al. 2014). 
The magnetic mineral phase of RCPFeHA provided an ion exchange and slightly improves the expression of 
osteogenic genes. The low concentration of iron released from calcium phosphate cements have enhanced 
osteogenesis and angiogenesis in mouse BMSCs and in human umbilical vein endothelial cells, respectively 
(Boda et al. 2016).  
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4.4 Effect of microspheres composition on differentiation of human mesenchymal stem cells  
The main goal was to engineer a new 3D template composed by microspheres and human mesenchymal stem 
cells that provides an ideal biomimetic microenvironment for bone tissue applications. The cytotoxicity of 
RCP, RCPHART and RCPFeHA microspheres were assessed after 7 days of cell culture and the effect of 
those microspheres combined with human mesenchymal stem cells triggering the regulation of osteogenesis 
in vitro was evaluated.  
hMSCs were grown, spread and high cell viability in presence of all tested microspheres was showed. 
Moreover, high density of live cells was surrounding the hybrid microspheres indicating the great affinity to 
the microspheres and non-cytotoxicity effect in the presence of hMSCs.  
The cell-seeding efficacy was similar in all the tested 3D templates, as showed by the DNA content after two 
hours of seeding, while DNA content among the Donors and in all the tested microspheres was maintained 
over the course of the experiment. In recent studies with hMSCs aggregates, the DNA amount decreased 
after 2 weeks of cell culture in osteogenic medium and the slightly variances on DNA level were suggested 
as occurrence of calcification of cartilage matrix (Phuong N. Dang et al. 2016; Phuong N Dang et al. 2016). 
After 21 days of cell culture, the formation of extracellular matrix and possibly formation of 
glycosaminoglycan in presence of RCPFeHA was showed by haematoxylin & eosin and thionin staining.   
Several ions and proteins are presented in biological environments and by immersion of calcium phosphate 
biomaterials, a sustained dissolution-reprecipitation cascade was presented. In concordance with the results 
showed in previous topic of this thesis, an ion exchange in the cell medium was showed in presence of 
RCPHART and RCPFeHA. The non-equilibrium of ions in cell culture medium due to ion exchange might 
affect the cells activity, while in in vivo the ion equilibrium is regulated by homeostasis (Barrere et al. 2006).  
The effect of microspheres composition on osteogenic differentiation was evaluated by the expression of 
relevant genes on bone formation. Osteoblasts synthetize and secrete collagen type I (COL I), alkaline 
phosphatase (ALPL), osteocalcin (BGLAP), osteopontin, osteonectin (SPARC) and bone sialoprotein 
(IBSP). In the beginning of cell proliferation and extracellular matrix synthesis and in post-proliferative of 
extracellular matrix, COL I and ALPL are expressed. On the other hand, osteopontin, osteocalcin and bone 
sialoprotein are expressed during the extracellular matrix mineralisation (Barrere et al. 2006; Calabrese et al. 
2016; Boda et al. 2015; Westhrin et al. 2015). Low expression of BGLAP and ALPL osteogenic genes were 
presented. The mineral composition of mineralised microspheres (i.e. RCPHART and RCPFeHA) may inhibit 
the production of ALPL from the hMSCs (Barrere et al. 2006), without inhibition of mineralisation, as 
showed by the high expression of SPARC and IBSP in Donor 1. Hydroxyapatite scaffolds in presence of 
hMSCs do not significantly improve the expression of osteogenic genes in vitro (i.e. BGLAP and SPARC), 
although a completely cellular maturation and in vivo bone formation was observed (Viti et al. 2016). On the 
other hand, iron based biomaterials in presence of cells were showed as potential device to improve the 
osteogenic differentiation of genes. For example, superparamagnetic nanoparticles (SPIONS) were labelled 
with hMSCs and an up-regulation of osteogenic related genes were showed (Wang et al. 2017). An 
improvement on bone-related gene expression by human bone marrow mesenchymal stem cells in presence 
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of iron containing mesoporous bioactive glass scaffolds was obtained (Wu et al. 2011). Or going further, the 
use of mineralised collagen with biomimetic iron doped hydroxyapatite showed an improvement on 
osteogenesis by applying an external magnetic field (Tampieri et al. 2014).    
The as-investigated 3D template with RCPFeHA, non-cytotoxic effect on hMSCs and improvement in 
expression of relevant genes for bone tissue formation was showed and prompt the use of this template in 
bone tissue applications.    
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4.5 Superparamagnetic microspheres as a sustained carrier for rhBMP-2 delivery 
rhBMP-2 is one of the most investigated growth factors in bone tissue regeneration, due to induce the 
osteogenic differentiation of stem cells and improve the formation of high quality of new bone tissue (Kim et 
al. 2016; Autefage et al. 2009). Herein, hybrid superparamagnetic microspheres were proposed as carrier for 
sustained release of rhBMP-2 over the time and the effect of porosity, microspheres composition and 
physical-chemical properties of microspheres were evaluated on rhBMP-2 release.   
The main challenge is to understand and tailor the adsorption and bioactivity of rhBMP-2 in engineered bone 
devices. Protein-material interactions are influenced by charge, chemistry, topography and hydrophobicity, 
as well as nature of proteins, and surrounding environment (e.g. pH and ions). By adsorption process, the 
first interactions between proteins and materials surfaces are hydrophobic interaction, electrostatic 
interaction, hydrogen bond, surface topography and surface chemistry (Huang et al. 2016). The surface 
morphology, surface charge, wettability and swelling properties were different by comparing non 
mineralised (i.e. RCP and RCPfluidMAG-CT) with mineralised microspheres (i.e. RCPHART and 
RCPFeHA). Regarding to the rhBMP-2 adsorption strategies by take into account the specific surface area of 
microspheres, statistical significant differences on luciferase activity from collected supernatant among the 
microspheres were obtained, while a trend of luciferase activity was similar in both strategies. This result 
suggested that the specific surface area did not improve the control release of rhBMP-2, although the surface 
chemistry was showed as an important factor. Moreover, limitations are still presented on evaluation of the 
effect of the binding mode of rhBMP-2 to bone morphogenetic protein receptors, as well as the mechanism 
involved to guarantee the rhBMP-2 activity (Huang et al. 2016). The binding sites of proteins adsorbed in 
hydroxyapatite can be divided in C-sites or N-sites, as well as protein interacted with hydroxyapatite during 
the protein adsorption until matching the specific crystal surface. Therefore, the adsorption phenomena is 
mainly conducted by electrostatic interactions (i.e. negatively charged carboxylate groups and calcium 
cations on hydroxyapatite surface) and intermolecular H-bonds between N-containing groups and phosphate 
groups of hydroxyapatite (Zhou et al. 2007; Dong et al. 2007). The as-investigated rhBMP-2 had pH = 6.5 
and positive surface charge (i.e. 35.1±5.4 mV), thus high affinity to the mineral phase of the microspheres 
was showed.  
The release profile of rhBMP-2 from all tested microspheres and their bioactivity were evaluated in vitro. A 
controlled release profile of rhBMP-2 from RCPHART and RCPFeHA was showed, over 14 days, whereas a 
burst release was showed for RCP microspheres, suggesting the strong interaction with mineral phase of the 
microspheres. Moreover, the released rhBMP-2 was showed to be bioactive for all the tested microspheres.  
High fluorescence of texas red rhBMP-2 was obtained in presence of mineralised microspheres, while by 
deconvolution of phosphate vibration mode, various peaks were detected and broad peaks or slight shift were 
showed in presence of rhBMP-2. Altogether, adsorption of rhBMP-2 in mineralised microspheres was 
suggested by chemical, electrostatic and hydrophobic interactions.  
RCPFeHA was previously showed to improve the osteogenic differentiation of MC3T3-E1 and human 
mesenchymal stem cells, thus combining the sustained release of rhBMP-2 might improve the regenerative 
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ability of the device, as well as its clinical application. On the other hand, the biomimetic, osteogenic 
properties and the sustained release of rhBMP-2 and tailored release with PEMF provide interesting 
advantages compared to the available commercial devices (Quinlan et al. 2015). 
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4.6 Preliminary investigations on Scaffold fabrication 
Several approaches have been reported in the functionalization of scaffolds with magnetic properties, for 
bone tissue engineering and iron oxide nanoparticles has been extensively used (Bock et al. 2010; Xu et al. 
2014; Singh et al. 2014; Mertens et al. 2014; Skaat et al. 2012; Wu et al. 2011).  
Taking into account the promising properties of magnetic biomineralised scaffolds, in this work the 
biomineralisation of iron-doped apatite nanophase on synthetic collagen peptide matrix was studied. The 
main aim was to produce porous scaffolds with magnetic and adequate biomechanical properties for bone 
tissue applications. By applying a biomineralisation synthesis to RCP matrix, chemical interaction of 
carboxylic groups from RCP with iron and calcium ions from mineral phase were presented. The 
optimisation of the synthesis parameters, temperature and inorganic phase (until a certain amount, 40 wt%) 
were showed as fundamental parameters to obtain superparamagnetic properties.  
Biomineralisation of RCP matrix with hydroxyapatite or magnesium doped hydroxyapatite and applied to 
scaffolds fabrication by freeze-drying process was described as successful methodology (Ramírez-Rodríguez 
et al. 2016). However, by applying and modifying this methodology for the fabrication of superparamagnetic 
materials, the as-produced scaffolds composed by RCP mineralised with iron-doped hydroxyapatite showed 
non-adequate 3D porous structure and weak biomechanical properties. Non-adequate cell migration, cell 
proliferation, cell viability, as well as transport of oxygen and nutrients, were hypothesised as additional 
drawbacks of those scaffolds. The results suggested that was reached the degree of mineralization on RCP 
matrix and the biomaterial was not suitable for the production of the scaffolds.    
Furthermore, the production of RCP mineralised with hydroxyapatite and superparamagnetic properties 
might be attempted by applying one of the following strategies: i) Mineralisation of RCP with 
hydroxyapatite nanophase at room temperature, scaffold production by freeze-drying followed by 
crosslinking and then scaffolds can be soaked in ferrofluid (i.e. solution composed by iron oxide 
nanoparticles); or ii) during the biomineralisation of RCP matrix the as-used iron sources might be 
substituted by predetermined concentration of iron oxide nanoparticles.  
The first strategy was investigated with mineralised collagen scaffolds and iron oxide nanoparticles were 
kept inside of the scaffold up to 8 days, without significant modifications on 3D structure of the scaffold and 
preliminary in vitro tests with human bone marrow stem cells, indicated cell adhesion and cell proliferation 
(Bock et al. 2010).  
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Chapter 5. Conclusions and Future perspectives  
 
The growing numbers of bone defects, diseases and fractures create a high impact on public health and new 
solutions must be implemented. Bioactive magnetic based materials are promising solutions that have been 
investigated to treat bone tissue, through release of ions, composition and surface topography.  
This thesis describes a bio-inspired mineralisation process and water-in-oil emulsification method that were 
successfully optimized and used to produce new hybrid microspheres with bone-like composition, composed 
by collagen type I based recombinant peptide mineralised with Fe2+/Fe3+-doped apatite nanophase. 
Biomineralisation process confirmed to be a promising synthesis approach that can be flexibly directed to a 
variety of biomimetic materials with properties tailored on the basis of the nature and chemistry of the 
organic matrix and designed ion doping in the mineral nanophase. The high active surface exhibited by the 
apatite nanophase provides specific sites to link several drugs or growth factors. On this basis, such new 
magnetic microspheres with bone-like composition, cytocompatibility and by immersing microspheres in 
physiological mimicking conditions, an ion exchange was observed and can be an inductive factor on 
osteogenic differentiation and bone regeneration, as was showed by the improvement on osteogenic genes 
expression. Those promising features prompt the use of magnetic microspheres in medicine, particularly in 
bone tissue engineering, to regulate the osteogenic differentiation in vitro and supposedly bone metabolism 
in vivo. Biomimetic composition of microspheres promotes high cell viability, adhesion and proliferation, 
thus the use of 3D templates composed by cells and microspheres can be proposed for bone tissue 
engineering. On the other hand, the interesting chemical – physical features of superparamagnetic 
microspheres enable a sustained release of rhBMP-2 and can be suggested to overcome the actual rhBMP-2 
carriers, by offering bone-like composition, slow degradation rates and sustained release over the time. The 
superparamagnetic properties of the new microspheres can enable smart mechanisms for the on demand 
release of therapeutic factors in situ by low alternated magnetic signals. 
Regarding to clinical perspective, magnetic microspheres are suggested to be use as bioactive bone filler, or 
as bioactive bone filler as a carrier of rhBMP-2, or as 3D template composed by microspheres and 
cells. Take into account the swelling properties of magnetic microspheres the injectability might be tailored 
by the amount of adsorbed water. On the other hand, the use of water does not change the phase composition 
of microspheres, as well as cytocompatibility and the induction of osteogenic differentiation (Figure 61A). 
The use of 3D template composed by microspheres and human mesenchymal stem cells showed interesting 
results on improvement of gene expression and prompt their use as support for bone tissue regeneration 
(Figure 61B). Furthermore, superparamagnetic microspheres were investigated as suitable carrier of rhBMP-
2. In this case, might be suggested as bone filler and the adsorbed water might contain predetermined 
concentration of rhBMP-2 (Figure 61C). A new 3D template composed by magnetic microspheres with 
adsorbed rhBMP-2 and human mesenchymal stem cells was also proposed (Figure 61D). In the last two 
purposes, the osteogenic differentiation of the cells might be improved by i) using a bone-like biomaterial 
and by ii) the use of important growth factor on bone tissue regeneration (i.e. rhBMP-2). Nevertheless, after 
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implantation of one of the as-mentioned devices the regeneration of bone tissue can be enhanced by applying 
an external magnetic field. As showed in the introduction of this thesis, the use of magnetic fields improves 
the cell activity and also can induces the release of rhBMP-2 and iron ions, both important on boost bone 
tissue regeneration.  
 
 
 
Figure 61. Proposed devices by using magnetic microspheres. A) Bone filler composed with swollen 
microspheres; B) 3D template composed by magnetic microspheres and cells; C) Bone filler composed 
by swollen magnetic microspheres as a carrier of rhBMP-2; D) 3D templates composed by swollen 
magnetic microspheres as rhBMP-2 carrier and cells.  
 
The main scope of the thesis was achieved and superparamagnetic microspheres showed promising 
properties to be used in bone tissue regeneration, although to achieve the as-mentioned applications it will be 
necessary to go further and to evaluate some of the following aspects. First, concerning on the production of 
3D templates (i.e. hMSCs with cells) and to conclude the effect of microspheres composition in the 
development of mineralisation will be interesting to evaluate the calcium deposition in the microspheres 
surface, by SEM and by ICP-OES analysis; sliced samples can be stained with several indicators and maybe 
to perform in vivo tests. Second, will be relevant to perform in vitro tests and to evaluate the effect of 
superparamagnetic microspheres with external magnetic field on cells viability and osteogenic 
differentiation. Moreover, if from those tests an interesting effect on cells behaviour is achieved; in vivo tests 
are proposed without and with magnetic stimulation. Third, effect of superparamagnetic microspheres as a 
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carrier of rhBMP-2 in presence of human mesenchymal stem cells can be analysed, then in vivo tests might 
be planed and the effect of this device in the development of new bone tissue might be evaluated by applying 
or no an external magnetic field. Fourth, the as-mentioned superparamagnetic microspheres can be used in 
clinical practise as bone filler and tests on rheological properties, injectability and microspheres size and the 
effect in the formation of new bone tissue in vivo might be clarified. Furthermore, if all these aspects showed 
promising properties for bone tissue engineering will be relevant to scale-up the production of 
superparamagnetic microspheres, thus to facilitate the future clinical trials and future microspheres 
commercialization.  
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Annex I 
	  
Preliminary investigations on microspheres production with low amount of mineral phase 
 
Brief introduction 
Preliminary investigations on microspheres production were performed during the secondment in Fujifilm 
Manufacturing Europe B.V. (The Netherlands). RCP was mineralised with iron doped hydroxyapatite at 25 
°C and 40 °C with mineral extend of 10 wt% and final biomineralised slurry contained 5 wt% of RCP. 
Chemical, physical, morphological, degradation and preliminary tests on magnetisation were presented. 
Those results were fundamental to define the appropriate characterisation techniques as well as the feasibility 
of DHT crosslinking method. 
 
Materials and Methods   
Chemical, physical and morphological characterisation were followed the information presented in the 
chapter 2.  
 
Results  
Phase composition was presented in the section 3.1.2. SEM results showed that the emulsification process 
allowed to produce microspheres with different materials and properties (Figure 1). RCP microspheres 
presented a smooth surface and well defined geometry. Biomineralised microspheres exhibited a roughness 
surface and heterogeneous size and shape. On the other hand, biomineralised magnetic microspheres at 25°C 
showed higher roughness compared to the samples biomineralised at 40°C.  
 
 
Figure 1. SEM micrographs of the as-produced microspheres A) RCP; B) RCP/HA (90:10, 40 °C); C) 
RCP/FeHA (90:10; 3:2; 25 °C); D) RCP/FeHA (90:10; 3:2; 40 °C); E) RCP/FeHA (90:10; 5:4; 40 °C).   
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The amount of different elements (Ca, P and Fe) in the microspheres was determined by ICP-OES (Table 1). 
RCP and RCP/HA microspheres were used as control materials. In RCP microspheres Ca, P and Fe were 
detected. The presence of these elements is likely related to the used method in the development of RCP. For 
example, gelatin obtained by denaturation of collagen contains divalent metal ions, such as calcium, copper, 
iron and zinc that can form ionic bonds with the carboxylic acid groups on the gelatin polypeptides (Xing et 
al. 2014).   
By comparing RCP/FeHA 25°C (3:2) and RCP/FeHA 40°C (3:2), the real amount of Fe in the samples was 
higher at 40 °C, indicating that the temperature favoured the entrance of iron into the crystal lattice 
(Tampieri et al. 2014). Decrease in Ca/P ratio was showed and is close to the theoretical one Ca/P ratio 
(1.67). Probably, this behaviour was related to the nucleation of Fe and partial replacement of Ca with Fe 
ions, which was also confirmed by XRD analysis. TGA analyses were performed to evaluate the mineral 
amount inside of the biomineralized samples. The theoretical ratio composition of the hybrid microspheres 
(RCP/HA and RCP/FeHA) was 90:10wt%. Mineral amount in the mineralised materials range between 20-
30 wt%, as reported in table 1.  
 
Table 1. Chemical amount evaluation and mineral composition of the microspheres, obtained by a ICP-OES 
and b TGA/DSC analysis.  
  
RCP  RCP/HA  
RCP/FeHA (90:10, 
3:2, 25ºC) 
RCP/FeHA (90:10, 
3:2, 40ºC) 
RCP/FeHA (90:10, 
5:4, 40ºC) 
Ca (wt%)a 0.046±0.01 0.563±0.03 0.321±0.01 0.379±0.01 0.409±0.02 
P (wt%)a 0.172±0.02 0.272±0.02 0.120±0.05 0.118±0.04 0.184±0.03 
Fe (wt%)a 0.005±0.01 --- 0.071±0.01 0.073±0.01 0.082±0.01 
Ca/P (mol)a  0.210±0.11 1.597±0.34 2.067±2.05 2.488±1.87 1.716±0.69 
(Fe+Ca)/P (mol)a 0.226±0.11 --- 2.397±2.37 2.832±2.13 1.965±0.79 
Fe/Ca  (mol %)a 7.376±6.29 --- 15.945±2.73 13.797±2.03 14.541±2.19 
Fe/(Ca+Fe) (mol %) a 0.069±0.06 --- 0.137±0.02 0.121±0.02 0.127±0.02 
% of organic phase in 
the samples (≈)b  
90 78:22 78:22 82:18 70:30 
 
Hybrid microspheres with Fe were preliminary tested to assess magnetization by using a neodymium magnet 
(Figure 2) and all biomineralised microspheres presented magnetic behaviour. According to the ICP results 
the sample produced at 25°C probably have less magnetization compared to the samples produced at 40°C. 
Analysing the samples produced at 40°C, the sample with 3:2 (Fe2+/Fe3+) ratio present better magnetic 
properties. These preliminary tests allow to concluded that the temperature and the (Fe2+/Fe3+) ratio are 
important parameters to produce magnetic microspheres for further tissue engineering applications.    
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Figure 2. Preliminary evaluation of magnetic properties of the microspheres, by neodymium magnet.   
 
DHT treatment was carried out by placing the dried magnetic microspheres in separately aluminium foil 
packet inside an oven at 160°C, during 24h and 48h.  
Figure 3 shows the morphological properties of microspheres obtained by SEM after 24h and 48h of DHT 
treatment. The results showed that the geometry, morphology and microspheres size were not affected by the 
treatment. The roughness morphology was due to the presence of the mineral phase on the surface of the 
microspheres. 
 
Figure 3. Crosslinked microspheres, A) RCP; B) RCP/HA (90:10, 40 °C); C) RCP/FeHA (90:10; 3:2; 25 
°C); D) RCP/FeHA (90:10; 3:2; 40°C); E) RCP/FeHA (90:10; 5:4; 40°C), (Scale bar: 20 µm).     
 
The following results were referred to RCP/FeHA (90:10; 3:2; 40°C) microspheres. As showed in the 
previous results, apparently the DHT method did not influence the microspheres properties. According to 
this, the thermal, chemical and magnetic properties of the magnetic microspheres were also evaluated. In the 
DSC graph (Figure 4, left), three relevant peaks were showed: water loss of RCP (≈ 80 °C), DHT 
crosslinking temperature (≈ 160 °C) and the starting point of polymer degradation (at ≈ 260 °C). All samples 
present similar thermal behaviour, in terms of denaturation and degradation starting point. The results 
indicated that the temperature and the exposition time of the material to DHT treatment do not influence the 
thermal properties and no evident material degradation was occurred. Figure 4 (right), shows the real amount 
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of organic phase present in the microspheres before and after treatment, that also does not reveal significant 
changes on the as-produced materials, after DHT crosslinking.     
 
 
Figure 4. Thermal properties of the materials before and after DHT crosslinking, a) RCP; b) RCP/FeHA (40 
ºC, 3:2), t = 0; c) RCP/FeHA (40 ºC, 3:2), t = 24h; d) RCP/FeHA (40 ºC, 3:2), t = 48h, (Desnt) RCP 
desnaturation; DHTTrtm) temperature used in the DHT treatment; Startdeg) starting the degradation of RCP). 
 
The effect of crosslinking processes on organic-inorganic interactions and on the phase composition of the 
samples was evaluated by FTIR (Figure 5A) and XRD (Figure 5B), respectively.  
The FTIR spectra of RCP before crosslinking treatment showed three main peaks of amide groups 
(≈1240cm-1 (Amide I), 1550cm-1 (Amide II), 1650cm-1 (Amide III)). The biomineralized samples also 
presented the main peaks of RCP and endorse the presence of calcium phosphate (CaP) nucleated into RCP 
structure, indicated by ≈1026cm-1 asymmetrical stretching (ν3) of PO43− from apatite (Wei et al. 2014; Cai et 
al. 2011), ≈960cm-1 very weak peak that correspond to ν1PO43−, presence of CaP in RCP material, ≈ 870cm-1 
ν2CO3 vibrational mode that can substitute for PO43− in the HAp lattice (Chang et al. 2006; Wei et al. 2014). 
Regarding to the spectrums after DHT treatment, main groups of RCP and CaP were presented. The decrease 
of intensity of Amide II peak, ≈1553 cm-1, indicated the conversion of RCP free amide groups to amine 
groups (Haugh et al. 2009).   
The effect of temperature and exposition time of DHT crosslinking on the phase composition of hybrid 
magnetic was analysed by XRD. XRD pattern (Figure 5B) before and after DHT presents a broad peak at 
≈20 2θ° (*), due to the higher amount of RCP into bio-hybrid materials and also were presented the 
characteristic peaks of hydroxyapatite (** in Figure 5) (Koutsopoulos, 2002). This result indicates that the 
temperature and the exposition time do not influence the phase composition of the materials and also do not 
induce formation of any secondary phase, such as magnetite. It is also evident the maintenance of the 
magnetic properties after 24h and 48h of treatment (Figure 5C). 
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Figure 5. Chemical and magnetic characterisation of the magnetic microspheres analysed by FTIR (A), 
XRD (B) and neodymium magnet (C), (£) RCP; a) RCP/FeHA (90:10; 3:2; 20 mol %), t = 24h; b) 
RCP/FeHA (90:10; 3:2; 20 mol %), t = 48h; §) RCP/FeHA (90:10; 3:2; 20 mol %), t = 0).  
 
Investigations on the swelling ratios were carried out by immersing the samples in PBS solution (pH 7.4), 
during 24h. The sample used in this study was RCP/FeHA (90:10; 3:2; 40°C), after 24h of DHT 
crosslinking. Optical microscope was used to evaluate the microspheres size at different times. Optical 
micrographs (Figure 6) show an increase of the particle size and a well-defined geometry, due to the medium 
absorption. According to the results of the optical micrographs and the graph (Figure 6 A, 6 B) it is possible 
to observe a higher absorption of medium, during the first hours. After that, magnetic microspheres reach the 
equilibrium state, which is due to the osmotic phenomena that promote a relaxation of the hybrid material 
matrix (Valente et al. 2013). Microspheres composed by iron doped hydroxyapatite presented less water 
content due to the interaction of FeHA with RCP matrix, that reduce the hydrophilicity of RCP by the 
electrostatic binding of carboxyl or amine groups with calcium and phosphate (Figure 6B) (Lee et al. 2014). 
 
Figure 6. Swelling ratio and water content of RCP/FeHA (90:10; 3:2; 40°C), after 24h DHT crosslinking. 
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Magnetic microspheres (i.e. RCP/FeHA (90:10; 3:2; 40°C)) were immersed in PBS solution (pH 7.4) and 
placed on orbital incubator at ≈100rpm, at 37°C, during 30 days and the medium was replaced 3 times. 
Morphological, chemical, thermal and magnetic preliminary characterisation was performed in order to 
evaluate the stability/degradation of the magnetic particles after 30 days immersed in PBS.  
Figure 7 presents the surface morphology of the microspheres before and after 30 days immersed in PBS. 
SEM micrographs show that after 30 days in PBS the surface morphology became rougher and also a 
decrease of particles size was evident, probably due to the degradation of RCP in the microspheres. This 
result was also confirmed by FTIR (Figure 8A) and TGA (Figure 8B) analysis. Looking to the crosslinked 
hybrid magnetic materials after 30 days of immersion in PBS, peaks at ≈ 601 cm-1 and ≈ 566 cm-1 appeared. 
These two peaks are related to the triply degenerated bending mode of ν4PO4 of calcium phosphate 
(Delgado-López et al. 2012); probably this can indicate some degradation of RCP on magnetic microspheres. 
Regarding to the thermogravimetric graph (Figure 8B), the samples without and with treatment present a 
similar weight loss. After 30 days of immersion in PBS in both situations the degradation of the organic 
material occurred. Comparing to the organic material percentage on the microspheres after 30 days in PBS, 
the weight loss was approximately of 20% and 8.75%, respectively to t=24h and t=48h of DHT treatment. 
After 30 days immersed in PBS the magnetic properties were still evident in the samples (Figure 8C).  
 
 
Figure 7. Morphological characterisation after immersed during 30 days in PBS.  
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Figure 8. Magnetic microspheres (RCP/FeHA (90:10, 40 °C)) evaluation after 30 days immersed in PBS. A) 
Chemical characterisation; B) Thermal characterisation; C) Preliminary magnetic properties, (a) no 
crosslinked; b) crosslinked at t= 24h; c) crosslinked at t = 48h; d) crosslinked at t = 24h and after 30 days; e) 
crosslinked at t = 48h and after 30 days).  
 
Final remarks 
- Microspheres were produced by emulsification process;  
- Dehydrothermal crosslinking enable suitable crosslinking of the microspheres, after 24h and 48h; 
- DHT process does not influence the morphological, chemical, thermal and magnetic properties of the 
samples;  
- No evident presence of secondary phases after DHT crosslinking; 
- Magnetic microspheres presented higher swelling ratio and water content after 24h immersed in 
PBS; 
- After 30 days immersed in PBS the degradation of the microspheres was observed by morphological, 
chemical and thermal characterisation, while magnetic properties were not influenced. 
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